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Embryonic stem cells (ESCs) are pluripotent cells derived from the early embryo and 
are able to differentiate into cells belonging to the three germ layers. They are a 
valuable tool in research and for clinical use, but their applications are limited by 
ethical and technical issues. 
In 2006 a breakthrough report described the generation of induced pluripotent stem 
cells (iPSCs). IPSCs are ESC-like cells generated from somatic cells by forcing the 
ectopic expression of specific transcription factors. This circumvents the ethical 
issues about the use of embryos in research and provides multiple opportunities to 
understand the mechanisms behind pluripotency. 
The aim of this project was to generate sheep iPSCs and characterise them. In order 
to learn the technique I initially repeated the original iPSC methodology: the putative 
mouse iPSCs I have generated display a morphology typical of ESCs, characterised 
by a high nuclear to cytoplasmic ratio, and form colonies with neat edges and smooth 
domes. These cells are positive to Nanog, a marker of pluripotency, and can give rise 
to cells belonging to the mesodermal and the ectodermal lineages when differentiated 
in vitro. Since the main aim of the thesis was the derivation of sheep pluripotent 
cells, once established the protocol in mouse, I then moved to the generation of ovine 
iPSC colonies. The cells I have generated have a morphology similar to that of 
mouse ESCs, express markers of pluripotency such as alkaline phosphatase and 
Nanog and can differentiate in vitro and in vivo into cells belonging to the three germ 
layers. Additionally, these ovine iPSCs can contribute to live born chimeric lambs, 






"I have always believed that in the lives of individuals, just as in society at large, the 
profoundest changes take place within a very reduced time frame. When we least 
expect it, life sets us a challenge to test our courage and willingness to change; at 
such a moment, there is no point in pretending that nothing has happened or in 
saying that we are not yet ready. 
 
The challenge will not wait. Life does not look back. A week is more than enough 
time for us to decide whether or not to accept our destiny." 
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1.1 The embryo 
The embryo is generated by the fecundation of the female gamete (oocyte) by the 
male gamete (sperm). Approximately 24 hours after fertilization the so generated 
zygote starts dividing exponentially until the morula stage, when compaction 
happens and cells on the outer part of the morula become bound tightly together with 
the formation of desmosomes and gap junctions; previously discrete cells become 
indistinguishable. A central cavity, the blastocoele, begins to form and the embryo 
becomes a hollow ball of cells, the blastocyst. At the morula-blastocyst stage the first 
event of differentiation occurs: two distinct cell populations arise; the cells remaining 
in contact with the outside are destined to form the trophoblast, while the cells inside 
will form the inner cell mass, ICM (Fig. 1). The trophoblast will give rise to most of 
the extra embryonic tissues, while the ICM will give rise to the whole animal and 
some more embryonic tissues. While the embryo develops, the ICM cells continue 
dividing and are responsible for the second event of differentiation: the cells facing 
the blastocoele become primitive endoderm, which will form the extraembryonic 
endoderm, while the inner cells will give rise to the epiblast, which is the precursor 
of the whole individual (Zernicka-Goetz, 2005). 
 
1.2 Embryonic stem cells 
 
1.2.1 What are stem cells? 
Stem cells are defined as undifferentiated cells presenting two main characteristics: 






Figure 1. A representation of the early stages of embryo development: once fertilised, the zygote starts 
dividing becoming morula first and then blastocyst. All stages are shown in the same orientation. In 
the zygote, the female pronucleus is labelled in red, while the male pronucleus is labelled in blue. The 
second polar body is present at the animal pole. From the 2-cell stage to the beginning of the 8-cell 
stage all blastomeres are round, but then they flatten giving rise to the process of compaction and 
undergo apical–basal polarization (shown by blue to yellow gradient). Yellow circles represent the 
cell nuclei, which are shown only up to the 8-cell-stage. At the morula, the embryo consists of both 
inside (yellow) and outside (light blue) cells. At the blastocyst, inner cells form the inner cell mass 
(yellow), which is surrounded by polar trophectoderm (light blue) whereas the mural trophectoderm 




Self-renewal is the ability of the cells to go through numerous cycles of division 
while maintaining the undifferentiated state; differentiation occurs when the 
undifferentiated cells give rise to one or more specialized cells. According to the 
types of differentiated cells that can be generated from them, stem cells are classified 
into different categories: 
- totipotent stem cells: cells that can differentiate into all embryonic and extra 
embryonic cell types (e.g. fertilized egg); 
- pluripotent stem cells: they can develop into any cell of the three germ layers 
(endoderm, mesoderm, ectoderm), but are not able to generate 
extraembryonic tissues (e.g. cells from the epiblast); 
- multipotent stem cells: cells that can give rise to cell types only within one 
particular lineage (e.g.  hematopoietic stem cells); 
- unipotent stem cells: they can only differentiate into one cell type, but have 
the property of self-renewal which distinguishes them from terminally 
differentiated cells (e.g. keratinocyte stem cells). 
 
Stem cells are also generally divided into two overall classes: embryonic stem cells 
(ESCs) and adult stem cells (ASCs). As the names suggest, ESCs are stem cells 
derived from the embryo, while ASCs are present in the postnatal animal, where they 
are responsible for the replacement of tissues during the normal turnover or as a 
result of injury (Dor and Melton, 2004). ASCs have a restricted differentiation 
potential compared with ESCs, since they can often give rise only to cells belonging 







Figure 2. A schematic diagram of the key features of stem cells: stem cells (green in the image, are 
round and are characterised by a high nuclear-to-cytoplasmic ratio) can proliferate maintaining their 
undifferentiated status or differentiate towards more specialised cells (red in the figure, usually have a 




ESCs exist only transiently in the blastocyst, meaning that they do not exist as cells 
in vivo, but are only defined as a cell line in vitro. 
 
1.2.2 Embryonic stem cells 
ESCs belong to the class of pluripotent stem cells and can give rise to any cell type 
of an adult animal (Smith, 2006). ESCs are cell lines derived from the ICM of the 
blastocyst. 
ESC isolation was the outcome of earlier observations about the ability of the 
embryo to give rise to tumours composed of different cell types (teratocarcinomas) 
after a graft into a mouse (Stevens, 1968; Solter, 1970; Stevens, 1970) and was 
supported by the evidence that embryonal carcinoma cell lines cultured in the 
presence of fibroblasts were characterised by a broad differentiation potential. 
Although ESCs derive from the ICM, they are not identical to those cells: in vivo 
pluripotent cells exist only transiently, while in vitro ESCs represent cell lines which 
can be kept indefinitely. The maintenance in culture changes ESC properties; ESCs 
are therefore a useful model for the understanding of the processes unfolding in the 
early embryo, but are not entirely equivalent to the cells in the ICM. 
 
After isolation, ESCs are normally characterised following a precise protocol 
(Robertson, 1987): 
- morphological criteria: colonies must be round and domed, with defined 




- immunocytochemistry and/or RT-PCR to evaluate the expression of markers 
of the pluripotency (e.g. Nanog, Oct4, Sox2) and the absence of markers 
typical of more differentiated cells (Robertson, 1987); 
- in vitro differentiation followed by immunocytochemistry and/or RT-PCR to 
confirm that the cells can give rise to differentiated cells belonging to all 
three germ layers (Doetschman, 1985); 
- in vivo differentiation to verify whether the cells can differentiated into the 
three lineages even in a more complex biological system; 
- injection into blastocysts to show that ESCs can contribute to different tissues 
of an adult animal, forming chimeras (Nagy, 1990); 
- germ line transmission: it means that, after generating a chimera, ESCs are 
found in the germ cell population of the adult animal and can generate 
offspring; 
- tetraploid complementation: ESCs are inoculated in tetraploid embryos; the 
foetus will be exclusively derived from the ESCs, while the 
extraembryonic tissues are exclusively derived from the tetraploid cells 
(Nagy, 1993). 
The last two evidences are considered definitive proof of pluripotency. 
 
Authentic ESCs have been derived only from a few species; mouse ESCs were 
generated in 1981 and were the first pluripotent stem cells to be maintained in culture 
(Evans and Kaufman, 1981; Martin, 1981); rat ESCs were obtained much later, in 




to grow for virtually unlimited time and have passed the key test for pluripotency: 
the germline transmission (Bradley, 1984; Bradley, 1987; Li, 2008). 
Human ESCs have been derived too; yet their characteristics and culture conditions 
significantly differ from those employed for mouse and rat. This has raised doubts 
about the true nature of their pluripotency, but, for obvious reasons, chimera 
formation, germline transmission or tetraploid complementation have never been 
assessed.  
Many putative ESCs from other animals (e.g. pig, sheep, cow, horse, rabbit, dog, cat) 
have been described (Chen, 1999; Wang, 2005; Wobus and Boheler, 2005; Dattena, 
2006; Li, 2006; Vackova, 2007; Wang, 2007; Hayes, 2008; Gómez, 2010) but they 
lack of the final evidence of their pluripotency. Many ESC-like cells have been 
isolated either, but those cells, although pluripotent in the first few passages, soon 
differentiated (Saito, 1992; Dattena, 2006; Gómez, 2010).  
 
Because of their unique features, ESCs have drawn a lot of attention and have 
become a valuable tool in research and for clinical application. They represent a 
robust model to study the mechanism underlying pluripotency and can be used to 
better understand biochemical pathways that drive differentiation and senescence. 
The knowledge of how the cell decide their fate represents the first step for the 
comprehension of developmental biology; this will eventually lead to gaining the 
ability to manipulate stem cells to achieve our goals. 
ESCs can provide an in vitro model of mammalian development and can represent a 
valuable system for drug discovery and for toxicology tests and in the future may 




theoretically provide a limitless source of cell types which could be used to treat 
degenerative diseases such as type I diabetes or Parkinson’s disease (Gardner, 2007). 
These cells have revolutionized the field of transgenesis allowing the selection of 
mutant cells before senescence sets in, thus making possible the creation of cell lines 
carrying specific mutation typical of different disease (Gossler, 1986; Liew, 2005; 
Alenzi, 2010). Due to their ability to contribute to adult animals and go germline, 
ESCs have made also possible the generation of knockout or knock-in animals as 
models of human disease (Ben-Nun and Benvenisty, 2006) or to produce humanized 
tissues for xenotransplantation (Yamada, 2005; Oropeza, 2009). 
 
ESCs, however, undergo several limitations due to the difficulty of their derivation. 
True ESCs have been derived from mouse (Evans and Kaufman, 1981; Martin, 
1981), rat (Buehr, 2008; Li, 2008) and human (Thomson, 1998), even though 
controversies regard the exact definition of the latter (Brons, 2007; Tesar, 2007). The 
derivation of ESCs from other species have been hampered mainly by technical 
problems: the conditions for the isolation of ESCs vary among species; in order to 
find the correct cocktail of cytokines and growth factors able to sustain pluripotency 
many attempts must be carried out. So a large number of embryos must be employed 
in order to pursue and identify the suitable conditions; this can be easy in case of the 
small laboratory animals, such as mouse and rat, that produce a large amount of 
embryos with little cost and little time limitations. However, the generation of 
embryos from large animals is time consuming and very expensive and often the 




horse, are seasonal, so the access to their embryos is limited only to a part of the 
year. 
In parallel the use of human ESCs has given rise to an important debate about moral 
and religious issues: since these cells are created from an embryo, for those who 
believe that the embryo has the moral status of a person from the moment of 
conception, research or any other activity on the blastocyst means the destruction of 
a human life and is therefore ethically wrong. 
The use of ESCs as a source of tissues for the use in therapy is hampered by the 
difficulty to differentiate the cells towards a specific fate, by issues such as immune 
rejection and by the risks associated with the difficult selection of the differentiated 
cells to be injected for the therapy: even a little carry-over of pluripotent cells in the 
organism might induce cancer.   
 
1.3 Mouse embryonic stem cells 
The first mouse ESCs were derived in 1981 by two independent groups, which 
reported the direct isolation of pluripotent stem cell lines from the mouse embryo 
(Evans and Kaufman, 1981; Martin, 1981). Mouse ESCs were first derived by 
plating ICMs isolated from expanded blastocyst on a feeder layer composed of 
mitotically inactivated fibroblasts in medium conditioned by teratocarcinoma stem 
cells.  
 
1.3.1 LIF/BMP4 medium 
While conditioned medium was first used to derive and grow ESCs, with time the 




understood: the feeder layer was found to be dispensable when the cells were 
cultured in medium containing leukaemia inhibitory factor, LIF (Smith, 1988; 
Williams, 1988) and, in 2003, the first defined conditions for mouse ESC culture 
were established. A serum-free medium containing the supplements N2 and B27 
(Ying, 2003) and supplemented with LIF and BMP4 was sufficient for the derivation 
and propagation of pluripotent ESCs. 
 
Leukaemia inhibitory factor. LIF, a member of the IL6 cytokine family, fulfils its 
role by binding to the glycoprotein 130 (gp130) which then heterodimerizes with LIF 
receptor (LIFR); both gp130 and LIFR are members of the cytokine receptor family. 
This interaction leads to the recruitment and subsequent activation of at least three 
different pathways: JAK/STAT, Ras/ERK and PI3K (Fig. 3). 
 
JAK/STAT (Janus kinase/signal transducer and activator of transcription) pathway: 
the activation and autophosphorylation of the tyrosine kinase JAK promotes STAT3 
phosphorylation and dimerization. STAT3 homodimers translocate to the nucleus 
where they bind to a consensus DNA sequence in the promoter of its target genes to 
regulate transcription and promote self-renewal. 
Although many STAT3 target genes still remain elusive, some of them have been 
identified; cMyc (Kiuchi, 1999) for example has a significant role in self-renewal: its 
constitutive expression causes ESC self-renewal to be independent from LIF 
(Cartwright, 2005). Myc also confers increased proliferative capacity to the cells, 
acting through the induction of the regulatory subunit of the telomerase and being 




Eilers, 2005). Another identified target of STAT3 is the transcription factor Klf4 (Li, 
2005), which is a zinc finger transcription factor that contributes to self-renewal 
through a dual mechanism: Klf4 increases expression of Oct4 (Jiang, 2008), which is 
a master regulator of pluripotency, and downregulates p53 expression (Rowland, 
2005), which, in turns, blocks the expression of Nanog (Lin, 2005), another key 
regulator of pluripotency (Zindy, 1998). 
 
Ras/ERK (extracellular-signal-related kinase) pathway: in addition to STAT3, LIF 
can also activate the Ras/ERK pathway, which starts from the activation of the 
GTPase Ras, with subsequent activation of Raf, MEK and finally ERK, whose role is 
the stimulation of the transcription of target genes. In contrast to STAT3, the 
Ras/ERK pathway is responsible for cellular differentiation through inhibition of 
Nanog expression (Burdon, 1999; Hamazaki, 2006). Despite this, ESCs can maintain 
their pluripotency because the Ras/ERK pathway is suppressed by BMP4 (Qi, 2004). 
 
PI3K (phosphoinositide-3 kinase) pathway: when activated by the dimerization of 
gp130 and LIFR, PI3K maintains self-renewal by activating Akt (Watanabe, 2006), a 
protein kinase B (PKB) that inhibits glycogen synthase kinase 3β (GSK3β). GSK3β 
is a major inhibitor of the Wnt/β-catenin pathway, which is involved in the 
maintenance of pluripotency (Sato, 2004; Hao, 2006; Ogawa, 2006) furthermore, 
GSK3β activates p53 which, as already mentioned, promotes differentiation of 
mouse ESCs by suppressing Nanog expression (Lin, 2005; Liu, 2007b). AKT is also 
involved in survival and proliferation because it promotes a quick G1 to S phase 







Figure 3. The figure summarises the main pathways that are stimulated by the interaction between LIF 
with its receptor in mouse ESCs. The binding of LIF to the LIFR induces its heterodimerization with 
gp130. The formation of this complex results in the activation of the JAKs and finally in the 
recruitment of Src homology-2 (SH2) domain containing proteins such as STAT3. When bound to the 
receptor, STAT3 directly targets gene promoters by homodimerizing and translocating to the nucleus 
of the cell, without the need for second messengers. 
In parallel to the activation of the STAT3-pathway, the binding of LIF to the its receptor leads to the 
activation of the mitogen-activated protein kinase (MAPK) and the PI3K pathways. Active gp130 
receptor associates with the protein tyrosine phosphatase SHP-2 and leads to the recruitment of 
GRB2-associated-binding protein 1 (Gab1). The so formed complex starts a phosphorylation cascade 
that ends in the activation of the ERK kinases. 
LIF binding to the LIFRβ/gp130 receptor also induces the activation of PI3Ks, which mediate signal 
transduction through downstream effector molecules including the serine/threonine protein kinase B 




Bone morphogenetic protein 4. Mouse ESCs grown in the presence of LIF, but in the 
absence of serum differentiate towards the neuronal lineage. This means that LIF 
does not inhibit neural differentiation, but an additional signal is required to suppress 
the differentiation and sustain self-renewal. This signal is provided by BMP4, which 
acts inhibiting the Ras/ERK pathway and activating the Smad transcription factors. 
This leads to the expression of the inhibitor of differentiation protein, which blocks 
the neural differentiation (Ying, 2003; Gerrard, 2005). 
 
1.3.2 3i medium 
For almost thirty years the medium supplemented with LIF and serum or BMP4 had 
been the only culture condition known to maintain pluripotency in mouse ESCs. In 
2008, however, Ying et al (Ying, 2008) reported that ESCs do not require any 
external signalling, but have an intrinsic plan for the maintenance of pluripotency. 
This was evidenced with the introduction of the  3i medium, which is based on 
N2B27 and is supplemented with three inhibitors (PD184352, SU5402 and 
CHIR99021) is able to maintain ESC self-renewal without the addition of LIF or 
BMP4. The medium bases its effect solely upon inhibition of the differentiation 
pathways and the stimulation of the proliferation. PD184352 and SU5402 both act on 
the ERK pathway: the former is a MEK inhibitor, while the latter operates upstream, 
blocking the activation of the FGF receptor in response to the binding with its ligand. 
This prevents the cells to respond to FGF signalling cascade, which consists in the 
activation of the ERK and PI3K pathways. While PD184352 and SU5402 maintain 





Later an optimised medium named 2i medium, based on only two inhibitors 
(PD0325901 and CHIRON99021) was developed: in the new medium PD184352 
and SU5402 were replaced by a more potent MEK inhibitor, which alone proved to 
be sufficient to switch off the ERK pathway. 
Surprisingly the STAT3 signalling, which was considered the key pathway involved 
in the maintenance of pluripotency, is dispensable when ESCs are grown in 3i or 2i 
media, as demonstrated by the derivation of mouse ESCs from STAT3-null 
homozygous mutant embryos (Ying, 2008). 
 
1.3.3 Transcriptional network controlling pluripotency 
Pluripotency is sustained through the tight regulation of gene expression which is 
coordinated by a small group of key transcription factors: Oct4, Sox2 and Nanog 
(Fig. 4). 
Oct4 and Sox2 form a complex which can bind enhancer elements close to each 
other in the promoter of target genes. One of the most important targets of 
Oct4-Sox2 complexes is Nanog (Rodda, 2005). When Oct4 is expressed at 
physiological levels Nanog transcription is activated, whereas when Oct4 is 
overexpressed Nanog is not transcribed (Rodda, 2005; Chambers and Tomlinson, 
2009). Additionally both Sox2 and Oct4 promoters contain the Oct4-Sox2 complex 
recognition elements; this means that they can reciprocally regulate their own 
expression (Tomioka, 2002; Chew, 2005). Sox2 also sustains Oct4 transcription by 
indirectly regulating the expression of other transcription factors that affect Oct4. 
Oct4 regulates itself too: when its expression levels rise above the steady state level, 







Figure 4. Oct4 (in the yellow circle), Nanog (in the blue circle) and Sox2 (in the red circle) are the 
master regulators of pluripotency and act in a complex network regulating their own and each other 
expression (auto-regulatory and cross-regulatory transcriptional loops are shown with arrows; the 
interactions carried out by Oct4 are represented by the yellow arrows, the interactions carried out by 
Nanog are represented by the blue arrows and the interactions carried out by Sox2 are represented by 




This inhibits Oct4 expression, which in turn represses Nanog transcription. 
Conversely, Nanog and FoxD3 function as activators for Oct4 expression. 
 
Oct4 (octamer-binding transcription factor 4) belongs to the family of POU (Pit, Oct, 
Unc) transcription factor, which is characterized by a bipartite DNA binding domain 
called POU domain (Scholer, 1991a; Herr and Cleary, 1995). The POU domain 
consists of two structurally independent subdomains: an N-terminal POU specific 
region (POUs), which is unique to each POU factor, and a C-terminal homeodomain 
(POUh) (Scholer, 1991a). These two domains are connected by a variable linker, 
both can make specific contacts with DNA through a helix-turn-helix structure and 
have a role in transactivation (Vigano and Staudt, 1996; Brehm, 1997), but while the 
activity of the C-domain is cell type specific and is regulated through 
phosphorylation, the activity of the N-domain is not (Brehm, 1997; Brehm, 1998; 
Brehm, 1999). 
In mouse Oct4 is expressed specifically in pluripotent and totipotent cells:  in vivo it 
is expressed in the embryo from the embryonic transcriptional activation till the ICM 
and then the epiblast of the blastocyst stage; Oct4 expression is later restricted to the 
primordial germ cells and undergoes downregulation during oogenesis and 
spermatogenesis (Pesce, 1998b; Pesce and Scholer, 2001). In vitro Oct4 is 
upregulated in ESC lines and carcinoma cell lines (Pan, 2002).  
Studies suggest that the expression pattern and function of Oct4 are very similar 
between mouse and human cells (Hansis, 2000; Hansis, 2001; Hay, 2004). 
Oct4 expression is continuously required for the maintenance of pluripotency: Oct4 




in somatic cells after cell fusion with ESCs (Tada, 2001; Kimura, 2004) or after 
nuclear transfer into oocytes (Boiani, 2002; Bortvin, 2003). Oct4 controls the 
pluripotency of stem cells in a quantitative fashion and very small changes in its 
expression level can have significant impact on cell fate and growth properties 
(Niwa, 2000; Niwa, 2001; Hay, 2004): Oct4 maintains pluripotency in ESCs when 
expressed at steady level, but promotes cellular differentiation into endoderm and 
mesoderm when expressed 1.5 fold higher than normal; a greater than 0.5 fold 
reduction of Oct4 level causes cells to differentiate into trophoblast instead (Niwa, 
2000). This is consistent with the observation that embryos lacking Oct4 form 
outgrowths consisting entirely of trophoblast-like cells when plated on gelatin 
(Nichols, 1998). Although Oct4 is a master regulator of pluripotency, its expression 
alone is not sufficient: removal of LIF results in differentiation even if Oct4 is 
maintained at a proper level by an inducible transgene (Niwa, 2001). 
Oct4 is a transcription factor that can both activate and repress target genes (Pan, 
2002). Oct4 promotes transcription through two main mechanisms: by directly 
binding to POU sites immediately upstream to the promoter, where it can synergize 
with other transcription factors, or by binding sites located at a considerable distance 
from the target gene; in this case adaptor proteins must be involved to bridge Oct4 to 
the basic transcription machinery near the target gene. Oct4 represses gene 
expression either directly, by binding to promoters or indirectly, by neutralizing 
activators such as FOXD3. 
Oct4 target genes are classified into three groups based on their response to Oct4: 




that are activated at physiological levels, but are repressed at high levels of Oct4 
(Scholer, 1991b). 
Many Oct4 target genes have been identified: fibroblast growth factor 4 (FGF4), 
osteopontin, Sox2, Utf1, Rex1, Fbx15, Nanog, Cdx2, INFτ and both α and ß forms of 
human chorionic gonadotropin (hCG) (Pesce, 1998a; Okumura-Nakanishi, 2005; 
Liu, 2007a). 
FGF4 is expressed by the ICM and is necessary for development shortly after 
implantation (Feldman, 1995); Oct4 activates this element synergistically with Sox2 
(Yuan, 1995). 
Oct4 together with Sox2 also regulates Nanog expression: analyses of Nanog 5' 
promoter region have revealed a composite Oct4/Sox2 site upstream of the 
transcription start which is important for Nanog regulation (Kuroda, 2005; Rodda, 
2005): when Oct4 is at a physiological level, Nanog transcription is activated, 
whereas when Oct4 is above the normal level Nanog expression is repressed. 
Oct4 acts as a repressor of the genes coding for α and ß hCG (Liu, 1997) and for 
Cdx2 (Niwa, 2005), a marker of trophoblast; indeed when Oct4 is inhibited in ESCs, 
the cells differentiate towards the trophoblast lineage (Niwa, 2005; Pan, 2006). When 
Cdx2 is overexpressed, however, differentiation in trophoblast happens even though 
the levels of Oct4 are physiological; this also suggests that that loss of Oct4 
expression is not required for differentiation. 
Finally, Oct4 regulates itself: when its expression levels rise above steady state 
levels, Oct4 represses its own promoter in a negative feedback regulation loop (Pan, 





Sox2 (Sex determining region Y box 2) is a member of the SRY-related high 
mobility group (HGM) box family of transcription factors (Gubbay, 1990; Sinclair, 
1990; Wegner, 1999). 
Sox2 expression pattern is similar to that of Oct4; with Sox2 detectable from the 
oocyte to the blastocyst stage, and later becomes restricted to the ICM and the 
epiblast and finally to the germ cells and the neural stem cells (Li, 1998; Zappone, 
2000; Avilion, 2003). Sox2 downregulation correlates with a commitment to 
differentiate, since this protein is no longer expressed in cell types with restricted 
developmental potential (Avilion, 2003). 
Sox2 protein interacts with DNA through the highly conserved HMG domain. 
Whereas the overall conformation of the HMG domain remains unaltered upon DNA 
binding, a large conformational change is induced into target DNA, such that its 
minor groove follows the concave binding surface of the HMG domain perfectly. As 
a consequence, DNA bound by Sox proteins is helically unwound relative to classical 
B-DNA (Ferrari, 1992; Weiss, 2001). 
Sox2 protein regulates different sets of target genes depending on the cell type in 
which the protein is expressed: it acts as a transcriptional activator after forming a 
protein complex with other proteins such as Oct4, Nanog and Rex1; such partner 
proteins are specifically expressed in different tissues, therefore, depending on the 
tissue, different sets of genes will be activated (Kamachi, 2000; Smith, 2001b; Shi, 
2006). 
 
Nanog was identified independently by two groups; through a functional cDNA 




through differential expression analysis in the other (Mitsui, 2003). Nanog is 
expressed first in the morula, then in the ICM of the blastocyst.  Nanog levels 
decrease in the late blastocyst where it become restricted to the epiblast. Nanog is 
also detected in primordial germ cells during the migration and the colonisation of 
the genital ridges, but is later downregulated. 
Nanog is a homeobox domain-containing protein expressed specifically in 
pluripotent cells. It acts as both transcription repressor of genes important in 
differentiation such as Gata4 and Gata6 (Chambers, 2003; Mitsui, 2003) and 
transcription activator of genes essential for self-renewal like Rex1(Shi, 2006) and 
Oct4 (Pan, 2006). 
Before the development of the 3i medium, Nanog was thought to hold a key role in 
maintaining the pluripotency of mouse ESCs. Indeed when Nanog is downregulated, 
ESCs acquire a morphology and express markers typical of endoderm, while its 
overexpression alone is able to sustain the undifferentiated state of the cells without 
the supplementation of the culture medium with LIF. This ability, however, requires 
a continued physiological expression of Oct4, as the downregulation of Oct4 leads to 
differentiation of the cells even when Nanog is upregulated (Cavaleri and Schöler, 
2003; Chambers, 2003). Although LIF is dispensable for pluripotency when Nanog is 
overexpressed, self-renewal occurs with higher efficiency when the cells are also 
stimulated with LIF; this indicates that Nanog and LIF function in parallel 
(Chambers, 2003). 
Although Nanog null cells retain the ability to contribute to chimeras, they cannot 
contribute to the germline, suggesting that Nanog may play a role in establishing the 




the support of self-renewal by protecting the pluripotent state of the cells (Chambers, 
2007). This is consistent with the reduction in spontaneous differentiation observed 
upon forced expression of Nanog (Chambers, 2003). 
 
1.4 Epiblast stem cells 
In 2007 a novel type of stem cells, named epiblast stem cells (EpiSCs), was derived 
from the mouse embryo. While mouse ESCs are derived from the ICM of the 
pre-implantation blastocyst, EpiSCs were isolated from the post-implantation 
epiblast (Brons, 2007; Tesar, 2007). The EpiSCs are able to self-renew, express 
numerous markers of pluripotency such as Oct4, Nanog and Sox2 at the same level 
of ESCs and can differentiate in vitro when grown in suspension as aggregates 
(Brons, 2007; Tesar, 2007); moreover EpiSCs can form, after injection into SCID 
mice, teratomas composed of many differentiated cell types, (Brons, 2007; Tesar, 
2007). These results indicate that EpiSCs have a wide developmental ability. 
Many features of EpiSCs, however, differ considerably from those of ESCs: EpiSC 
colonies are large and grow flat, while mouse ESCs typically grow in small, 
compact, domed colonies; unlike ESCs, EpiSCs are Rex1 negative and express FGF5 
and Nodal; while both X chromosomes are active in ESCs (Brons, 2007), EpiSCs 
correspond to a stage when X inactivation has already been initiated (Wutz, 2011). 
Most importantly, chimeric mice can be efficiently generated after injection of 
mouse ESCs into the pre-implantation embryo, while EpiSCs can generate chimeras 





EpiSCs rely on the supplementation of basic fibroblast growth factor (bFGF) and 
activin to proliferate and maintain their undifferentiated marks (Fig. 5). Removal of 
one of these molecules, in fact, leads to differentiation promoting rapid neural 
induction and subsequent neurogenesis (Greber, 2010; Sterneckert, 2010). Activin 
pathway promotes self-renewal of EpiSCs via activation of Nanog through activation 
of the SMAD2/3 transcription factors; on the other hand bFGF acts by activating the 
ERK pathway, which, instead of promoting differentiation as in mouse ESCs, 
inhibits lineage commitment (Greber, 2010). 
Initially it was believed that the differences observed between EpiSCs and ESCs 
were due to the developmental stage from which they were derived, but recently 
Najm et al (Najm, 2011) reported the isolation of EpiSCs from a pre-implantation 
embryo when culturing the ICM in bFGF and activin instead of LIF and BMP4 
(Najm, 2011). Additionally post-implantation-derived EpiSCs are able to revert into 
ESCs in response to LIF signalling (Bao, 2009). This process is characterised by the 
erasure of key properties of epiblast cells, resulting in DNA demethylation, X 
reactivation and expression of E-cadherin; furthermore the reverted cells are able to 
give chimera contribution in both somatic tissues and germ cells (Bao, 2009). 
 
1.5 Human embryonic stem cells 
Mouse ESCs had been the only pluripotent cell line available for many years, until 
1998, when Thomson et al (Thomson, 1998) developed a technique to isolate human 
ESCs. Initially human ESCs were grown in conditions very similar to those 







Figure 5. The main pathways activated in mouse EpiSCs: activin promotes Nanog expression, while 
FGF stimulates proliferation and inhibits cellular differentiation: the Activin pathway promotes 
self-renewal of EpiSCs via direct activation of Nanog, whereas inhibition of this pathway induces 
neuroectodermal differentiation, like in hESCs. FGF signalling appears to stabilize the epiblast state 
by inhibiting the differentiation towards neuroectoderm the reversion to a mouse embryonic stem 




ESCs could not be maintained in feeder-free culture utilising the same mouse 
conditions: indeed the supplementation of medium with LIF was not able to inhibit 
the differentiation (Thomson, 1998; Reubinoff, 2000; Daheron, 2004; Humphrey, 
2004). Currently, when human ESCs are grown in absence of feeder layer the 
medium employed consist in a serum-free culture medium supplemented with bFGF 
and activin (Beattie, 2005). 
Like mouse ESCs, human ESCs have the ability to self-renew for an undefined time 
and to differentiate towards somatic cells belonging to different lineages. They are 
both characterised by a high nuclear to cytoplasmic ratio (Wobus, 2001). They also 
have a similar expression pattern: they both show high AP levels, high telomerase 
activity and Nanog, Oct4 and Sox2 expression. 
Although there are many properties in common between mouse and human ESCs, 
many other features are different. Human ESCs, unlike mouse ESCs, form large, 
flattened colonies and although many cellular markers overlap with those of mouse 
ESCs, others are different. Murine ESCs express Rex1 and SSEA1, while human 
ESCs express these markers upon differentiation  (Draper and Fox, 2003). On the 
other hand human ESCs express SSEA3 and SSEA4, while their mouse counterparts 
do not. In addition human ESCs survive poorly when dissociated into single cells and 
exhibit X chromosome inactivation, while in mouse ESCs tolerate clonal densities 
and both X chromosomes are active. 
Those differences between human and mouse ESCs have raised many questions 
regarding the equivalence of the cells coming from the two species and in particular 




contribution of the ESCs to chimeras and germ cells, but for human this cannot be 
tested. 
 
The derivation of EpiSCs has underlined how human ESCs more closely resemble to 
these new cells than to mouse ESCs: human ESCs proliferate under the same culture 
conditions employed for EpiSCs and have an expression profile, a morphology and 
epigenetic marks more similar to that of those cells. 
These observations have led to the belief that human ESCs and mouse ESCs 
represent two distinct pluripotency states: whereas mouse ESCs are the early, naïve, 






1.6 Induced pluripotent stem cells 
 
1.6.1 Reprogramming differentiated cells 
Although ESCs are very useful tools in research and for clinical applications, the 
technical and ethical limitations related to their derivation have hampered their 
routine use. 
In order to avoid these concerns, attempts to create pluripotent cells without the use 
of any embryo have been pursued. For a long time it had been uncertain whether it 




Somatic cell nuclear transfer (SCNT) before (Campbell, 1996) and cell fusion later 
(Cowan, 2005) have clearly demonstrated that the cytoplasm of totipotent and 
pluripotent cells contain sufficient information to modify the nucleus of somatic cells 
to convert them back to a pluripotent state. Reprogramming requires that epigenetic 
marks of the differentiated cells are modified, allowing the expression of genes that 
have been silenced during development and, vice versa, impeding the translation of 
genes switched on when the differentiation process had started. 
 
1.6.2 Induced pluripotent stem cells 
SCNT and fusion results have revealed that ESCs and oocyte cytoplasms contain 
proteins able to reprogram a somatic nucleus. Based on this assumption, Takahashi 
and Yamanaka (Takahashi and Yamanaka, 2006) hypothesized that overexpression 
of specific pluripotent genes in differentiated cells could induce them to acquire 
embryonic properties. Twenty four factors, which were chosen among transcription 
factors, genes frequently upregulated in tumours as well as genes specifically 
expressed in ESCs, were selected as candidates for the direct reprogramming 
strategy. These genes were introduced in different combinations into mouse foetal 
fibroblasts (MFFs) and mouse tail tip fibroblasts by retroviral transduction with a 
Moloney murine leukaemia viral (MoMLV) vector. In order to assess whether the 
cells were able to acquire a more pluripotent state, fibroblasts were isolated from 
mice expressing a drug selection cassette (ßgeo) under the control of an ESC specific 
promoter (Fbx15), so that, if reprogramming had taken place, the fibroblasts would 





Among the 24 genes tested, 4 were found to be essential for the induction of 
pluripotency in somatic cells: cMyc, Klf4, Oct4 and Sox2. Colonies with 
morphology similar to that of ESCs and resistant to neomycin were generated. These 
cells, referred to as induced pluripotent stem cells (iPSCs), were tested for the salient 
features of authentic ESCs (Takahashi and Yamanaka, 2006). As ESCs, iPSCs 
exhibited immortal growth characteristics and were able to differentiate into the three 
germ layers in vitro and in vivo. 
 
1.6.3 The four genes 
Oct4 and Sox2 features and functions within the pluripotency network have been 
widely described above. During direct reprogramming the role of the exogenous 
expression of Oct4 and Sox2 might be to stimulate the basic transcriptional backbone 
necessary for the acquisition of the ESC-like properties. Klf4 is proposed to act in 
reprogramming as an upstream regulator of a larger loops addressing Oct4 and Sox2 
(Li, 2005); furthermore Klf4 is thought to be a regulator of Nanog and a potential 
regulator of Myc, as it binds the cMyc promoter (Kim, 2008a). Klf4 also inhibits 
p53, regulaing cMyc induced apoptosis (Rowland, 2005).  Additionally Klf4 
maintains Nanog levels high, since p53 is a repressor of Nanog expression (Zindy, 
1998). The last of the four reprogramming factors, cMyc, is not greatly involved in 
the activation of pluripotency regulators, but it plays an important role in the initial 
phases of reprogramming, in particular it is required to improve the efficiency of 





cMyc (myelocytomatosis cellular oncogene) belongs to the Myc family of 
transcription factors, which also includes L-myc, N-myc, S-Myc and B-Myc. 
Myc is characterized by an N-terminal transcription regulatory domain and by a 
C-terminal basic Helix-Loop-Helix Leucine Zipper (bHLH/LZ) domain, where the 
bHLH domain interacts with the DNA, while the LZ domain allows the dimerization 
of cMyc with other proteins (Steiger, 2008).  
Myc transcription is activated upon various mitogenic signals via the ERK pathway, 
the Wnt pathway and the STAT pathway and works as a transcription regulator both 
activating and repressing transcription of its target genes (Henriksson and Luscher, 
1996; Amati, 2001). 
In vivo, cMyc needs to be associated with Max (Kretzner, 1992) in order to carry out 
its role: the heterodimerization is required for both activation and inhibition of 
transcription. Activation is achieved through the binding to enhancer box consensus 
sequences, while inhibition is realised through protein-protein interactions with other 
DNA-binding proteins (Roy, 1993; Shrivastava, 1993; Peukert, 1997; Gartel, 2001; 
Izumi, 2001; Staller, 2001; Herold, 2002; Mao, 2003). 
Among its key target genes are p21, p15, p18, p27, p19, Bcl-x and Bcl2 (Zindy, 
1998; Eischen, 2001; Adhikary and Eilers, 2005; Gartel and Radhakrishnan, 2005). 
The protein p21, also known as CDKN1A, is inhibited by cMyc; p21 is upregulated 
by p53 after exposure to DNA damage and inhibits the activity of cyclin-CDK2 or 
cyclin-CDK4 complexes, preventing the cells to progress to S phase of the cell cycle 
(Gartel and Radhakrishnan, 2005). In addition, cMyc also represses the genes 
encoding for INK4 inhibitors (p15 and p18) and the gene encoding for p27; this leads 




G1 (Adhikary and Eilers, 2005). The suppression of the proteins involved in the 
control of the cell cycle is responsible for the proliferation of cells with pre-
tumorigenic mutations as a result of the failure of the cells to go towards apoptosis 
after DNA damage (Herold, 2002; Seoane, 2002). Myc also blocks the anti-apoptotic 
Bcl-x and Bcl2 proteins, contributing to the release of cytochrome c (Eischen, 2001). 
Myc activates several genes that encode for ribosomal proteins (Boon, 2001), 
translation factors (Rosenwald, 1993), proteins involved in the biogenesis and 
processing of ribosomal RNA (Greasley, 2000; Menssen and Hermeking, 2002), 
ribosomal RNA (Poortinga, 2004; Arabi, 2005; Grandori, 2005; Grewal, 2005), 
RNA-pol-III-dependent genes (Gomez-Roman, 2003) and non-coding RNA 
molecules (Cawley, 2004). Myc also probably acts through the induction of the 
regulatory subunit of the telomerase (Wang, 1998). 
Beside its direct role in activation and repression of transcription, cMyc can also  
modulate the epigenetic state: it recruits histone acetyltransferases such as  TIP60, 
GCN5 (McMahon, 1998), CREB-binding protein and p300 (Vervoorts, 2003) to its 
target genes (Bouchard, 2001; Frank, 2001). This enrolment is probably required for 
the transcriptional activation of these genes. Myc also recruits a DNA 
methyltransferase (DNMT-3a) to the Myc-Miz1 complex, indicating that 
Myc-dependent gene repression could at least partly be mediated by methylation of 
its target promoters (Brenner, 2005). 
 
Klf4 (Krüppel-like factor 4), also known as gut-enriched Krüppel-like factor (gKLF), 
belongs to the Kruppel-like factor family, which is an evolutionarily conserved 






Figure 6. The figure shows how the reprogramming factors interact with each other to induce 
pluripotency in somatic cells. Oct4 (in the yellow circle) and Sox2 (in the red circle) act in a complex 
network regulating their own and each other expression; Klf4 (in the green circle) stimulates the key 
pluripotency genes such as Oct4, Sox2 and Nanog (in the blue circle); cMyc (in the purple circle) is 
responsible of the augmented proliferation and loss of senescence of the cells (auto-regulatory and 
cross-regulatory transcriptional loops are shown with arrows; the interactions carried out by Oct4 are 
represented by the yellow arrows, the interactions carried out by Nanog are represented by the blue 
arrows, the interactions carried out by Sox2 are represented by the red arrows and the interactions 
carried out by Klf4 are represented by the green arrows). The induced expression of cMyc, Klf4, Oct4 




Like cMyc, Klf4 is a downstream target of STAT3 in ESCs (Lewitzky and 
Yamanaka, 2007). Previous reports have shown that Klf4 is expressed in many 
tissues e.g. gut (Shields, 1996; Zhang, 2006), skin (Segre, 1999), thymus (Panigada, 
1999), adipocytes (Birsoy, 2008), fibroblasts (Zhang, 2000). Furthermore, it is 
detectable in the mouse embryo, with the highest expression occurring in the later 
stages (Garrett-Sinha, 1996; Ton-That, 1997). Klf4 is responsible for cell 
differentiation in some tissues and cell growth in other tissues (Matsumoto, 1998; 
Yet, 1998; Adam, 2000; Swamynathan, 2007). The mechanisms of this bi-functional 
action in differentiation and proliferation are not fully known, however it is known 
that Ras has a determinant function (Rowland, 2005). 
When it is overexpressed, Klf4 acts by activating p21 and repressing p53 (Rowland, 
2005); these proteins are both inhibitors of proliferation, consequently it is the 
background environment that decides the fate of the signalling: when p53 prevails 
the cells are driven toward proliferation; vice versa, when p21 activation overcomes 
p53 inhibition differentiation prevails and the consequence is cell cycle arrest. The 
addition of Ras, which inhibits p21, changes the equilibrium allowing Klf4 to repress 
p53 preventing apoptosis and eventually leading to enhancement of proliferation. 
 
1.6.4 Advances in the technology 
Although the iPSCs generated by Takahashi and Yamanaka shared many crucial 
pluripotency features with ESCs, they were not able to contribute to an adult 
organism after injection in a blastocyst: they were shown to be part of embryos only 
up to 13.5dpc. The absence of any contribution to postnatal animals following 




was intermediate between somatic and ESCs indicated that Takahashi and 
Yamanaka’s iPSCs were not identical to ESCs: even though the nuclear 
reprogramming observed was substantial, it was not complete. 
In this first study, the choice of the Fbx15 promoter was revealed to be the main 
problem in the failure of a complete reprogramming: although specifically expressed 
in mouse ESCs and early embryos, Fbx15 is dispensable for the maintenance of 
pluripotency, so better markers should have been used to replace of the nonessential 
Fbx15. This is the strategy employed in three following reports (Maherali, 2007; 
Okita, 2007; Wernig, 2007), in which the key improvement was the selection of 
iPSCs using Oct4 and/or Nanog promoters as indicators of reprogramming. The 
iPSCs derived with this approach are functionally equivalent to ESCs, can give rise 
to chimeras (Maherali, 2007; Okita, 2007; Wernig, 2007), are able to contribute to 
the germline (Okita, 2007; Wernig, 2007) and are capable of generating viable, 
fertile offspring by tetraploid complementation (Zhao, 2009). 
 
Further improvements to the iPSC isolation method have later been documented. For 
example, in murine cells it was demonstrated that reprogrammed pluripotent cells 
can be isolated from genetically unmodified somatic donor cells solely based upon 
morphological criteria (Meissner, 2007) and without the requirement of cMyc 
(Nakagawa, 2008; Park, 2008). Induced pluripotent stem cell isolation was reported 
by several independent groups employing different combination of factors including 
Oct4, Sox2, cMyc, Klf4, Nanog, Lin28, SV40L-T and H-TERT (Takahashi, 2007b; 
Yu, 2007; Park, 2008). Additionally, it was found that Klf4 and cMyc are 




2008b; Nakagawa, 2008; Lyssiotis, 2009). In neural stem cells, where Sox2 is 
expressed at high levels, Oct4 alone is able to induce pluripotency (Duinsbergen, 
2008; Eminli, 2008; Kim, 2009c). 
 
In the initial study, the reprogramming genes were delivered to differentiated cells 
using retroviral transduction. New strategies for delivering the exogenous factors 
have been developed with time (Table 1). Lentiviruses were employed, initially 
carrying the transgenes under the control of a constitutive promoter; then, since 
differentiation of these cells was severely impaired by the continuative expression 
levels of the reprogramming factors (Brambrink, 2008; Sommer, 2010), the lentiviral 
vectors were modified using inducible promoters, so that the expression of the 
reprogramming factors could be switched off when reprogramming had occurred. 
Despite the efficiency of retroviral and lentiviral vectors as reprogramming tools, the 
resulting iPS clones contain proviral integrations, the significance of this being the 
risk of insertional mutagenesis and/or spontaneous transgene reactivation, either of 
which could result in tumour formation (Okita, 2007). Several methods have been 
investigated to mitigate these risks, including the removal of the integrated 
transgenes by the Cre/LoxP technology (Chang, 2009; Soldner, 2009; Sommer and 
Mostoslavsky, 2010) or the use of the piggyBac transposon/transposase system 
(Woltjen, 2009), which is inserted in the genome of the host cells, but is 
characterized by a precise self-excision mechanism. 
Reprogramming without genomic integration has been reported: a number of studies 









ADVANTAGES DISADVANTAGES REFERENCES 
Integrative 
Retrovirus 
-Good efficiency  
-Silenced transgenes   
in iPSCs 
-Multiple genomic integrations 
(Takahashi and 
Yamanaka, 2006; Okita, 





-Multiple genomic integrations 
-Differentiation potential may 
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-No vector sequence 
left behind 
-Analysis of transposase-
mediated excision can be 
demanding 
(Kaji, 2009; Woltjen, 








-Screening for possible 
integration can be demanding 
(Okita, 2008) 





(Stadtfeld, 2008c; Zhou 







passaging to eliminate virally 

















(Kim, 2009a; Zhou, 
2009) 
 
Table 1. A summary of the different methods employed to reprogram somatic cells: the most efficient 
protocols for reprogramming are carried out employing retroviruses and lentiviruses. This however 
integrate in the iPSCs, making them unsuitable in vivo applications. On the other side, non-integrative 





expression of plasmids (Okita, 2008; Gonzalez, 2009) or by using adenoviral vectors 
(Stadtfeld, 2008c) providing proof of principle that insertions are not necessary for 
iPSC generation. Most recently, expression of reprogramming factors from a 
non-viral minicircle vector proved capable of converting human adipose stem cells to 
pluripotency (Jia, 2010). Likewise, Sendai virus RNA based vectors achieved 
reprogramming of human somatic cells and were able to produce transgene-free 
iPSCs by antibody-mediated selection (Fusaki, 2009). Alternatively an oriP/EBNA1 
episomal vector has been utilized to reprogram human fibroblasts (Yu, 2009). 
Two groups achieved the generation of iPSCs through the delivery of reprogramming 
proteins. In order to enable cellular uptake, the reprogramming factors were tagged 
with a poly-arginine protein transduction domain and produced either in E. coli and 
purified (Zhou, 2009) or in HEK293 cells, where the whole-protein extract was then 
employed for reprogramming (Kim, 2009a). Finally, a recent report demonstrated 
that a single transfer of ESC-derived proteins is able to induce pluripotency in adult 
mouse fibroblasts (Cho, 2010). The main methods employed for reprogramming are 
summarised in Table 1. 
 
While improving different ways of delivering the reprogramming genes, efforts have 
also been made to locate molecules capable of substituting the reprogramming 
factors or enhancing the reprogramming efficiency. In agreement with the knowledge 
that nuclear reprogramming to pluripotency is a gradual process that involves the 
conversion of the epigenetic state of a differentiated cell into that of an ESC-like cell 
(Jaenisch and Young, 2008), many of the compounds which proved to be useful for 




example in the presence of the DNA methyltransferase inhibitor 5'-azacytidine or the 
histone deacetylase inhibitor valproic acid, the efficiency of reprogramming can be 
enhanced by approximately 10-fold and 100-fold, respectively (Huangfu, 2008a). 
Other molecules found to increase the efficiency of reprogramming are the ROCK 
inhibitor Y27632 (Park, 2008), BIX-01294, a G9a histone methyltransferase 
inhibitor (Shi, 2008a; Shi, 2008b),  BayK8644, a L-type calcium channel agonist 
(Shi, 2008a), ALK5 (Ichida, 2009; Maherali and Hochedlinger, 2009) and RepSox, 
both inhibitors of TGFβ signalling (Ichida, 2009), kenpaullone, a kinase inhibitor 
(Lyssiotis, 2009), vitamin C (Esteban, 2010), butyrate, a natural small fatty acid and 
histone deacetylase inhibitor (Liang, 2010), apigenin and luteolin (Chen, 2010). 
Induced pluripotent stem cells were initially derived from embryonic and adult 
fibroblast, but many other cell types have been reprogrammed in the following years 
(summarised in Table 2). In particular, both ASCs and terminally differentiated cells 
have been turned into pluripotent cells; also, the reprogramming process has been 
successful on cells deriving from each of the three germ layers (Table 2). The direct 
reprogramming process proved to be also effective not only in mouse, but in many 
different species, going from human, to pig, to rat (Table 2). This indicates that the 
key mechanisms of regaining pluripotency are not specific to a particular cell type or 
species, but are shared among a number of tissues from many different species. 
 
1.6.5 Importance of induced pluripotent stem cells 
As discussed above, ESCs are viewed as a promising resource for medical 





CELL TYPE SPECIES REFERENCES 
Adipose stem cells Mouse, human (Sun, 2009; Tat, 2010) 
Amnion-derived cells Human (Zhao, 2010) 
B lymphocytes mouse (Hanna, 2008) 
Bone marrow cells Human, rat, pig (Liao, 2009; Wu, 2009; Kunisato, 2011) 
Cord blood derived cells Human (Giorgetti, 2009; Haase, 2009) 
Dental pulp stem cells Human (Yan, 2010) 
Fibroblasts 
Mouse, human, pig, 
rat, dog, primates, 
sheep, bovine and 
horse 
 (Takahashi and Yamanaka, 2006; 
Takahashi, 2007b; Liu, 2008; Esteban, 
2009; Liao, 2009; Shimada, 2010; Han, 
2011; Li, 2011; Nagy, 2011) 
Hematopoietic stem cells Human (Loh, 2009) 
Hepatocytes Human (Liu, 2010) 
Keratinocytes Human (Aasen, 2008) 
Liver cells Mouse, rat (Aoi, 2008; Stadtfeld, 2008c; Li, 2009) 
Malignant cells Mouse, human (Utikal, 2009; Carette, 2010) 
Melanocytes Mouse and human (Utikal, 2009) 
Meningiocytes Mouse (Qin, 2008) 
Neural progenitor cells Mouse, human (Eminli, 2008; Kim, 2008b; Kim, 2009a) 
Pancreatic B-cells Mouse (Stadtfeld, 2008a) 
Smooth muscle cells Human (Lee, 2010) 
Stomach cells Mouse (Aoi, 2008) 
 




technical difficulties encountered in their derivation in large animals; besides, 
although the derivation of human ESCs has been achieved, major ethical concerns 
about the destruction of human embryos have limited their derivation and their use. 
 
Induced pluripotent stem cells share the key feature of ESCs, but are derived from 
differentiated cells. This circumvents the moral and technical problems linked to the 
use of embryos. Being ESC-like, iPSCs maintain the same applications of ESCs: 
they can be a tool for the screening of new drugs or toxics, represent a model for the 
study of pluripotency and differentiation, are a source of tissues for regenerative 
medicine and can be exploited for the creation of animals carrying specific disease. 
Additionally, iPSCs will open opportunities beyond those provided by ESCs: iPSCs 
will help to better understand the mechanisms of regaining pluripotency and will be a 
further tool in medicine: patient-specific iPSCs might be created, in vitro modified 
and differentiated toward a specific cell type and reinserted into the patient, with 
little risk of immune rejection. 
 
Induced pluripotent stem cells have great promise, but their generation by employing 
integrating viral vectors to drive the expression of the reprogramming factors does 
not allow full exploitation of the potential of iPSCs in research and in particular  in 
the clinical field: the resulting iPS clones contain proviral integrations, the 
significance of this being the risk of insertional mutagenesis and/or spontaneous 
transgene reactivation, either of which could result in tumour formation (Okita, 




systems in order to mitigate the risks, their efficiency is still much lower than that of 
viral transduction. 
 
1.7 A step forward: transdifferentiation 
The idea that the nucleus of somatic cells could be reprogrammed to pluripotency 
through overexpression of specific transcription factors typical of ESCs has raised 
the question whether reprogramming could be achieved by directly converting one 
differentiated cell type into another differentiated cell type. This has opened the door 
to studies where factors were identified that can drive the transdifferentiation of 
readily available cells, such as fibroblasts, to therapeutically desirable cells, such as 
neurons (Vierbuchen, 2010; Caiazzo, 2011), cardiomyocytes (Ieda, 2010), 
progenitors of blood cells (Szabo, 2010) or hepatocytes (Huang, 2011; Sekiya and 
Suzuki, 2011). 
 
One of the major issues in the employment of ESCs or iPSCs in therapy regards the 
concern about the potential tumorigenicity of these cells: although the cells employed 
in clinics are differentiated cells derived from ESCs, the selection methods to avoid a 
carry-over of pluripotent cells are not completely efficient. Induced 
transdifferentiated cells do not go through the pluripotent step; therefore they are 
seen as a safer way for the production of patient specific cells for medical purposes; 
even though there may be issues of scale up. 
 
Despite their relevance, these cells, likewise ESCs, are produced by viral 




cocktails of proteins should be used for generating induced transdifferentiated cells 
for clinical applications. Furthermore it must be shown that induced 
transdifferentiated cells have undergone a stable conversion of cell fate. Likewise 
induced transdifferentiated cells should be assayed to determine their suitability for 




1.8 Aim of the project 
I had two main goals: 1) establishing the protocol to induce pluripotency in our 
institute and 2) applying it to the ovine species. 
Initially MFFs were reprogrammed through retroviral transduction employing the 
four original factors: cMyc, Klf4, Oct4 and Sox2. Once the protocol was optimised 
in mouse, it was translated to ovine somatic cells. This species was chosen because it 
is a recognised model for human disease and it takes further relevance for those 
syndromes where the mouse model have failed, such as cystic fibrosis (Harris, 1997; 
Abraham, 2008). When putative ovine iPSCs were derived, they were assessed for 
the main features of pluripotency, such as  pluripotency marker expression,  
transgene silencing and ability to differentiate in vitro and in vivo. Once the cells 
demonstrated an iPSC phenotype they were inoculated into ovine blastocysts to test 





Materials and methods 
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2.1 DNA and RNA manipulation and analysis 
 
2.1.1 Transformation of bacteria 
The Subcloning Efficiency DH5α Competent Cell kit (Invitrogen, 18265-017) was 
employed for the routine propagation of all plasmids. The amount of 50µl of DH5α 
cells was thawed on ice and incubated on ice with 1µg of DNA for 30min. Cells were 
then heat-shocked for 20s at 42°C and placed on ice again for 2min; 950µl of 
pre-warmed LB medium were added and tubes were incubated at 37°C for 1h in a 
shaker at 225rpm. From 20µl to 200µl of each transformation were spread on 90mm 
LB-agar plates containing 100µg/ml ampicillin and incubated overnight at 37°C. The 
following day colonies of bacteria containing the plasmid would appear. 
 
2.1.2 Extraction of plasmid DNA from bacteria 
Large-scale extraction of plasmid DNA from bacteria was performed using the 
PureLink HiPure Plasmid Maxiprep Kit (Invitrogen, K2100-07): one individual 
bacterial colony was picked from a selective plate and inoculated into a 15ml Falcon 
tube containing 5ml of LB medium supplemented with 100µg/ml ampicillin. Bacteria 
were then incubated for 4-5h at 37°C at 225rpm in a shaker. Starter culture was 
diluted (1:250) into 250ml of LB complemented with 100µg/ml ampicillin in a 1l 
conical flask and grown overnight at 37ºC in a shaker at 225rpm. The following day 
the bacterial culture was transferred into a 250ml dry-spin bottle (Sorvall) and 
harvested by at 4000g for 30min at 4ºC. After removing the supernatant, the bacterial 
pellet was resuspended in 10ml of resuspension buffer R3 (50mM Tris-HCl pH8.0, 
10mM EDTA, 20mg/ml RNase A) and transferred to a 50ml Falcon tube. In order to 
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lyse the bacteria, 10ml of lysis buffer (0.2M NaOH, 1% SDS) were added and the 
tube was mixed gently by inverting the tube. 
The lysis reaction was carried out at RT for 5min and then 10ml of precipitation 
buffer (3.1M potassium acetate pH5.5) were added. The sample was mixed 
immediately by inverting the tube until the mixture was homogeneous and was 
centrifuged at 13400g for 10min at RT. 
The supernatant was loaded onto a column previously equilibrated with 30ml of 
equilibration buffer EQ1 (0.1M Sodium acetate pH5.0, 0.6M NaCl, 0.15% (v/v) 
TritonR X-100) and allowed to drain by gravity flow; the column was then washed 
with 60ml of wash buffer (0.1M Sodium acetate pH5.0, 825mM NaCl) and 15ml of 
elution buffer (100mM Tris-HCl pH8.5, 1.25M NaCl) were added to the column to 
elute the DNA. The resulting DNA was precipitated with 10.5ml of isopropanol and 
centrifuged at 15,000g for 30min at 4°C. 
The supernatant was discarded, the DNA pellet resuspended in 5ml of 70% ethanol 
and centrifuged again at 15000g for 5min at 4°C. The supernatant was carefully 
removed and the DNA pellet was air-dried, resuspended in 500µl of ddH2O, 
quantified by NanoDrop (ND1000 Thermo Scientific) and stored at -20°C. Plasmid 
DNA was usually tested by restriction enzyme digestion. 
 
2.1.3 Extraction of genomic DNA from cells 
Genomic DNA (gDNA) from cells and embryos was extracted using the DNeasy 
Blood and Tissue Kit (Qiagen, 69504). 
While passaging cells, aliquots were pelleted at 300g for 5min, the medium was 
removed and the cells were stored at -20°C. Before starting the extraction, frozen cell 
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pellets were allowed to thaw, dislodged by gently flicking the tube and were 
resuspended in 200µl of PBS.  In order to lyse the cells and digest the proteins, 200µl 
of buffer AL and 20µl of proteinase K were added. Samples were mixed thoroughly 
by vortexing and incubated at 56°C for 10min. After adding 200µl of 96% ethanol, 
the samples were then mixed thoroughly by vortexing to yield a homogeneous 
solution and transferred into a DNeasy Mini spin column. The mixture was 
centrifuged at more than 6000g for 1min, washed with 500µl of buffer AW1 and 
centrifuged again for 1min at more than 6000g. The column was washed a second 
time with 500µl of buffer AW2 and centrifuged for 3min at 20000g; the 
flow-through was discarded and the column was centrifuged again for 1min at full 
speed to allow the membrane to dry. The DNeasy Mini spin column was placed in a 
clean 1.5ml microcentrifuge tube and 200µl of buffer AE were added directly onto 
the DNeasy membrane; the column was incubated at RT for 1min and then 
centrifuged for 1min at 6000g to elute. The elution step was repeated a second time 
using a clean 1.5ml microcentrifuge tube. Genomic DNA was quantified on the 
NanoDrop (ND1000 Thermo Scientific) and stored at 4°C. 
 
2.1.4 Extraction of genomic DNA from tissues 
Extraction of gDNA from tissues was performed using the DNeasy Blood and Tissue 
Kit (Qiagen, 69504): samples were cut into small pieces and placed in a 1.5ml 
microcentrifuge tube with 180µl of Buffer ATL and 20µl of proteinase K, mixing 
thoroughly by vortexing and incubating at 56°C until the completely lysed. During 
the incubation the samples were occasionally vortexed to disperse them. After 
complete digestion, the tubes were vortexed for 15s and 200µl of buffer AL were 
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added; the samples were then mixed thoroughly by vortexing and, after adding 200µl 
of 96% ethanol, were mixed again by vortexing to yield a homogeneous solution and 
were transferred into a DNeasy Mini spin column. The mixture was then centrifuged 
at more than 6000g for 1min, washed with 500µl of buffer AW1 and centrifuged 
again for 1min at 6000g. The column was washed a second time with 500µl of buffer 
AW2 and centrifuged for 3min at 20000g. The flow-through was discarded and the 
column was centrifuged again for 1min at full speed to allow the membrane to dry. 
The DNeasy Mini spin column was placed in a clean 1.5ml microcentrifuge tube, 
200µl of buffer AE were added directly onto the DNeasy membrane and the column 
was incubated at RT for 1min and then centrifuged for 1min at 6000g to elute the 
DNA. The elution step was repeated a second time using a clean 1.5ml 
microcentrifuge tube. Genomic DNA was quantified on the NanoDrop (ND1000 
Thermo Scientific) and stored at 4°C. 
 
2.1.5 Extraction of RNA from cells 
RNA was extracted using RNeasy Mini kit (Qiagen, 74104): while passaging the 
cells, aliquots were pelleted at 300g for 5min. The medium was removed and the 
cells were stored at -80°C. On the day of the extraction, frozen cell pellets were 
loosened by flicking the tube and 350 or 600µl of buffer RLT were added. The 
solution was mixed by pipetting, loaded into a QIAshredder spin column (Qiagen, 
79654) and centrifuged for 2min at full speed to homogenize the lysate. One volume 
of 70% ethanol was added to the homogenized lysate, mixed well by pipetting, 
transferred to an RNeasy spin column and centrifuged for 15s at more than 8000g. 
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In order to wash the column membrane 350µl of buffer RW1 were added and the 
RNeasy spin column was centrifuged for 15s at 8000g. At this point on-column DNA 
digestion was performed using RNase-Free DNase Set (Qiagen, 79254): 10µl of 
DNase I stock solution were added to 70µl of buffer RDD, mixed by gently inverting 
the tube, added directly to the RNeasy spin column membrane and placed on the 
bench top (20–30°C) for 15min; 350µl of buffer RW1 were added and the column 
was centrifuged for 15s at more than 8000g. The membrane was washed with 500µl 
of buffer RPE, centrifuged for 15s at more than 8000g, washed again with 500µl of 
buffer RPE, centrifuged for 2min at more than 8000g and centrifuged again at full 
speed for 1min. The RNeasy spin column was placed in a new 1.5ml collection tube 
and 30 to 50µl of RNase-free water were added directly to the membrane. The 
column was centrifuged for 1min at more than 8000g to elute the RNA. The elution 
step was repeated a second time using a clean 1.5ml microcentrifuge tube. 
RNA was quantified by NanoDrop (ND1000 Thermo Scientific) and immediately 
used for a second DNase digestion or stored at -80°C. 
 
2.1.6 DNase digestion 
Before reverse transcription, the RNA was treated a second time with DNase in order 
to degrade completely the gDNA. The kit used was RQ1 RNase-Free DNase 
(Promega, M6101). The reaction was set up as follows: 
  8µl RNA 
  1µl 10x Reaction Buffer 10x 
  1µl RNase-free DNase (1U/µg RNA)   
10µl 
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The digestion was incubated at 37°C for 30min, then 1µl of RQ1 DNase Stop 
Solution was added and the sample was incubated at 65°C for 10min to inactivate the 
DNase and terminate the reaction. 
The DNase digested RNA was immediately used for reverse transcription or stored at 
-80°C. 
 
2.1.7 Reverse transcription 
The reverse transcription reaction was performed employing SuperScriptIII 
First-Strand Synthesis System for RT-PCR (Invitrogen, 18080-051). The reaction 
was set up as follows: 
  8µl DNase digested RNA 
  1µl Oligo(dT)20 50µM 
  1µl dNTP mix 10mM 
10µl   
  
 
The mixture was incubated at 65°C for 5min, placed on ice for at least 1min and the 
following reagents were added: 
   
    2µl RT buffer 10x 
    2µl DTT 0.1M 
    4µl MgCl2 25mM 
    1µl RNase OUT (40U/µl) 
    2µl SuperScript III RT (200U/µl) or H2O 
  21µl  
          
 
Alongside the reverse transcription, in order to ensure the absence of contaminant 
gDNA, a control reaction was always performed in which the reverse transcriptase 
was replaced by water. The reaction tubes were gently mixed, solutions collected by 
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brief centrifugation and incubated for 50min at 50°C. The reaction was terminated at 
85°C for 5min and chilled on ice. The cDNA was used for PCR reaction or stored at 
-20°C. 
 
2.1.8 Polymerase chain reaction 
Polymerase chain reaction was performed using the Taq DNA Polymerase kit 
(Roche, 11146173001). A typical setting for DNA amplification can be summarized 
as follows: 
  
  1-16µl  DNA 
       3µl buffer 10x   
       3µl dNTPs 2mM 
       6µl primers enJSRV F + enJSRV R) 2.5µM   
       1µl Taq 
   1-16µl Water 
     30µl   
        
 
The reaction mix and the DNA were mixed together in 0.2ml thermo-strip tubes 
(Abgene) and the samples were placed in gradient thermal cycler (Biometra 
TProfessional gradient). Primers and cycling parameters were adjusted for every 
individual experiment (see table 3). The PCR results were analysed by agarose gel 
electrophoresis. 
 
2.1.9 Restriction enzyme analysis 
Restriction enzyme digestions of plasmid were performed according to the 
manufacturer’s instructions. DNA was usually digested with a 10-fold excess of 
enzyme with a final volume of glycerol not exceeding 5% (v/v). 
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2.1.10 Agarose gel electrophoresis 
Agarose gels were prepared by dissolving agarose at 0.5-2% (w/v) in TAE buffer by 
heating the suspension in a microwave oven. Ethidium bromide at 0.5µg/ml (Sigma) 
or 1x Sybr Safe (Invitrogen, S33102) were added to the solution and poured into a 
gel tray.  Once set, the gel was submerged in TAE buffer in a gel tank; a DNA 
loading buffer (6x solution composed with 30% glycerol, ddH2O and bromophenol 
blue or xylene cyanol) were was added to the sample and the mix was loaded into the 
wells. DNA was visualized by illumination on a UV light box and photographed. The 
size of the DNA fragment was examined by comparison of their mobility to that of 
restriction fragments of known size, typically 1kb DNA ladder (Fermentas). 
 
2.2 Cell cultures 
 
2.2.1 Cells 
The cells employed in this project were human embryo kidney HEK 293T/17 cell 
line (ATCC, CRL-11268), mouse foetal fibroblasts, ovine foetal fibroblasts (OFFs, 
prepared by Dr Alison Thomson), immortalised MFFs (10T1/2 cell line, ECACC, 
99072801), SNL 76/7 cell line (ECACC, 07032801), H9 cell lines, provided by Dr 
Alex DiDomenico (Thomson, 1998), HM1 mouse ESC line (provided by Dr Alex 
DiDomenico (Magin, 1992), Bruce4 mouse ESC line (Kontgen, 1993), human 
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2.2.2 Coating of flasks and plates for cell culture 
Gelatin-coated flasks and plates were prepared dissolving gelatin from porcine skin 
(Sigma G2500) in water to obtain a 0.1% solution which was autoclaved twice. Prior 
to seeding the cells, the 0.1% gelatin solution was poured in the flasks or plates and 
left at RT; after 1h the gelatin was removed and the flasks or plates were washed 
once in PBS in order to remove the excess of gelatin. 
Matrigel (Becton Dickinson) stored at -20°C was thawed at 4ºC for at least 2h to 
avoid the formation of a gel and was then diluted 1:100 in cold Knock Out 
Dulbecco's modified Eagle medium (KO-DMEM, Invitrogen) using a chilled pipette. 
T25cm2 flasks were normally coated with 3ml of the Matrigel solution.  Flasks were 
either incubated at RT for 1h-2h before use or stored at 4ºC for no longer than 2 
weeks. Before use, the Matrigel solution was removed from the flasks and washed 
with KO-DMEM. 
Poly-L-lysine (Sigma, P4832) was poured in flasks or plates and left for 1h at 37°C. 
It was then removed and flasks or plates were rinsed once with PBS. 
 
2.2.3 General maintenance of cells (thawing, passaging and freezing) 
Vials containing frozen cells were placed into a 37ºC water bath. When the cells 
were thawed, in order to remove the freezing mix 5ml of appropriate medium were 
added to the content of a vial in a 15ml falcon tube and centrifuged at 200g for 5min.  
Supernatant was discarded and pellet was resuspended in an appropriate volume of 
medium for plating out. 
Cells were grown in the appropriate culture medium at 5%CO2, 37°C and, when 
confluent, were passaged by trypsinization: the medium was removed and cells were 
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washed in warm PBS; trypsin-EDTA solution (Sigma, T3924) was added and cells 
were placed at 37°C until a single cell suspension was obtained. The appropriate 
culture medium was added to stop the enzymatic activity and the remaining clumps 
of cells were disaggregated by pipetting. Cells were collected by centrifugation for 
5min at 200g, the supernatant was discarded and pellets were resuspended either in 
the appropriate culture medium and seeded again or prepared to be frozen. 
For freezing cells were resuspended in an appropriate volume of freezing mix 
composed of foetal calf serum (FCS, PAA), 10% dimethyl sulfoxide (DMSO, 
Sigma) and the suspension was gently mixed and aliquoted into pre-chilled cryovial 
tubes. Vials were stored at -80ºC for 24h and then transferred to -150ºC. 
 
2.2.4 Foetal fibroblasts 
For the preparation of MFFs, pregnant mice were sacrificed on day 13 or 14 post 
coitum. The abdomens were swabbed with 70% ethanol and the abdominal cavities 
were dissected to expose the uterine horns. The foetuses were removed and placed 
into a 10cm Petri dish containing PBS supplemented with 5000µg/ml penicillin and 
5000µg/ml streptomycin (Penicillin-Streptomycin Solution, Invitrogen, 15140-130). 
Placentas and membranes were removed and heads and soft tissues were separated 
from individual embryos. The foetuses were then washed twice in PBS supplemented 
with Penicillin-Streptomycin Solution and placed individually into tubes containing 
2ml of Trypsin-EDTA. Tubes were finally incubated for at least 20min at 37ºC and 
vortexed every 5min. When the embryos were well disaggregated, 3ml of MFF 
medium were added, tubes were vortexed again and allowed to stand for 5min. When 
large masses settled, the top 4ml of liquid from each tube were removed and 
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transferred to a gelatin-coated 75cm2 flask with 10ml of (DMEM, Sigma), 10% FCS 
(fibroblast medium). MFFs were then incubated at 37ºC, 5%CO2 and the medium 
was changed the following day to remove cellular debris. 
Sub-confluent 75 cm2 flasks were washed once with PBS and incubated with 2ml of 
Trypsin-EDTA solution at 37ºC for 2-3min. When cells were in single cell 
suspension, 8ml of MFF medium were added, cells were centrifuged and supernatant 
removed. Cells were then frozen in FCS, 10% DMSO and stored at -80ºC or plated 
for immediate use. 
MFFs could be expanded for up to 6 passages before senescence set in. 
For the preparation of OFFs pregnant ewes were sacrificed on day 35 post coitum. 
The preparation of the ovine cells was performed employing the same protocol 
employed for MFFs. 
 
2.2.5 SNL 76/7 cell line and feeder layer preparation 
The SNL 76/7 cell line was clonally-derived from a STO cell line and express LIF 
and neomycin phosphotransferase (Neo). This cell line can be used as a feeder layer 
to support the growth of mouse ESCs and iPSCs (McMahon and Bradley, 1990). 
Cells were purchased frozen from ECACC and were thawed in a 37°C water bath. 
The content of the vial was transferred to a 15ml centrifuge tube containing 5ml of 
DMEM, 10% FCS, 2mM L-Glutamine (Invitrogen). Cells were pelleted by 
centrifugation at 300g for 5min. The supernatant was discarded and cells were 
resuspended in 10ml of warm medium, plated in a gelatin-coated 25cm2 flasks and 
incubated at 37°C, 5% CO2. 
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Medium was changed every 2-3 days and when subconfluent, the cells were washed 
once with PBS and incubated with 1ml of Trypsin-EDTA solution at 37ºC for 
2-3min. When cells were in single cell suspension, 4ml of medium were added, cells 
were centrifuged and supernatant removed. Cells were then stored in FCS, 10% 
DMSO at -160ºC or plated for expansion. 
In order to prepare the feeder layer, SNL cells were expanded typically in nine 
gelatin-coated 150cm2 flasks. When subconfluent, cells were collected by 
trypsinization in 50ml Falcon tubes and mitotically inactivated by irradiation at 
10000rad (Yi, 1999). Feeder cells were then frozen in working aliquots and stored at 
-80ºC. Plating density of the SNL feeders is summarised in table 4. 
 
2.2.6 Human embryonic stem cell line H9 
Human ESCs H9 were grown on Matrigel-coated flasks in filtered conditioned 
medium supplemented with 4ng/ml human basic fibroblast growth factor (bFGF, 
Peprotech, 100-18B) at 37°C, 5% CO2. In order to prepare conditioned medium, 
MFFs were grown in 150 cm2 flask and fibroblast medium was replaced with 50ml 
of serum-free human ESC medium: 80% knock-out DMEM (KO-DMEM, 
Invitrogen), 20% knock-out serum replacement (SR, Invitrogen), 0.1mM non-
essential amino acids (Invitrogen), 2mM L-glutamine, 0.1mM 2-mercaptoethanol 
(Invitrogen) and 4ng/ml bFGF; conditioned medium was collected from the flask the 
following day and stored at –20º C. 
 The medium was changed every day. When cells reached 80-90% confluence, the 
conditioned medium was removed and the cells were washed once with 
KO-DMEM. Typically, for a 25cm2 flask, cultures were rinsed with PBS incubated 




Plate/Dish/Flask SNL plating density 
96 well plate 2x104 
48 well plate 5x104 
24 well plate 1.7x105 
12 well plate 3x105 
6 well plate 7x105 
10cm dish 5x106 
T25cm2 flask 2x106 
T75cm2 flask 6x106 
 
Table 4. Plating density of the SNL feeder layer.  
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with 1ml of Trypsin-EDTA at 37ºC until cells were detached, then 5ml of 
KO-DMEM were added to the cells and a single-cell suspension was obtained by 
pipetting vigorously. Cells were then transferred to a Falcon tube and centrifuged at 
200g for 5min. The supernatant was discarded, the pellet was resuspended in fresh 
filtered conditioned medium supplemented with 4ng/ml bFGF and seeded in a 
Matrigel-coated flask. 
 
2.2.7 Mouse pluripotent cells 
Mouse ESCs (Bruce4 and HM1) and putative mouse iPSCs were maintained in 
mouse ESC medium: DMEM, 15% FCS, 2mM L-glutamine, 0.1mM non-essential 
amino acids, 0.1mM 2-mercaptoethanol, 1000 U/ml mouse LIF (Millipore, 
ESG1107). Medium was renewed daily. When at 70-80% confluent the cells were 
passaged at 1:3 to 1:5 ratio;  the medium was renewed and around 2-3h later cells 
were rinsed with PBS, trypsinized for 2 to 5min at 37°C and collected in a Falcon 
tube after adding some culture medium in order to inactivate the trypsin-EDTA. The 
cells were then centrifuged at 200g for 5min, the supernatant was removed and the 
cell pellet was resuspended in culture medium and plated. Bruce4 and putative 
mouse iPSCs were typically grown on a feeder layer of irradiated SNL cells, while 
HM1 cells were normally grown in gelatin-coated plates or flasks. 
 
2.2.8 Ovine induced pluripotent stem cells 
Ovine iPSCs were derived on γ-irradiated SNL feeder layer employing two different 
media: mouse ESC medium or human ESC medium (KO-DMEM, 20% SR, 2mM 
L-glutamine, 0.1mM non-essential amino acids, 0.1mM 2-mercaptoethanol, 8ng/ml 
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human bFGF). Medium was renewed daily. When the cells were around 70-80% of 
confluence, medium was renewed and after 2 to 3h the cells were rinsed with PBS, 
trypsinized for 2 to 5min at 37°C, resuspended in culture medium and plated for 
15-20 min in gelatin-coated plates in order to separate them from the feeder layer: 
feeder cells would adhere tightly, while the iPSCs would adhere weakly and 
differentiated cells and dead feeders would remain afloat. The loosely adhering ESCs 
were detached from the dish by vigorously pipetting with a 5ml pipette (protocol 
modified from (Tompers and Labosky, 2004) and plated on feeder layer. Typical 
passaged ratio was between 1:3 to 1:5. 
 
2.2.9 Maintenance of other cell lines 
Immortalised MFFs were grown in DMEM, 10% FCS. OFFs were cultured in 0.1% 
gelatin-coated plates in medium composed of DMEM, 10% FCS. HEK 293T/17 
were grown in DMEM, 10% FCS, 2mM L-glutamine, 0.1mM non-essential amino 
acids. LS174T were maintained in Eagle's minimum essential medium (EMEM, 
EBSS), 10% FCS, 2mM L-Glutamine, 0.1mM non-essential amino acids. 
 
2.2.10 In vitro differentiation of pluripotent cells 
For the differentiation of mouse ESCs and putative mouse iPSCs, clones were grown 
in one well of six well plate in mouse ESC medium on SNL feeder layer until 
subconfluent (50-70% confluence). On day 0 cells from a T25cm2 flask were fed 
and, after 2-3h, washed with warm PBS and trypsinized for around 2min at 37°C in 
order to get small clumps of cells instead of a single cell suspension. Cells were then 
plated in a gelatin-coated T25cm2 flask for 15-20min to separate them from the 
__________________________________________________Materials and methods 
72 
 
feeders. The loosely adhering cells were detached by vigorously pipetting with a 5ml 
pipette and the clumps of cells were collected and grown in suspension in a 9cm 
bacterial Petri dish in mouse EB medium (mouse ESC medium without LIF). 
On day 2 floating EBs were washed: the medium containing the cells was collected 
in a tube and the EBs were let to sink at the bottom of the tube. The supernatant was 
removed and the cells were resuspended in fresh EB medium and plated again in a 
new Petri dish. On day 5 EBs were washed again and on day 7 they were plated in 
gelatin-coated wells of 24 well plate with 1 to 10 EBs per well. Differentiating cells 
were fed every 3-4 days and, when confluent, were rinsed twice in PBS, fixed in 4% 
PFA for 20min, rinsed again twice in PBS and stored at 4°C in PBS. 
The protocol performed for the differentiation of the ovine iPSCs was similar, with 
only few modifications: before differentiation putative ovine iPSCs were grown in 
human ESC medium; on day 0 cells were seeded again in human ESC conditions, 
while on day 1 they were resuspended in human EB medium (KO-DMEM, 10% 
FCS, 2mM L-glutamine, 0.1mM non-essential amino acids and 100µM 
β-mercaptoethanol). EBs were then plated in gelatin-coated wells of a 24 well plate 
or in poly-L-lysine-coated plates or glass chambers. 
 
2.3 Viral transduction and reprogramming 
 
2.3.1 Moloney Murine Leukaemia viral and lentiviral vector packaging 
A total of 3x106 cells HEK 293T/17 cells were plated in a gelatin-coated 10cm dish 
in HEK medium. When at 70% of confluence, they were transfected using FuGENE 
HD Transfection Reagent (Roche, 04709691001) according to the manufacturer’s 
recommendation. The transfection was carried out as follows: 





- Expression vector 8  µg 
- Packaging vector 8  µg 
- OPTI-MEM I Reduced Serum Medium (Invitrogen 
  31985) to a final volume of     
 
600  µl 
  
Oct4-EGFP and CMV-EGFP:  
- Expression vector    6.5µg 
- pLP1    5   µg 
- pLP2    2.5µg 
- pVSV-G    2   µg 
- OPTI-MEM I Reduced Serum Medium to a 




The solution was mixed and 68µl of Fugene HD were added. The mix was left for 
20min at RT and added dropwise to the cells. The day after the medium was 
removed and replaced with 6ml of fresh HEK medium. After 24h the supernatant 
was taken, filtered with a 0.45µm filter and either immediately used for transduction 
or frozen -20°C in 1ml aliquots. 
The packaging vectors employed for MoMLV packaging were pCL-Eco Retrovirus 
Packaging Vector (Imgenex, 10045P) or pCL-10A1 Packaging Vector (Imgenex, 
10047P). The expression vectors utilized for MoMLV packaging were pMXs-cMyc, 
pMXs-Klf4, pMXs-Oct4, pMXs-Sox2 (Addgene) and pCLXSN-GFP (provided by 
Gillian Parham). The packaging vectors employed for lentiviral packaging were 
pLP1, pLP2  and pVSV-G (Invitrogen).The expression vectors utilized for lentiviral 
packaging were Oct4-EGFP and CMV-EGFP (provided by Dr Debiao Zhao). 
 
2.3.2 Transduction of ovine induced pluripotent stem cells 
PGK-GFP (pRRL-PGK-eGFP-WPRE, Genethon), CAG-GFP (provided by Dr 
Simon Lillico) and Ubi-EGFP (provided by Dr Feifei Song) viruses were transduced 
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in ovine iPSCs in two different ways in order to assess which protocol resulted in a 
higher number of green cells. Cells were either transduced when subconfluent or 
transduced just after passage. 
For the first protocol cells were plated in one well of 12 well plate on feeders and, 
when subconfluent, the medium was renewed. After 3h medium was removed and 
500µl of medium containing 25µ of virus were added to the cells. After other 3h 
2.5ml of medium were included and the day after medium was renewed. Cells were 
looked at under the fluorescence microscope in order to estimate the number of green 
cells. 
According to the second protocol, when cells were subconfluent, medium was 
changed and, after 3h, cells were trypsinized, feeders were removed and cells were 
seeded again in a new well of 12 well plate on feeders with 200µl of medium 
supplemented with 25µl of virus. After other 3h 2.5ml of medium were included and 
the day after medium was renewed. Cells were looked at under the fluorescence 
microscope in order to estimate the number of green cells. 
 
2.3.3 Reprogramming transduction 
For the reprogramming of mouse cells, a total of 1.3x105 passage 2 MFFs were 
seeded in each well of a 6 well plate on 2x105 SNL feeder layer in 2ml fibroblast 
medium. The day after (day 0), the medium was removed and 1ml of each fresh viral 
vector carrying a different reprogramming gene (cMyc, Klf4, Oct4 or Sox2) was 
added to the MFFs, after being supplemented with 4µg/ml of polybrene. One well of 
MFFs was not transduced to be used as negative control. After 5h, 2ml of fresh HEK 
medium was added. The same viral transduction was repeated the day after. At day 2 
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the HEK medium containing the viral vectors was replaced with MFF medium. At 
day 3 fibroblast medium was replaced with mouse ESC medium. 
For the reprogramming of ovine cells the protocol was slightly modified: 1.3x105 
OFFs at passage 6 were plated in each of 5 gelatin-coated wells of a 6 well plate in 
2ml of fibroblast medium. At day 0 and day 1 the cells were transduced with the four 
viral vectors (1ml of each) supplemented with 4µg/ml of polybrene. One well of 
MFFs was transduced with pCLXSN-GFP for the double aim of being used as 
negative control and of verifying the ability of the amphotropic viral vector to 
transduce OFFs. On day 2 the ovine fibroblasts were passaged to a new 6 well plate 
(4x104 cells/well) on SNL feeder cells. On day 4 the fibroblast medium was replaced 
with mouse ESC medium in 2 wells and human ESC medium in the other 2 wells. 
 
2.3.4 Picking colonies 
In order to pick colonies ESC medium was removed from the plates and cells were 
washed twice with warm PBS. A thin layer of PBS was left in the plated in order to 
avoid the cells to dry. The colonies were dislodged from the feeders by pipetting up 
and down with a Gilson pipette and each colony was transferred in a round bottom 
well of a 96 well plate. To disaggregate the cells 30µl of trypsin were added and left 
for 10min. Afterwards, 70µl ESC medium were added and colonies were transferred 
to gelatin-coated wells of 96 well plate on SNL feeder layer (5x103 cells/well) in 









2.4.1 Giemsa staining 
Medium was removed and cells were washed twice in PBS. A 3% Giemsa's stain 
improved R66 solution Gurr (VWR) was added to the cells and left for 20min at RT. 
Wells were then rinsed with water and left to dry. 
 
2.4.2 Alkaline Phosphatase staining 
Alkaline Phosphatase (AP) staining of pluripotent colonies was performed with 
Leukocyte Alkaline Phosphatase Kit (Sigma, 86R-1KT). 
Before the staining cells were washed twice with PBS, fixed with 4%PFA for 20min 
at RT, washed again twice with PBS. For a 24 well plate 0.2ml of Sodium Nitrite 
Solution were added to 0.2ml of FRV-Alkaline Solution, then mixed by gentle 
inversion and allowed to stand for 2min. Nine millilitres of deionized water were 
added, the solution was mixed and 0.2ml Naphthol AS-BI Alkaline Solution was 
included. At this point the tube was wrapped in foil because the resulting solution is 
light-sensitive. After mixing thoroughly, 0.35ml were added into each well. Plates 
were wrapped in foil and left overnight. The following day the stain was removed 
and cells were rinsed with PBS. Positive cells were pink. 
 
2.4.3 Immunofluorescence 
For immunocytochemistry against intracellular markers cells were permeabilized for 
20min at RT. For both intracellular and surface markers, cells were blocked from 1h 
to 2h at RT. Primary antibodies were diluted in the blocking solution and applied to 
the cells overnight at 4˚C. Plates were then washed four times for 5min in washing 
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buffer and blocked again for 15min at RT. The appropriate FITC conjugated 
secondary antibody was diluted in washing solution (in blocking buffer for Nanog) 
and added to the cells for 1h to 2h at RT in the dark. Cells were later washed four 
times for 5min in PBST and the nuclei were stained with 1µg/ml of DAPI (Sigma). 
The markers, their corresponding antibodies and the condition employed for each 
antibody are listed in table 5. 
 
2.4.4 Metaphase spreads 
Subconfluent cells growing in a T25cm2 flask were passaged at 1:3 ratio in a 
gelatin-coated well of 6wp, without separating cells from the feeders. The day after 
the medium was renewed and 5ml of fresh medium supplemented with 0.1µg/ml of 
KaryoMAX Colcemid Solution (Invitrogen, 15210-040) for 1.5-2h at 37°C. Medium 
was then removed, cells were washed once with PBS and dissociated with trypsin.  
Trypsin was not quenched with serum, but diluted in 5ml of PBS. The suspension 
was pipetted to disaggregate the cells, transferred into a Falcon tube and centrifuged 
at 250g for 8min. The supernatant was discarded and the tube flicked to release the 
pellet into the remaining supernatant. The amount of 10ml of 75mM KCl were 
added, and the suspension was mixed and incubated for 8-15min at 37°C. 
One77millilitre of ice-cold 3:1 methanol/acetic acid was added at RT, the cells were 
centrifuge at 200g for 5min and the supernatant was removed. The pellet was 
resuspended in 5ml of ice-cold 3:1 methanol/acetic acid, the cells were then 
centrifuged at 200g for 5min and the supernatant was discarded. This last step was 
repeated two more times. The cells were then suspended in 1ml of ice-cold 3:1 
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methanol/acetic acid and spread on a glass microscope slide refrigerated at 4°C in 
70% Ethanol: 10-20µl were dropped onto the slide and blown briskly. Slides were 
kept at 70-80°C overnight and stained with 10% Giemsa. 
 
2.4.5 Population doubling time 
Ovine iPSCs were seeded at low density (3.55x104 cells per well of a 48 well plate) 
and counted in triplicates every 12h for 96h. Using MiniTab, a linear regression was 
performed on the exponential phase of the growth curve to establish population 
doubling time. After evaluation of the data with MiniTab, two outliers (mouse ESCs 
at 48h and G2 cells at 72h) were excluded from the analysis. 
 
2.4.6 STAT3 induction assay 
OFFs, MFFs, ovine iPSCs and mouse ESCs were seeded each on 
gelatin-coated wells of a 6 well plate, in the appropriate culture medium. When 
subconfluent, the medium was removed and fresh medium without LIF, bFGF, FCS 
or SR (starvation media) was added to starve the cells. After 4h one well for each cell 
line was trypsinized and cells were counted; starving media supplemented with 
mouse LIF (1000U/ml) but without SR or FCS were added to the remaining wells 
(200µl/well). Cells were incubated at 37°C for 10min, then medium was removed, 
cells washed with PBS and 125µ of SDS lysis buffer (10% Glycerol, 3% SDS, 
62.5mM TrisHCl pH 6.8, 0.005% Bromophenol Blue, 3% β mercaptoethanol) were 
added directly into the wells. The plates were incubated on a rocking table for 20min 
at 4°C on ice. Remaining on ice, the wells were scraped and the lysates collected 
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with a p1000 and transferred in 1.5ml tubes. Samples were frozen at -20°C and later 
used for western blot. 
 
2.4.7 Western immunoblotting 
Reagents employed for Western Blot are listed in table 6. Samples were thawed in a 
37°C heating block, placed on ice and sonicated for 8min. Tubes were  flicked and if 
the samples were still viscous they were sonicated again. Just before loading, the 
samples were heated to 98°C for 5min, vortexed and centrifuged for 30s. NuPAGE 
Novex 7% Tris-Acetate Gel 1.0 mm, 10 well (Invitrogen, EA0355) was inserted into 
the running chamber; 10µl of Precision Plus Protein All Blue Standards (BioRad, 
161-0373) were loaded into the gel. The samples were loaded at different volumes, 
which were calculated in order to load the amount of protein extracted from the same 
amount of cells (26.56x104 cells) for all cell lines. 
A total of 500µl of antioxidant was added in cold 200ml running buffer (NuPage 
Tris-Acetate SDS Running Buffer, Invitrogen, LA0041), the mix was poured into the 
running chamber and the gel was allowed to run for 1h at 200V. 
The gel was then blotted onto a nitrocellulose membrane: materials previously 
immersed in transfer buffer were assembled with the gel in the following order into a 
cassette: sponge, paper, membrane, gel, paper and sponge. The cassette was 
assembled into the transfer tank with the protein side of the gel facing the positive 
pole of the tank. The transfer was carried out at 28V for 2h 30min. 
The sandwich was then dismantled and the membrane, with the protein side up, was 
washed in TBST 4 times for 15min. Twenty millilitres of blocking solution were 
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Transfer buffer stock solution (10x)  
29.3g Glycine 
58g Tris  
18.8ml SDS 20%  
Bring to 1l with dH
2
O 
Transfer buffer  
100ml transfer buffer stock solution 10x 
200ml EtOH 100% 
700ml dH2O  
TBS 10x  
24.2g Tris 
80g NaCl  
Bring to 1l with dH2O 
pH 7.6 
TBST  
1x TBS  
Tween 0.1%  
dH2O  
Blocking solution  
5% dried skimmed milk (Marvel) 
1x TBST 
Transfer buffer stock solution (10x) 
29.3g Glycine 
58g Tris 
18.8ml SDS 20% 
Bring to 1l with dH2O 
Transfer buffer 
100ml transfer buffer stock solution 10x 
200ml EtOH 100% 
700ml dH2O  
 
Table 6. Solutions employed in the Western immunoblotting assay.  
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then added and the membrane was incubated over night at 4°C on a rocking plate. 
The day after the blocking solution was removed and an anti-phoshpoSTAT3 
primary antibody (Cell signalling, 9131), diluted 1:1000 in TBST, 5% BSA was 
added onto the membrane and incubated over night at 4°C on a rocking plate. The 
following day the membrane was rinsed 4 times for 15min in 20ml TBST on a 
rocking plate. An anti-rabbit secondary antibody (Cell signalling, 7074) diluted 
1:5000 in TBST, 10% blocking solution was added on the membrane and incubated 
1h at RT on a rocking plate. The membrane was then rinsed 4x15 min in 20ml TBST 
on a rocking plate. The Amersham ECL detection systems (GE Healthcare, 
RPN2109) was employed for detection: the ECL Detection reagents A + B were 
mixed at 1:1 ratio, added on the membrane and incubated for 5min. 
The excess of reagents was drained and the blot was placed between two 
transparency sheets side up in an X-ray film cassette and the film was exposed for 
3min. The blot was then rinsed in TBST for few minutes and 10ml of stripping 
buffer (Thermo Scientific, 21059) were added. The membrane was placed at 37°C 
for 20min on a rocking plate. The blot was then washed 4 times for 15min in TBST. 
An anti-β actin antibody (Sigma A3854) diluted 1:50000 in 5% dried skimmed milk 
(Marvel), TBST was added to the membrane and incubated for 1h at RT on a rocking 
plate. The detection step was performed again and the blot was exposed to the film 
for 30s. The membrane was stripped again and incubated with an anti-STAT3 
primary antibody (DB Transduction Laboratories, 610190) diluted 1:1000 in TBST, 
5% BSA over night at 4°C on a rocking plate. The blot was rinsed 4 times for 15min 
in 20ml TBST on a rocking plate and an anti-mouse secondary antibody (Cell 
signalling, 7076) diluted 1:5000 in TBST, 10% blocking solution was added. The 
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secondary antibody was incubated 1h at RT on a rocking plate. The detection step 
was performed and the blot was exposed to the film for 3min for STAT3. 
 
2.4.8 LIF withdrawal assay 
Ovine iPSCs and mouse ESCs were seeded at low density (1.3x105 cells/well in a 12 
well plate) on SNL feeder layer or gelatin in the appropriate media (mouse ESC 
medium or human ESC medium) in the presence or absence of mouse LIF. The 
medium was renewed daily and after 10 days the cells were fixed with 4% PFA and 
assessed for AP activity.  
 
2.4.9 In vivo differentiation of mouse and putative ovine pluripotent cells 
Ovine iPSCs resuspended in 100µl PBS were intramuscularly injected in the right leg 
of SCID mice (106 cells/mouse). After 3 to 5 weeks, mice were sacrificed. Tumours 
were collected and either enclosed in OCT embedding medium 
(Tissue-Tek) and snap frozen in liquid nitrogen for 2h or fixed in a formal saline 
solution (ddH2O, 4% w/v formaldehyde, 0.9% w/v NaCl) and paraffin embedded. 
Sometimes bones were included in the tumours, therefore, before paraffin 
embedding, the lumps were placed in at least 15 volumes of neutral EDTA solution 
(10% w/v EDTA, ddH2O, pH 7.4) which was changed daily in order to decalcify the 
tissues. 
Sections ranging from 3µm to 7µm were cut with the microtome or cryostat for 
paraffin embedded or frozen tissues respectively. The slides were stained with H&E 
or against markers of differentiation and histologically analysed. 
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2.4.10 Hematoxylin and eosin staining 
Slides were deparaffinised with 2 changes of xylene for 10min each, then rehydrated 
in 2 changes of absolute ethanol for 5min each. Sections were then left twice in 90% 
ethanol for 5min and twice in 70% ethanol for 5min. The slides were washed twice 
in distilled water for 5min and stained in hematoxylin (Sigma, MHS-16) solution for 
5min. They were then washed in running tap water for 5min and stained with 0.5% 
eosin for 2-3min. Slides were washed again in running tap water for 5min and 
dehydrated quickly (6 times for 2-3s) in 70% ethanol and 90% ethanol. The samples 
were then placed twice in 100% ethanol for 5min and once in xylene for 10min. In 
order to mount the slides, 2-3 drops of DPX mounting (Raymond A. Lamb) were 
added to the cover slip and the slide was placed on top of cover slip with section side 
down; the air bubbles where expelled by gently tapping on the cover slip. Slides were 
placed on a flat surface for at least 24h to allow the mounting solution to set. When 
looking at the microscope nuclei should be blue and cytoplasms pink to red. 
 
2.4.11 Immunohistochemistry 
Sections were cut, fixed in acetone for 2min at RT and then rinsed in 0.1M PBS for 
2min. They were post-fixed in fresh Periodate Lysine Paraformaldehyde solution for 
8min at room temperature, rinsed in PBS for 2min, rinsed in distilled water for 2min 
and transferred to Sequenza coverplates using filtered TBST (Tris buffered saline pH 
7.5, tween 20). The sections were later washed twice in TBST, incubated with 
diluted primary antibody for 1h at 25°C, rinsed three times in TBST and blocked 
with 100µl Dako Real blocker for 20min at room temperature. The slides were 
washed again three times in TBST and 100µl of Secondary link polymer complex 
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(Dako Envision kit) were added for 30min at 25°C. The sections were washed five 
times in TBST and allowed to drain completely. They were then rinsed in distilled 
water and allowed to drain completely. One hundred microlitres of DAB chromogen 
were added twice for 5mins at 25°C and the sections were washed once in TBST. 
Counterstaining was carried out with haematoxylin using the Gemini autostainer). 
The primary antibodies utilised were those already employed for 
immunocytochemistry, with the exception of the anti-cardiac troponin T antibody 
(Abcam, ab19615) and the anti-neurofilament antibody (Dako, M0762). 
 
2.5 Chimera production 
 
2.5.1 Ovary collection, in vitro maturation and in vitro fertilization 
Ovine ovaries were collected at the abattoir, maintained at 30°C during transport to 
the laboratory and washed in warm PBS. Follicular fluid was collected using an 
18-gauge needle and a 10ml syringe and placed into 15ml centrifuge tubes 
containing fresh warm wash medium (1x Medium 199, 4.76mM NaHCO3, 12.5mM 
HEPES, 112.5U/ml Heparin, 10.875µl/ml oestrus sheep serum, H2O, pH7.4). Good 
quality oocytes surrounded by a compact cumulus mass were selected and washed 
again three times in the wash medium and once in fresh maturation medium (1x 
Medium 199, 6.25mM NaHCO3, 2mM L-glutamine, 5ng/ml ovine FSH, 5ng/ml 
ovine LH, 0.5ng/ml estradiol, 250µl/ml oestrus sheep serum, H2O, pH7.6). The 
oocytes were eventually placed in 800µl of maturation medium in a 4-well Nunc 
tissue culture plate (40-50 oocytes/well) and incubated for approximately 22h at 5% 
CO2, 38.5°C. After this time, oocytes which have been matured to MII stage of 
development are prepared for fertilisation removing cumulus cells by pipetting in 
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wash medium. Oocytes surrounded by coronal cells were washed twice in 
fertilisation medium (SOF medium, 2% oestrus sheep serum, pH7.8) and fertilised 
with the upper fraction of ram semen pellets stored in liquid nitrogen and previously 
thawed and activated using a swim up technique (Parrish, 1986). Cells were then 
incubated at 5% CO2, 38.5°C and after 22-24h were washed twice in warm 
SOFaaBSA medium (SOF medium, 1x BME amino acids solution, 1x MEM non-
essential amino acids solution, 2mM L-glutamine, 4mg/ml BSA, pH7.4), removing 
the sperm and any remaining cumulus cells by gently pipetting. Fertilised oocytes 
were then placed into pre-equilibrated 4-well plates in SOFaaBSA medium and 
overlaid with mineral oil and culture in a 5% CO2, 5% O2 incubator at 38.5°C. After 
24h oocytes were checked to assess development and remove any that have not 
cleaved. 
 
2.5.2 Injection of ovine induced pluripotent stem cells in ovine embryos 
Ovine iPSCs were microinjected into day 6 or day 7 in vitro produced blastocysts as 
follows: starting from one subconfluent well of 6 well plate (50-70% confluent), 2-3h 
before harvesting the medium was changed, ovine iPSCs were trypsinized to obtain a 
single cell suspension and plated in a gelatin-coated T25cm2 flask. In order to 
separate the cells from the feeder layer, the flask was placed for 20min in the 
incubator at 37°C, 5% CO2. Immediately prior to microinjection, cells were 
collected, centrifuged, resuspended in 500µl of medium and stored at room 
temperature until microinjection was complete.  
 
 




2.5.3 Synchronization of recipients 
Sponges impregnated with 30mg cronolone (flugestone acetate) were inserted into 
the vagina of recipient ewes. The sponges remained in the vagina for 11 to 16 days. 
When removed the animals showed oestrus within 36-48h later. The insertion of the 
sponge was calculated so that the recipient ewes were at 6 days post oestrus when the 
blastocysts were at day 6.  
 
2.5.4 Embryo transfer 
Following microinjection, embryos were cultured until blastocyst stage in 850µl 
drops of SOFaaBSA under mineral oil at 38.5°C in an atmosphere of 5% CO2, 5% 
O2; SOFaaBSA, Synthetic Ovidictal Fluid (Walker, 1996) plus 1x essential and 
non-essential amino acids (Sigma, Poole, UK) and 4 mg/ml of fatty acid-free BSA 
(Sigma, Poole, UK). If these embryos developed into blastocysts they were then 
transferred in recipient ewes. Blastocysts that were micro-injected were transferred 
into recipient ewes on the same day as the micro-injection. Recipient ewes were 
selected from groups of cycling adults in which oestrus was synchronised using 
intravaginal progestagen sponges (Veramix, Upjohn). Oestrus was detected by 
introduction of vasectomised males. Animals that had exhibited oestrus 6 or 7 days 
previous to transfer were selected as recipients for blastocysts. Following a general 
anaesthetic a midline laparotomy was performed to expose the uterine tract. A small 
puncture was made in the uterine wall using a blunt 16-gauge needle and a 20ml 
Drummond positive pipette fitted with sterile ‘fire polished’ capillaries were used for 
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Viral vector strategy for induced pluripotent stem cell induction 





Originally, iPSCs were derived by transduction of four reprogramming genes (cMyc, 
Klf4, Oct4 and Sox2) by employing a MoML retroviral vector (Takahashi and 
Yamanaka, 2006). 
Later, more efficient or safer ways of delivering the reprogramming factors have 
been achieved: lentiviral vectors (Yu, 2007), piggyBac transposon/transposase 
systems (Woltjen, 2009), adenoviral vectors (Stadtfeld, 2008c; Zhou and Freed, 
2009) or transient expression of plasmids (Okita, 2008; Gonzalez, 2009) have been 
successfully exploited; additionally three independent groups achieved to generate 
iPSCs simply delivering the reprogramming proteins instead of employing genetic 
material (Kim, 2009a; Zhou, 2009; Cho, 2010). Other changes to the method 
regarded the choice of the genes to be used (Kim, 2009b; Wu, 2009; Bao, 2011) and 
the supplementation of small compounds able to change the epigenetic state of the 
DNA (Feng, 2009). 
 
The work described in this thesis had two main goals: repeating the published 
experiment to establish the protocol in our institute, then applying it to the ovine 
species. We started one year after the first report about iPSCs (Takahashi and 
Yamanaka, 2006) and the only published method about the isolation of iPSCs was 
based on retroviral transduction of the four pluripotency genes cMyc, Klf4, Oct4 and 
Sox2 (Takahashi and Yamanaka, 2006). We therefore carried out the mouse 
reprogramming according to this protocol. By the time the ovine experiment started, 
many new strategies were available, but, since the reprogramming in mouse had been 
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successful, we decided to replicate the viral vector-based protocol. While the overall 
method was maintained, we faced two main issues. The first regarded the tropism: in 
the mouse experiment the packaging vector employed (pCL-Eco) was able to 
transduce only murine cells, thus in the sheep protocol pCL-Eco was replaced by a 
similar vector (pCL-10A1) expressing a different envelop protein, known to target 
most mammalian cells. The second matter referred to the choice of the species of the 
reprogramming genes. 
 
In this chapter I will describe the rationale behind the reprogramming strategy we 
utilised for the generation of mouse iPSCs and ovine iPSCs. In addition, I will 
illustrate in details the expression and the packaging vectors. Their viability and 





3.2.1 Expression and packaging plasmids 
The expression plasmids employed in the isolation of iPSCs were generated by 
Takahashi et al (Takahashi and Yamanaka, 2006) starting from the MoMLV-based 
retroviral plasmid pMXs (Kitamura, 2003) by employing the Gateway Technology. 
Briefly a Gateway cassette rfA was introduced into the retroviral plasmid pMXs and 
the four reprogramming genes were amplified by RT-PCR, cloned into appropriate 
plasmids and recombined in the pMXs backbone. 
The resulting pMXs reprogramming plasmids (Fig. 7a) harbour 5’ and 3’ long 
 





Figure 7. Schematic map of the plasmids employed for the murine and ovine reprogramming. a) The 
expression vector is composed of the cDNA of one of the reprogramming genes (represented by the 
grey box) which is under the control of the MoMLV promoter. In order to accommodate the 
exogenous cDNA and to make the vectors replication-defective pol, env and part of gag were 
removed. b) The packaging plasmid harbours the gag (yellow box), pol (green box) and env (pink 
box) genes required for the packaging under the control of a constitutive promoter (aquamarine box), 
but does not contain the packaging signal, so that the viral transcript will not be able to form a proper 
virus and does not carry the enhancer in U3 either, so that, once integrated, the retroviral sequence 
will lack a functional promoter in the 5’LTR. LTR (blue box): long terminal repeats; SD: splice donor 
site; SA: splice acceptor sit; Ψ: packaging signal; ∆gag: truncated gag sequence; att (red box): sites 
generated by the recombination reaction; CMV (aquamarine box): human cytomegalovirus immediate 
early enhancer-promoter.  
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terminal repeats (LTRs) which not only are essential for the integration in the host 
genome, but also drive the transcription of the viral genome. The expression 
plasmids also carry an extended packaging signal necessary for the efficient 
encapsidation of viral genomes and the cDNA of the reprogramming genes; 
furthermore they have the viral splice donor and acceptor sequences that are required 
for the generation of the sub-genomic viral mRNA carrying the reprogramming 
sequences. In order to avoid the production of the viral full-length genome RNA, the 
ATG start codon for gag was disrupted and four stop codons were inserted in 
different positions through the gag ORF: one downstream of the CTG start codon 
and the others in the three different reading frames, just before the Gateway site 
(Kitamura, 2003). 
Due to the lack of functional gag, pol and env genes in the expression plasmids, these 
factors need to be supplied in trans for the correct encapsidation of the viral genome 
into viral particles. This was obtained through the co-transfection of the pMXs 
reprogramming vectors and a packaging plasmid in 293T cells. The packaging 
plasmids employed in the mouse and ovine experiments are pCL-Eco Retrovirus 
Packaging Vector and pCL-10A1 Packaging Vector (Fig. 7b) respectively. Both of 
them express the MoMLV gag, pol and env proteins at high levels and with a 
balanced stoichiometry. The enhancer in U3 and the packaging signal are deleted to 
make the helper genome transcriptionally inactive and unable to be packaged 
(Naviaux, 1996). The pCL-Eco and pCL-10A1 vectors differ only for their tropism, 
which is given by the envelop glycoprotein gp70: in pCL-Eco gp70 is ecotropic, 
while in pCL-10A1 gp70 is amphotropic. 
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3.2.2 Viability of Moloney murine leukaemia vectors and expression of the 
reprogramming proteins 
Before the reprogramming experiment, the ability of the viral vectors to express the 
reprogramming proteins was tested. Due to the lack of any selectable markers or 
reporter genes in the reprogramming plasmids, the validation of the MoML viral 
vectors was performed through immunocytochemistry which was carried out on 
immortalized MFFs transduced with serial dilutions (ranging from 10-1 to 10-6) of the 
reprogramming vectors. The MoML viral vectors were separately packaged 
(Nakagawa, 2008) in 293T cells and stored at -80°C until use. For the transduction, 
cells were plated at low density (3x104 cells/well in a 24 well plate) so that they 
would not reach confluence in the following 4-5 days. The day after, the virus diluted 
in MFF medium and supplemented with 4µg/ml polybrene was added to the wells. 
After 24h medium was replaced and at day 4 or 5 cells were fixed with 4% PFA for 
immunostaining. Each well was transduced with only one type of virus. In each 
staining, non-transduced immortalized MFFs were employed as negative control, 
whereas mouse ESCs were employed as positive control. 
As shown in figure 8, Oct4-transduced MFFs were Oct4-positive with the staining 
restricted to the nucleus which is the typical localization of this protein. The negative 
control and the sample displayed some background, with a signal localized in the 
cytoplasm and much fainter than the one observed in the mouse ESCs; nonetheless, 
in the Oct4-transduced MFFs it was clearly possible to recognize, above the 
background, few fluorescent cells which are not visible in the non-transduced MFFs. 
The efficiency of the MoML viral vector expressing Oct4 was calculated as a ratio 
  




Figure 8. Immunocytochemistry of Oct4 transduced MFFs (Oct4-MFFs). Mouse ESCs (mESCs) 
represent the positive control, MFFs represent the negative control. Only the 10 time virus dilution is 
shown. Images were taken at 10x magnification. Scale bars: 100µm.  
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between the Oct4-positive cells and the total number of cells and was estimated to be 
around 34%. 
Despite some background in Sox2 immunocytochemistry, the signal was brighter and 
the proportion of green cells much higher (the efficiency was around 73%) than for 
Oct4 (Fig. 9). Again, while the background gave some fluorescence in the cytoplasm, 
Sox2 staining was clearly localized in the nucleus. 
In contrast to Oct4 and Sox2, Klf4 is expressed also in MFFs, so these cells cannot 
be a real negative control. However, we assumed that Klf4 expression in transduced 
MFFs would be significantly increased compared to that in non-transduced MFFs. 
Indeed, both transduced and non-transduced MFFs were Klf4-positive, but the 
number of stained cells was higher in transduced MFFs (Fig. 10), suggesting that 
Klf4 MoMLV was able to produce the Klf4 protein. Since both transduced and 
non-transduced cells were fluorescent, it was not possible to discriminate between 
endogenous and exogenous Klf4, therefore the efficiency was not calculated. 
Although the transduction to validate the reprogramming plasmids was performed on 
all the four genes, we were unable to obtain any results about the MoML vector 
carrying cMyc due to problems with the anti-cMyc antibody. An optimisation for the 
staining was performed in the laboratory using different dilutions of the primary and 
secondary antibodies with no success: the negative control was always positive, 
suggesting a poor specificity of the cMyc antibody. 
 
MoML viral vectors are known to be extremely sensitive to freezing/thawing cycles 
(Takahashi, 2007a); additionally their viability is substantially reduced when they are 
filtered after thawing. Both situations happened when the MFFs were transduced for 





Figure 9. Immunocytochemistry of Sox2 transduced MFFs (Sox2-MFFs). Mouse ES cells (mESCs) 
represent the positive control, MFFs represent the negative control. Only the 10 time virus dilution is 
shown. Images were taken at 10x magnification. Scale bars: 100µm. 
  





Figure 10. Immunocytochemistry of Klf4 transduced MFFs (Klf4-MFFs). Mouse ESCs (mESCs) 
represent the positive control. Although positive for Klf4, MFFs represent the negative control 
because their Klf4 expression is expected to be lower than that in Klf4-transduced MFFs. Only the 10 
time virus dilution is shown. Images were taken at 10x magnification. Scale bars: 100µm. 
  
_________________Viral vector strategy for induced pluripotent stem cell induction 
99 
 
the validation protocol. Therefore Sox2 was chosen among the four genes to be 
packaged again and transduced fresh into MFFs to assess whether the expression of 
the exogenous genes could be increased following the new protocol (Fig. 11). This 
was achieved: indeed the proportion of green cells raised from 73% obtained with the 
frozen virus to 99.7% with the fresh virus. 
 
3.2.3 Sequence alignment of murine and ovine reprogramming genes 
As already mentioned in the introduction to this chapter, for the ovine experiment we 
had to decide whether to employ the murine reprogramming genes already tested or 
to clone and use the ovine genes. The use of ovine orthologous genes is intrinsically 
more appealing but for a number of practical reasons we elected to use the mouse 
cDNAs. First, the mouse vectors were readily available and available in appropriate 
expression vectors. Second, the ovine sequences required to be identified, amplified 
and cloned. Third, the then status of knowledge of the ovine genome sequences was 
rudimentary; specifically the ovine sequences for Klf4 and Oct4 were not available. 
In order to evaluate whether the murine genes could be employed in place of the 
ovine equivalent genes, the amino acid homology between the proteins of the two 
different species was investigated (Fig. 12): sheep and mouse cMyc and Sox2 were 
compared and found 91.8% and 98.1% homologous respectively. Due to the lack of 
ovine Klf4 and Oct4 sequences and since bovine and ovine genomes are very closely 
related (Echard, 1994), B. taurus orthologs were chosen for the comparison with the 
mouse proteins as a replacement for the unavailable sheep sequences. We aligned the 
bovine and murine proteins and found again a high sequence homology (92.7% for 
Klf4, 81.9% for Oct4). 






Figure 11. Additional immunocytochemistry of Sox2 transduced MFFs (Sox2-MFFs). Mouse ESCs 
(mESCs) represent the positive control, MFFs represent the negative control. The Sox2 staining was 
performed on MFFs transduced with fresh virus. It is evident that the efficiency of MoML viral 
vectors is strongly increased when the viruses are not stored frozen. Images were taken at 10x 
magnification. Scale bars: 100µm.  
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Although electing to work with the mouse genes we initially started to isolate the 
ovine orthologs. As soon as ESC-like colonies started to appear we decided to focus 
on these cells rather than continue with isolation of the sheep genes. 
 
3.3 Discussion 
Several experimental strategies have been developed for the derivation of iPSCs. 
While non-integrating methods eliminate the risks associated with genome 
modifications, thus having broader applications in human regenerative medicine and 
in those fields where the generation of chimeric animals is required, retroviruses are 
still one of the most efficient ways for the production of iPSCs (Sommer and 
Mostoslavsky, 2010). 
MoMLV is one of the first viruses employed for the delivery of genetic material into 
host cells and it is still widely used (Barquinero, 2004) despite some drawbacks: its 
infectivity is limited to dividing cells (Miller, 1990), thus restricting the range of cell 
types that can be transduced; additionally MoMLV is known to undergo silencing in 
ESCs (Jahner, 1982; Wolf and Goff, 2007). The latter characteristics which is 
considered as a limitation for the application of the MoML viral vector in ESCs, 
provides a useful tool for direct reprogramming since only clones whose transgene 
expression has been silenced are considered authentic iPSCs (Maherali and 
Hochedlinger, 2008). This important feature of MoMLV-based vectors gives them an 
advantage above lentiviral vectors, a subclass of retroviruses which MoMLV does 
not belong to: although having a slightly higher efficiency of reprogramming 
(Stadtfeld, 2008b) and although able to transduce also non-dividing cells (Naldini, 
1996), lentiviruses do not undergo silencing. 


















Figure 12. Amino acid alignment of mouse and ovine cMyc and Sox2 and of mouse and bovine Klf4 
and Oct4, calculated utilising the SIM alignment tool for protein sequences. The sequence similarity 
of the orthologs is very high: above 90% for cMyc, Klf4 and Sox2 orthologous, while above 80% for 
Oct4 orthologous. 
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At the time of our mouse experiment the MoML retroviral strategy was the only 
published method. When starting the ovine reprogramming we utilised again the 
MoML viral vectors for two main reasons: we had already employed these vectors 
successfully in mouse reprogramming and they carry a major advantage, which is the 
ability to be silenced in pluripotent cells. 
 
Once selected the vectors, viruses carrying the four reprogramming factors were 
packaged and their efficiency was analysed. The titre of retrovirus is extremely 
important for iPSCs generation (Takahashi, 2007a). Often viral vectors carry either a 
reporter gene, which allows the quantification of the transduced colonies (i.e. with a 
GFP reporter gene the transduced cells will be green) or an antibiotic resistance gene 
that permits the selection of the transduced cells. Since the pMXs plasmids did not 
possess either of those strategies, we decided to evaluate the viability of the vectors 
through immunocytochemistry, transducing 293T cells with serial dilution of the 
viruses and staining them against the reprogramming factors. The efficiency of the 
transduction was calculated as the ratio between positive and total cells in a 
representative field of the microscope. This calculation does not provide an accurate 
titre as the result depends upon different factors (e.g. the expression levels driven 
from the plasmids, the protein stability, the immunocytochemistry protocol); 
however positive staining gives a clear evidence of the viability of the viruses and 
their ability to express the proteins of interest in MFFs. 
 
During Takahashi and Yamanaka’s reprogramming experiment the integration 
efficiency of their retroviral vectors was measured with a pMXs-based virus 
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expressing GFP and was found higher than 70% (Takahashi, 2007a). Initially, when 
validating my vectors, the efficiency was lower, reflecting the use of vectors from 
frozen virus stock. After repeating the protocol with fresh virus we notice that the 
viability of the MoML viral vector carrying Sox2 was greatly increased. Additionally 
during the validation protocol the viruses were diluted at least 10 times, while in the 
iPSC experiment they were to be used as a concentrated stock. 
Unfortunately, due to problems with the antibody, it was not possible to show the 
presence of cMyc through immunocytochemistry. Despite at different levels, the 
other three viral vectors proved to be viable, able to infect MFFs and capable of 
expressing the reprogramming factors. Since the vector carrying cMyc was the same 
as the vectors carrying Klf4, Oct4 and Sox2 and since the cMyc virus was packaged 
according to the same protocol employed for the other retroviral vectors, I assumed 
that the cMyc MoMLV production was successful. Note also that it was 
demonstrated that cMyc, although increasing the iPSCs isolation rate, is dispensable 
for the reprogramming process (Wernig, 2008b). 
Combining the above data and conclusions, I resolved that the yield of MoML viral 
vectors was acceptable to perform the transduction for iPSCs isolation as described 






Derivation and characterization of putative mouse induced pluripotent stem 
cells 




The aims of the current work were twofold: to repeat the work published by 
Takahashi and Yamanaka regarding the isolation of iPSCs in mouse (Takahashi and 
Yamanaka, 2006) and to then extend this to the derivation of iPSCs in sheep. 
In the first iPSC report, mouse foetal or adult fibroblasts were transduced with 
retroviruses carrying cMyc, Klf4, Oct4 and Sox2 in order to drive the cells toward a 
pluripotent state. A selectable marker driven by the promoter of Fbx15, a gene 
expressed in mouse ESCs, was employed to recognise the reprogrammed cells 
(Takahashi and Yamanaka, 2006): when the dedifferention had occurred, Fbx15 
promoter would have been switched on and the cells would have become resistant to 
the antibiotic. The expression cassette carrying the selectable marker was integrated 
in the genome of the experimental fibroblasts. Many ESC-like colonies were 
generated with this strategy, but none were able to give rise to live chimeras. 
In other studies the iPSC generation technique was optimized by placing the 
selectable marker under the control of Oct4 or Nanog promoters: both genes are 
present in ESCs, but in contrast to Fbx15 their expression is required for the 
maintenance of pluripotency (Maherali, 2007; Okita, 2007; Wernig, 2007). In these 
studies the iPSCs proved their ability to contribute to adult animals after injection in 
blastocysts (Maherali, 2007; Okita, 2007; Wernig, 2007) and to go germline (Okita, 
2007; Wernig, 2007). 
During the numerous attempts to derive iPSCs using antibiotic resistance genes, the 
evidence arose that the later the selection was applied, the more ESC-like colonies 
would appear (Maherali, 2007; Okita, 2007). This led to the successful attempt to 
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isolate iPSCs without any antibiotic resistance or reporter genes (Maherali, 2007; 
Meissner, 2007). 
 
In this chapter I will describe the experimental steps taken towards the derivation of 
mouse iPSCs. I will additionally illustrate the assays performed in order to 
characterise the newly generated cells, specifically immunocytochemistry and in 




4.2.1 Selection strategy for the induced pluripotent stem cell isolation 
My initial strategy for the derivation of iPSCs included the use of a marker: a 
selectable gene or a reporter gene placed under the control of the promoter of a 
pluripotency-specific gene and integrated into the genomic DNA of the cells that 
were going to be reprogrammed would have allowed to discern between 
reprogrammed and non-reprogrammed cells. Yet this required the creation of new 
chimeric mice carrying an appropriate expression cassette, which is a long process. 
Mice expressing the neomycin resistance gene under the control of the mouse Oct4 
promoter were already available at the Roslin Institute (McWhir, 1996); however 
these mice were old and not able to give offspring anymore. Consequently, in 
parallel to the Oct-Neo mouse strategy, I decided to employ a lentiviral vector 
expressing GFP under the control of the human Oct4 promoter (Fig. 13). This vector 
would be transduced into MFFs together with the four factors, so that the 
reprogrammed cells would fluoresce green. 
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First I verified whether the human Oct4 promoter was active in mouse: mouse ESCs 
were seeded into a gelatin-coated 6 well plate (106 cells/well) and the following day 
were transfected with 4µg of Oct4-EGFP plasmid; pEGFP-C1, a plasmid expressing 
GFP under the control of a constitutive promoter, was transfected at the same time as 
positive control. Even though the transfection of the Oct4-EGFP plasmid was not 
very efficient, one day after transfection the cells clearly displayed bright green spots 
(Fig. 14). 
After assessing that the species difference did not affect the activation of the 
promoter, the virus was packaged. In order to monitor the lentiviral production 
protocol, since Oct4-EGFP is only active in ESCs, we packaged in parallel a 
lentiviral vector expressing EGFP under the control of the CMV promoter (Fig. 15). 
When 293T cells, plated in 10cm dishes, reached 70% of confluence, they were 
transfected with 6.5µg of Oct4-EGFP or CMV-EGFP plasmid, 5µg of pLP1 
(carrying the gag/pol gene, whose expression was made rev-dependent), 2.5µg of 
pLP2 (coding for the rev protein) and 2µg of pLP/VSV-G plasmid (harbouring the 
envelope G glycoprotein from Vesicular Stomatitis Virus, which allows the 
production of a virus with a broad host range). Three days post transfection, when 
the supernatant containing the viral particles was collected, the cells were analysed at 
the fluorescence microscope in order to determine whether the transfection was 
successful: most CMV-EGFP transduced cells were fluorescent (Fig. 16), thus 
confirming the vectors penetrated into the cells. Also few Oct4-EGFP cells showed 
EGFP expression; this was not expected for the Oct4 promoter is supposed to be 
active only in ESCs (Tada, 2001; Pan, 2002; Kimura, 2004): the fluorescence 
 






Figure 14. Bright field and fluorescence images of mouse ESCs transfected with Oct-EGFP and the 
positive control pEGFP-C1. The plasmid pEGFP-C1 carries an expression cassette where the EGFP 
gene is driver by a CMV constitutive promoter. The negative control is represented by transfection of 
reagents only. Scale bars: 250µm. 
  











































































































































































































































































































































































































































Figure 16. Oct4-EGFP packaging: 293T cells were monitored three days after transfection to ensure 
the protocol was successful. CMV-EGFP virus was packaged and monitored at the same time as a 
control of the reaction. The negative control is represented by the packaging protocol of a virus that 
carried no reporter genes. The green cells in the CMV-EGFP and Oct4-EGFP plates confirmed that 
the transfection had taken place and that the expression cassettes of both plasmids were functional. 
Scale bars: 250µm.  
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observed is likely due to leaky expression of the Oct4 promoter rather than to its real 
activation. 
In order to verify whether the packaging protocol was successful, the CMV-EGFP 
virus was titred in 293T cells. Since the two lentiviruses are built on the same 
backbone and had been packaged at the same time, this could give a preliminary 
figure of the titre of Oct4-EGFP virus. 
Cells were plated at low density (7x104 cells/well in a 24 well plate) and, 24h later, 
were transduced in duplicate with serial dilutions (ranging between 10-1 and 10-4) of 
viral particles. Two days afterward the cells were monitored, but no fluorescence was 
visible, indicating that either the virus was not viable or the EGFP expression was 
too low to be detected. The packaging was repeated two more times employing fresh 
expression and packaging plasmids and the titration was performed supplementing 
the virus with 4µg/ml polybrene, which improves the transduction by neutralizing the 
charge repulsion between viral membrane and cell surface (Davis, 2004). Again, no 
green fluorescing cells were observed. This was unexpected and never resolved; it is 
indeed worth mentioning that, at the time others in the lentiviral laboratory 
experienced similar problems with different vectors. 
Due to the inability to produce efficient Oct4-EGFP viral vectors, we decided to 
isolate iPSCs only upon morphology criteria, supported by the success achieved by 
other groups following this protocol (Maherali, 2007; Meissner, 2007). 
 
4.2.2 Transduction of mouse foetal fibroblasts 
A schematic representation of the reprogramming process is shown in figure 17. 
 





Figure 17. The diagram shows the experiment time line of the mouse iPSC reprogramming: the 
packaging protocol for the 4 retroviral vectors (cMyc, Klf4, Oct4 and Sox2 viral vectors) was started 3 
days before transduction; 1 day before transduction MFFs were seeded in fibroblast medium. The day 
of the transduction (day 0), the medium was removed from the MFFs and each fresh viral vector 
carrying a different reprogramming gene (cMyc, Klf4, Oct4 or Sox2) was added to the MFFs, after 
being supplemented with 4µg/ml of polybrene. The same viral transduction was repeated the day 
after. At day 3 fibroblast medium was replaced with mouse ESC medium. The first colonies appeared 
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MFFs at passage 2 (Fig. 18a) were seeded in a 6 well plate (1.3x105 cells/well) on a 
feeder layer composed of 1.5x105 irradiated SNL cells/well. The day after, the MFFs 
were transduced twice (on day 0 and day 1) with four MoML viral vectors (1ml 
each), each carrying one reprogramming factor (cMyc, Klf4, Oct4 or Sox2). On day 
4 fibroblast medium was replaced with mouse ESC medium. In the following days 
the cells were examined for changes indicative of transformation events such as 
morphological alterations, loss of contact inhibition, increased growth rate, lack of 
senescence. On day 6 the transduced fibroblasts started changing morphology. Seven 
days after the transduction, foci of increased growth emerged and small ESC-like 
colonies appeared in the experimental MFFs (Fig. 18b), in contrast to the control 
where no aggregates of cells could be detected (Fig. 18c). 
To ease the handling of the cells, I decided to follow the strategy employed by 
Meissner et al (Meissner, 2007) who assumed that reprogrammed cells would have 
outgrown the starting fibroblasts; based on this assumption this group attempted to 
generate iPSCs by passaging the entire plate instead of picking colonies. Many small 
colonies appeared every 2-3 days after passaging (Fig. 18d), but they were not 
allowed to become large because every 4-5 days the cells would become confluent 
and would need to be passaged (Fig. 18e). When the cells reached passage 6, the 
non-transformed MFFs around the experimental putative iPSCs became senescent 
and stopped proliferating allowing ESC-like colonies to grow and be picked. 
A total of 211 colonies was picked at different time points (on day 17, 19, 25, 33 and 
34 days post-transduction), disaggregated and seeded on SNL feeder layer (3.5x103 
cells/well in 96 well plate) in mouse ESC medium. After picking, most of the 
 





Figure 18. (a) MFFs before the transduction with the four genes. (b) 4-gene MFFs at day 7 after 
transduction: the first colonies started appearing among the fibroblasts. (c) Non-transduced control 
MFFs at day 7 after transduction: no colonies could be located. (d) Example of a small colony 
appearing after the cells were passaged. (e) Confluent plate of 4-genes transduced MFFs. (f) An 
established putative mouse iPSC line at passage 10 after transduction, displaying a morphology 
similar to that of ESCs. Scale bars: 100µm for (a), (b), (d) and (f); 5µm for (c) and 250µm for (e).  
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colonies became flat. Based on morphology, I selected and expanded 4 colonies 
focussing on those clones whose appearance was more similar to that of mouse 
ESCs, with round bodies and sharp edges (Fig. 18f). 
 
4.2.3 Colony-formation efficiency 
In the experiment described above, the cells became quickly confluent and had to be 
passaged; consequently it was not possible to calculate the efficiency of 
reprogramming because it cannot be excluded that distinct iPSC lines were derived 
from the same reprogrammed parental cell. Another transduction was therefore 
carried out to assess the efficiency of reprogramming. Due to the lack of reporter 
genes, Giemsa staining was employed to mark the colonies so that it was possible to 
count theme. 
The protocol employed this time was slightly different from the previous: after the 
transduction MFFs were plated at much lower density (4x104 cells/well in 6 well 
plates), so that it could be possible to maintain the cells without passaging them. 
Twenty days post transduction experimental and control MFFs were stained with 
Giemsa. While in the control MFFs no aggregates of cells were detectable, the 
4-gene transduced fibroblasts gave rise to many colonies (Fig. 19a). The colonies 
were counted and the efficiency was expressed as the percentage of the ratio between 
the number of colonies and the number of seeded cells (Fig. 19b). Surprisingly, the 
four replicates, although performed following an identical protocol, yielded a 
considerably different number of colonies. 
In this experiment the efficiency of colony formation was very high, reaching 13.2%  
 




Figure 19. (a) Giemsa staining of 4-gene transduced MFFs 20 days after transduction. (b) The table 
shows the efficiency of the reprogramming process: the colonies generated by the transduction of the 
four reprogramming genes were counted and divided by the total number of cells seeded; the 
assumption is that each colony comes from a single reprogrammed cell.  
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in one of the four replicates. During reprogramming, however, only a partial number 
of the total colonies appearing during the early phases will develop in authentic 
iPSCs (Hotta and Ellis, 2008). Since Giemsa does not have any specificity for 
pluripotent cells, part of the stained colonies might represent only partially 
reprogrammed cells. As a result, it is not possible to compare the efficiency 
calculated in this experiment with that estimated in other reports, where more 
rigorous parameters based on the ratio of authentic iPSCs derived or on the activation 
of endogenous pluripotency genes have been employed (Meissner, 2007; Huangfu, 
2008b). 
 
4.2.4 Pluripotency of dedifferentiated mouse foetal fibroblasts 
In order to assess whether the isolated cells presented ESC-like features, mouse 
putative iPSCs were characterised according to the procedures utilised for ESCs 
(Wobus, 1984; Hoffman and Carpenter, 2005). We initially focussed on the 
expression of the pluripotency marker Nanog (Chambers, 2003; Mitsui, 2003). Four 
clones were stained alongside a positive (mouse ESCs) and a negative (MFFs) 
control: the clones were seeded into 2 wells of a 24 well plate (splitting ratio 1:2) and 
when at around 80% confluence (usually about one or two days later) they were 
fixed in 4% PFA and stained for Nanog. All clones were Nanog-positive, with a 
brighter signal in 2D10 clone (Fig. 20); however while in the ESCs the staining was 
clearly restricted to the nucleus, in the putative iPSCs the fluorescence appeared to 
be spread in the nucleus as well as in the cytoplasm. 
  





Figure 20 (legend in the next page).   





Figure 20. Nanog immunocytochemistry on the putative mouse iPSC lines obtained after expansion 
from single colonies. Mouse ESCs (mESCs) were employed as a positive control, whereas the 
parental MFFs were utilised as a negative control. For each cell line an immunocytochemical reaction 
was performed without adding the primary antibody in order to exclude the presence of any signal 
coming from unspecific binding of the secondary antibody. Images were taken at 10x magnification. 
Scale bars: 100µm.  
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4.2.5 In vitro differentiation and immunocytochemistry 
In order to assess the differentiation ability of putative mouse iPSCs in vitro, the 
2D10 cells (Fig. 21a), that displayed the more ESC-like morphology and the greater 
Nanog staining, were mildly trypsinized from a T25cm2 flask, separated from the 
feeder layer and seeded in a 9cm Petri dish (low attachment plate) in mouse 
differentiation medium (mouse ESC medium with no LIF). The differentiation was 
also performed on mouse ESCs (Fig. 21b) as a positive control for the experiment. 
After a few days in suspension culture, both 2D10 cell line and the mouse ESC 
positive control formed round structures (Fig. 21c, d) which were later plated in 
gelatin-coated wells. The cells were then allowed to attach to the bottom of the plate 
and spread. During this period of time the 2D10 clone and the positive control grew 
and expanded in a similar way. Among both cell lines it was possible to recognize 
signs of differentiation: from round and small cells with, many cells changed their 
shape enlarging their cytoplasm and acquiring different morphologies (Fig. 21e, f); in 
both cell lines it was also possible to detect beating cardiomyocytes. The outgrowths 
were eventually fixed and stained against markers of differentiation. 
At this stage of the characterisation  I wanted to identify at least one cell type for 
each germ layer. Induced pluripotent stem cells were examined by 
immunocytochemistry and were found positive for βIII-tubulin, an ectodermal 
marker (Fig. 22), and troponin T (Fig. 23), a mesodermal marker, were identified. 
The morphology and the position of the stained cells, together with the florescence, 
concurred in the identification of the differentiated cells. Neurons, which are detected 
with anti βIII-tubulin antibodies, are characterised by small nuclei and long, 
 





Figure 21. The figure shows the differentiation process of putative mouse iPSCs (a, c, e) and mouse 
ESCs (b, d, f). (a, b) Cells before differentiation. (c, d) In suspension culture, both cell types form 
round and smooth embryoid bodies. (e, f) When the embryoid bodies are seeded on gelatin-coated 
plates, they spread giving rise to an outgrowth composed of distinct differentiated cell types. Scale 
bars: 250µm. 
  




Figure 22. Differentiated 2D10 cell line gives rise to cells belonging to the ectodermal germ layer. 
Differentiated mouse ESCs are the positive control. Undifferentiated mouse ESCs are the negative 
control. A minus primary antibody control was performed alongside the βIII tubulin staining. Scale 
bars: 100µm. 
  






Figure 23. Troponin T staining was carried out on differentiated 2D10 cells, confirming their ability to 
give rise to mesoderm. Differentiated mouse ESCs are the positive control. Undifferentiated mouse 
ESCs are the negative control. A minus primary antibody control was performed alongside the 
troponin T staining. Scale bars: 100µm.  
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thin dendrites, as evident in the 2D10 staining and even more in the mouse ESC 
staining. Troponin T positive cells represent muscle cells and the fluorescent signal 
often appeared where beating cells had been previously recognised. 
In order to detect the endodermal lineage, an anti α-fetoprotein antibody was 
selected; yet the optimization of the immunocytochemistry protocol for this antibody 
was complicated and was achieved only when the sheep experiment had already 
started. The mouse experiment was not addressed towards the isolation of fully 
reprogrammed cells, its main aim was the validation of the transduction protocol, 
therefore the α-fetoprotein staining on mouse iPSCs was not continued. 
 
4.3 Discussion 
I have illustrated the isolation of mouse ESC-like cells obtained from MFFs utilising 
the 4-gene transduction protocol described in the original iPSC report. This work was 
performed primarily to establish the methodology and the strategy for subsequent 
sheep studies. 
In comparison to the Takahashi and Yamanaka method, only a few aspects were 
modified. The main difference between the published technique and that utilised here 
regarded the procedure aimed at selecting the reprogrammed colonies: while 
Takahashi and Yamanaka applied antibiotic in order to eliminate the 
non-reprogrammed cells, later reports stated that the use of selectable markers could 
even undermine the derivation of iPSCs when applied with the wrong timing 
(Maherali, 2007). My initial strategy, the production of a lentivirus carrying a 
reporter gene under the control of the Oct4 promoter, proved not possible. Given the 
inability to pursue this strategy and sustained by the evidence that pluripotent cells 
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could be isolated without the need for any selection (Meissner, 2007), I based the 
identification of the reprogrammed cells upon morphological criteria. In their study, 
Takahashi and Yamanaka let the cells grow in the same wells until colonies appeared 
and could be picked, while I followed Meissner’s strategy (Meissner, 2007) and 
passaged the cells with the expectation that eventually iPSCs would have outgrown 
the non-reprogrammed fibroblasts. 
While many colonies were generated as a consequence of the transduction, the 
technique could be improved in many ways, which I will discuss below. 
First, the transduction was carried out utilising MFFs plated on feeder layer. This can 
reduce the efficiency of the transduction since the irradiated SNL cells can compete 
with the MFFs for the virus. In the following reprogramming experiments, in order to 
avoid the competition between the feeders and the OFFs the transduction will be 
performed in the absence of irradiated SNL cells. 
Second, the reprogramming protocol requires fresh virus for the transduction. In 
order to verify that each new viral preparation is viable it would be desirable to build 
an expression vector similar to the pMXs plasmids but constitutively expressing 
GFP. While performing a reprogramming experiment, control parental fibroblasts 
could be transduced with the GFP virus and the success of the packaging could be 
confirmed by the appearance of green cells. 
The iPSC isolation might have benefited from the culture in 3i or 2i media instead of 
serum and LIF (Ying, 2008). The 3i and 2i culture conditions are a defined growth 
media where no cytokines are needed to maintain the cells in a pluripotent state: 
these media are supplemented with inhibitors which block differentiation pathways 
maintaining the population of cells in a pluripotent state and leading differentiated or 
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differentiating cells to death (Ying, 2008). These media may provide a more suitable 
environment for iPSCs, since they might represent a selection able to discern 
between differentiated and reprogrammed cells. 
Last, the amount of feeder layer was too low: SNL cells should be nicely spread with 
little gaps in between, while in this first experiment they were very sparse. 
 
Although the transduction protocol was successful and many of the generated 
colonies displayed morphology similar to that of ESCs, I elected to only partially 
confirm the derivation of authentic mouse iPSCs. The characterization of ESCs is 
normally achieved by staining them against markers of pluripotency such as Nanog, 
Oct4, Sox2, AP, SSEA1, Rex1 (Koestenbauer, 2006). I utilised only one marker, 
Nanog, and the immunocytochemistry showed that Nanog localization performed in 
the putative mouse iPSCs I generated is both nuclear and cytoplasmic; this is in 
contrast with what observed in in ESCs, where Nanog is strictly nuclear (Do, 2007). 
The cytoplasmic localization of this pluripotency marker has been found in ASCs 
(adipose-derived stem cells and mesenchymal stem cells, (Zuk, 2009; Carlson, 
2011), primitive germ cells (Goel, 2008) and is also often correlated with tumours 
(Ezeh, 2005; Goel, 2008; Ye, 2008). This leads to many hypotheses: the insertion of 
the four transcription factors, in particular cMyc, might have directed the MFFs 
towards a cancerous fate instead of driving them into a pluripotent state; another 
possibility is that the putative mouse iPSCs might be only partially reprogrammed, 
behaving more like ASCs than ESCs. Alternatively when Nanog staining was 
performed the cells were still in the process of reprogramming: the 
immunocytochemistry was performed at passage 7 after transduction, but 
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reprogramming is a long process and the cells might have been still in an 
intermediate state. Nanog staining should have been repeated later, in order to verify 
whether the expression pattern of this pluripotency marker had changed. 
Furthermore, while Oct4 and Sox2 were used as reprogramming factors and 
immunochemistry against them would have not been able to discern between the 
viral and the cellular protein, other markers should have been employed for a better 
characterization. 
In order to prove the pluripotency of the generated putative iPSCs, further assays 
should have been performed. As already discussed above, showing the expression of 
multiple markers of pluripotency would have given a more robust evidence of the 
generation of true iPSCs. In addition, an RT-PCR should have been done with the 
purpose to verify the silencing of the four transgenes without loss of pluripotency, 
which is considered one of the main evidences of full reprogramming (Hotta and 
Ellis, 2008). Again, in case of female cells, the re-activation of the X chromosome is 
another distinctive trait of true iPSCs. Moreover, in order to assess whether the 
reprogramming had led to chromosomal alterations, which are very common in fast 
cycling cells (Hanson and Caisander, 2005; Mantel, 2007), a metaphase spread 
should have been carried out. 
The in vitro differentiation potential was not completely investigated either. I showed 
the putative mouse iPSC ability to differentiate into mesoderm and ectoderm, but 
omitted the endoderm due to the long optimization required for the α-fetoprotein 
antibody. In order to identify endodermal markers or to provide further evidences of 
the other two lineages, immunocytochemistry might have been substituted or 
associated with RT-PCR. A complete characterization of the cells should also have 
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included in vivo analyses such as teratoma formation, chimera formation and 
germline transmission. 
Although the positive and negative controls employed for βIII-tubulin and troponin T 
stainings were appropriate, a better negative control would have been represented by 
the undifferentiated putative iPSC lines in place of the parental MFFs. This would 
have shown whether the original cells were effectively in a pluripotent state, 
demonstrating that the cell types we observed were indeed the result of the 
differentiation protocol. 
 
While aware that the above characterization results do not lead to strong conclusions 
and that many other important assays should be performed in order to prove that 
authentic mouse iPSCs have been generated, it is nevertheless true that our main aim, 
establishing and validating the transduction protocol, was achieved. The technique 
could therefore be exploited for the generation of ovine iPSCs. 
As described next, I was able to generate iPSC-like cells from sheep fibroblasts and 
their characterisation quickly became my focus preventing me form continuing with 







Derivation and in vitro characterization of ovine induced pluripotent stem cells 




In the previous chapter I have described the reprogramming protocol in mouse. After 
repeating the original Takahashi and Yamanaka’s work and proving its effectiveness 
in my hands, I moved to the main aim of the project: the derivation of iPSCs from 
sheep. 
The ovine species was chosen for it represents a distinctive platform in medicine and 
agriculture. The sheep is a recognised model for human disease, because its size, 
anatomy and physiology are closer to human if compared with other animal models 
such as the mouse and the rat (Harris, 1997; Abraham, 2008). The derivation of 
ovine pluripotent cells would offer significant opportunities to perform genetic 
modifications for the study of pluripotency in large animals, for the creation of 
disease specific mutants with significant human implications and for agricultural 
purposes (Harris, 1997; Abraham, 2008). On the other hand, ovine iPSCs would 
facilitate the understanding of developmental biology in this species. Additionally 
sheep pluripotent cells could be exploited in medicine and toxicology for the 
screening of drugs and other compounds (Telugu, 2010). 
 
In order to achieve the generation of ovine iPSCs, OFFs were transduced with an 
amphotropic MoML viral vectors carrying the four original reprogramming genes 
(the mouse orthologs of cMyc, Klf4, Oct4 and Sox2). The cells were then grown in 
different culture conditions and analysed both in vitro and in vivo to evaluate the 
acquisition of pluripotency. 
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The data presented in this chapter shows the isolation of ovine iPSCs and the in vitro 
aspects of their characterization, consisting of: 
- analysis of integration and silencing of the reprogramming transgenes, 
- assessment of the expression of pluripotency markers, 
- in vitro differentiation assay, 
-  karyotyping, 




5.2.1 Transduction of ovine foetal fibroblasts 
For the generation of ovine iPSCs, a protocol similar to that already employed for 
murine cells was utilised (Fig. 17), with only few modifications: OFFs (Fig. 24a) 
were seeded in gelatin-coated wells of 6 well plate (1.3x105 cells/well) in 2ml 
DMEM, 10% FCS and transduced the day after (day 0) with 1ml of each MoML 
viral vector. The transduction was repeated on day 1. In parallel, a control 
transduction performed employing a MoML viral vector expressing GFP indicated 
that the virus penetrated in the OFFs (Fig. 24b, c). MFFs were also transduced as a 
positive control for the reprogramming protocol. 
At day 2 both ovine and murine cells were passaged onto γ-irradiated SNL cells and 
at day 4 fibroblast medium was replaced. Mouse ESC medium was added into the 
plates containing transduced MFFs, while two different culture conditions were 
applied to the sheep cells: mouse ESC medium and human ESC medium, the former 
 




Figure 24. (a) OFFs at passage 6 before the transduction. Bright field (b) and fluorescence (c) images 
of GFP-transduced OFFs at day 8 post transduction; the cells are green, meaning that the viral vectors 
are functional. (d) Four-gene transduced OFFs grown in mouse ESC medium conditions display an 
irregular surface and indistinct borders. (e, f) Four-gene transduced OFFs grown in human ESC 
medium conditions have smoother domes and a morphology more similar to that of ESCs. (g-m) 
Different ovine iPSC lines isolated and expanded: (g) C2 clone, (h) C3 clone, (i) D1 clone, (l) F2 
clone, (m) G2 clone. (n) High magnification (20x) image of G2 clone; the cells show ESC-like 
characteristics, with high nucleus to cytoplasm ratio, and have a morphology different from the 
parental OFFs. Scale bars: 100µm for (b), (c), (d), (e), (f); 5µm for (a); 250µm for (g), (h), (i), (l), (m); 
25µm for (n).  
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containing FCS and mouse LIF, the latter including serum replacement and human 
bFGF instead. In the following 2-3 days the cells started changing morphology, 
becoming rounder, smaller and with larger nuclei. At day 7 the first aggregates of 
cells could be observed but at this stage it was difficult to discern between real 
ESC-like colonies and clusters of fibroblasts. Eight days after transduction, the ovine 
cells, but not the MFFs, became confluent. In the previous mouse experiment we had 
observed that MFFs had been plated at too high density, therefore in the sheep 
experiment the amount of seeded cells had been reduced. However, while the mouse 
cells were still quite sparse, OFFs although plated at the same density as MFFs, were 
confluent. This underlines a different behaviour between the embryonic fibroblasts 
belonging to the two species, with OFFs growing much faster than MFFs. For the 
transduction protocol ovine cells should be seeded at even lower density (i.e. 5 x104 
cells/well in 6 well plate). 
Due to the high confluence of OFFs I faced two possibilities: maintaining the cells 
too confluent for too long could possibly have affected the reprogramming process 
and eventually led to cell death; on the other hand, passaging the cells would have 
meant being unable to calculate the reprogramming efficiency. We decided to follow 
both strategies, passaging half of the wells, while maintaining the others at high 
confluence. 
At day 13 large ESC-like colonies were visible in the transduced OFFs which had 
been passaged but not in the ones maintained at high confluence, albeit the cells were 
not dying, since they stayed attached to the bottom of the plate. Morphologically 
different clusters of cells were noticeable in the two medium conditions. In mouse 
ESC medium the colonies looked granulated and without a precise segregation from 
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the layer of parental fibroblasts (Fig. 24d), suggesting that the reprogramming was 
not complete. Conversely, in human ESC medium the colonies showed a more 
ESC-like morphology, with sharp edges and smooth domes (Fig. 24e, f). 
At day 13, colonies were picked from the human ESC condition group and expanded 
on SNL feeder layer in human ESC medium. At first, different populations of cells 
growing together were clearly recognizable. Some non-reprogrammed OFFs, 
involuntarily carried along, continued proliferating alongside the iPSCs, but after 4-5 
passages the senescence set in and the clones became more homogeneous.  
Different cell lines were derived which displayed variegated morphology (Fig. 
24g-m) and growth characteristics: some stopped growing, some started 
differentiating, others flattened and acquired a very high proliferation rate, probably 
becoming tumour cell lines. Only few clones maintained the typical traits of ESCs, 
displaying compact colonies with defined borders and an even surface, characterised 
by small, round cells with a high nuclear/cytoplasmic ratio (Fig. 24n). Most of the 
clones with morphology similar to that of ESCs were characterised by a fast growth 
rate if compared to the parental fibroblasts and they required to be sub-cultured every 
2-4 days at a ratio between 1:3 and 1:5. 
 
5.2.2 Ovine identity of the colonies 
In the derivation protocol we have utilised mouse feeders, therefore we performed a 
sheep specific PCR assay on the gDNA of 8 clones in order to confirm the ovine 
identity of the iPSCs. Primers were selected specific for the endogenous Jaagsiekte 
sheep retrovirus (enJSRV), which is a provirus naturally integrated in the Ovis aries 
  





Figure 25. PCR reaction confirming the ovine origin of the iPSC clones. The PCR primers are specific 
for a virus integrated only in the ovine genome. The positive control was represented by gDNA 
extracted from ovine kidney. Two negative controls were included: mouse gDNA from SNL cells was 
employed to verify that the primers recognise only the sheep genome and an additional control, a PCR 
reaction without template, was utilised to detect contaminations in the reaction.  
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genome (Dunlap, 2006). As shown in figure 25, this PCR confirmed that all the 
clones analysed were indeed of sheep origin. 
 
5.2.3 Silencing of the retroviral vectors carrying the reprogramming genes 
As widely recognised, the silencing of the MoML viral vectors employed to deliver 
the transgenes is one of the most important elements that allow to discern between 
partially and fully reprogrammed iPSCs in mouse (Hotta and Ellis, 2008). Initially, 
the exogenous genes are active and drive the cells towards dedifferentiation, 
activating many transcription factors and pluripotency genes, including the same four 
endogenous reprogramming factors. Only once complete dedifferentiation has been 
achieved, with the viral genes silenced and the appropriate cellular genes active, is 
pluripotency maintained (Okita, 2007; Jaenisch and Young, 2008). Although mouse 
iPSC lines still expressing the transgenes had been found positive for markers of 
pluripotency, when analysed for in vivo differentiation these clones eventually failed 
to give rise to teratomas (Brambrink, 2008). 
The first step for the evaluation of silencing in the ovine iPSCs was to confirm the 
integration of all four transgenes in the clones. To achieve this, gDNA was extracted 
from the cell lines and a PCR reaction with primers specific for the four genes was 
performed. In order to discriminate between transgenic and endogenous transcripts, a 
common forward primer was designed in the retroviral vector, while single reverse 
primers were designed to be specific to each of the four mouse genes. The negative 
control was represented by the parental cells, while the positive control was obtained 
adding the four pMXs reprogramming plasmids, each carrying one of the transgenes, 
into the negative control. 
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As figure 26a shows, cMyc, Klf4 and Oct4 constructs are integrated in all the clones, 
while Sox2 is integrated only in six cell lines, but not in clone A2 and in clone C3. 
Interestingly, this reduced presence of Sox2 is in accordance with other studies 
(personal communication; Dr Amandine Bretton, University of Edinburgh, and Prof 
Scott Fahrenkrug, University of Minnesota). 
After proving the integration of the transgenes, in order to assess whether the ovine 
iPSC clones still expressed the four transduced factors, we carried out a RT-PCR on 
mRNA extracted from the clones at passage 7 and using the same primers employed 
for the integration assay (Fig. 26b). Again, the parental cells were used as negative 
control, while the positive control MFFs transduced with the four genes. As expected 
from the integration results, lines A2 and C3 did not show any Sox2 mRNA. Most 
clones still expressed the integrated genes (A2, C2, E2 and F1 cell lines). Of the 
remaining clones, C3 and F2 achieved to silence only Klf4, while G2 and D1 cell 
lines succeeded to silence three out of four genes (cMyc, Klf4 and Sox2), with G2 
clone retaining only a very low expression of Oct4 if compared to the positive 
control. Nevertheless this analysis does not allow to state whether all cells display 
very low Oct4 transcripts or only few cells retain a strong Oct4 expression. 
 
5.2.4 Markers of pluripotency 
The ovine iPSC clones were examined for their ability to express markers 
characteristic of ESCs. Time-wise, the first important marker appearing during 
reprogramming is AP (Brambrink, 2008). AP is a hydrolase enzyme most active at  






Figure 26. Silencing of the reprogramming genes: (a) PCR on the ovine iPSC gDNA to assess whether 
the reprogramming factors are indeed integrated. Negative controls: gDNA from OFFs, no DNA 
control; positive control: pMXs reprogramming plasmids mixed with OFF gDNA. (b) RT-PCR to 
verify the expression profile of the transgenes: most of the clones retained the transgene expression, 
while only D1 and G2 achieved to silence them, maintaining only a little expression of Oct4. 
Non-transduced OFFs represent the negative control; 4-gene transduced MFFs represent the positive 
control.  
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basic pH (Thomson and Marshall, 1998), responsible for removing phosphate groups 
from many types of molecules, including nucleotides, proteins and alkaloids. 
Elevated expression of this enzyme is associated with ESCs, embryonic germ cells 
and embryonal carcinoma cells (Shamblott, 1998; Thomson and Marshall, 1998) and 
its decrease is an evidence of differentiation. 
In order to evaluate whether the ovine iPSCs expressed AP, an activity assay was 
performed on clones at passage 7 (Fig. 27). Cells were seeded (1:3 ratio) on feeder 
layer in wells of 24 well plate and fixed one or two days post plating for 20min in 
4% PFA. In this assay, mouse ESCs were employed as a positive control and the 
parental OFFs as a negative control. Since the ovine iPSCs were plated on feeder 
layer, irradiated SNL cells were included in the analysis in order to exclude that any 
positive results in the samples could be attributed to the feeder layer. The negative 
control and the SNL cells, as well as A2, C2, C3 and F1 clones resulted negative for 
AP activity, while D1 and E2 cells displayed only a faint staining. Two clones (F2 
and G2) showed a very strong staining, which is comparable with that of the positive 
control. 
Interestingly, the clones positive for AP activity were the ones which displayed a 
morphology more similar to that of ESCs and, in the case of D1 and G2, also the 
better transgene silencing profile. F2, the other clone that together with G2 showed 
the strongest AP signal, silenced only one transgene; this might be explained by the 
fact that AP, although being an ESC marker, is not strictly specific to ESCs, being 
expressed also in tumour and germ cell lines. On the other hand, the faint staining of 
D1 and E2 cells could be explained as a partial reprogramming, with the cells 
 




Figure 27. AP staining of isolated iPSC clones: on the left the figure shows the AP staining in the 
wells of a 24 well plate containing different cell types; on the right, 20x magnification images of G2 
clone compared with mouse ESCs. Scale bars: 25µm.  
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trapped in a pre-iPSC state. An alternative hypothesis could be that these cells are 
just slower in their dedifferentiation process, as suggested by their slower growth rate 
compared with F2 and G2 clones. While AP expression marks the initial phases of 
reprogramming, Nanog and Oct4, two transcription factors, are later markers of iPSC 
induction (Brambrink, 2008) but more stringent for the assessment of the 
pluripotency (Koestenbauer, 2006). In our ovine iPSC clones Oct4 expression was 
not determined: as shown in the above silencing assay (Fig. 26) this protein is still 
expressed by the mouse transgene making it challenging to discern between 
exogenous and endogenous signal, either employing immunohistochemistry (because 
of the absence of a species specific antibody) or RT-PCR (because of the lack of the 
ovine Oct4 sequence).  
Ovine iPSCs at passage 7 were passaged at 1:3 ratio in a 24 well plate on feeder layer 
and fixed after one or two days in 4% PFA for 20min. They were stained against 
Nanog (Fig. 28), with the positive control represented by mouse ESCs and the 
negative by OFFs. A further control, the same staining but without primary antibody, 
was carried out on samples and controls in order to exclude a non-specific binding of 
the secondary antibody to the cells. Four clones (A2, C3, E2 and F1) showed no 
signal for Nanog, whereas the others were positive for it, with the signal restricted to 
the nucleus, which is Nanog characteristic localization (Do, 2007). 
SSEA1 and SSEA4 surface proteins are markers of pluripotency which are 
differentially expressed in mouse and human ESCs: in human SSEA4 is expressed in 
the pluripotent state, while SSEA1 is found only upon differentiation (Draper and 
Fox, 2003). Conversely, in mouse SSEA1 is expressed in ESCs, whereas SSEA4 is 
  





Figure 28 (legend in the next page).  





Figure 28. (a) Nanog immunocytochemistry of the ovine iPSC clones. Mouse ESCs are the positive 
control, OFFs are the negative control. A control without the primary antibody was performed for 
each clone. (b) Higher magnification images of G2 clone show that Nanog staining is restricted in the 
nucleus. Scale bars: 50µm for (a), 5µm for (b).  





Figure 29 (legend in the next page).  





Figure 29. SSEA1 staining on the isolated iPSC lines: only a very small amount of cells in some 
clones were positive. Positive control: mouse ESCs; negative control: OFFs. Scale bars: 50µm. 
  





Figure 30 (legend in the next page).  





Figure 30. SSEA4 immunocytochemistry: the ovine iPSC clones have a SSEA4 expression pattern 
similar to that obtained for SSEA1: only few cells were positive. The positive control is represented 
by human ESCs, whereas the negative control is represented by the parental fibroblasts. Scale bars: 
50µm. 
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absent (Koestenbauer, 2006). All the derived clones were tested at passage 7 for 
these two markers and found mostly negative, with a very small number of cells in 
only few clones displaying some staining (Fig. 29, 30). 
 
5.2.5 In vitro differentiation of ovine induced pluripotent stem cells 
In the light of the previous analyses (Table 7), we graded the cells and decided to 
perform the in vitro differentiation on three clones: 
- G2, which shares many characteristics of ESCs; 
- C3, which does not display any pluripotency feature; 
- D1, which lies in the middle as it shows an ESC-like morphology and a 
positive Nanog staining but it is slower in growth and presents a low AP 
activity when compared with ESCs. 
Since currently nothing is known about ovine pluripotency, the decision to carry out 
differentiation of these clones was made in order to compare whether there is a 
correlation between classical mouse pluripotency features and differentiation 
potential in ovine iPSCs. 
Spontaneous in vitro differentiation was performed as follows: cells at around 70% 
of confluence were trypsinized leaving clumps of cells, separated from the feeder 
layer and grown in differentiation medium for 4 to 7 days in low attachment plates 
(typically from 1 T25cm2 flask cells were plated into 2 6cm diameter bacterial Petri 
dishes). As shown in figure 31: 
- G2 cell line  formed smooth, spherical, floating EBs, which are typical of 
ESC differentiation (Fig. 31e); 
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- D1 clone also generated floating EBs, but their shape was more irregular and 
the edges were rough; moreover some cells attached to the bottom (Fig. 31h); 
- C3, the clone with characteristics more dissimilar from ESCs, did not form 
any floating clusters, but proliferated spreading at the bottom of the low 
attachment plate (Fig. 31m). 
 
Next mouse ESC EBs, G2 EBs and D1 EBs were seeded to cell culture plates 
(usually 1-5 EBs were plated in a single well of 24 well plate) where they attached 
and spontaneously differentiated for 2 to 4 weeks. Initially, in order to have better 
images of the differentiation markers, EBs were plated on glass chambers coated 
with gelatin, poly-L-lysine or laminin, but the cells either did not adhere to the plates 
or, if they did, did not succeed in spreading and differentiating. Following this, EBs 
were eventually plated into gelatin-coated plastic plates. 
During the differentiation process, cells with different shape and size could be 
recognized in the outgrowths, suggesting that the clones were differentiating towards 
many cell types (Fig. 31c, f, i). In the mouse control beating cardiomyocytes could 
be observed; in contrast these types of cells did not appear in the ovine cells, 
implying a restricted differentiation potential or sub-optimal differentiation 
conditions. 
To assess whether the differentiated cells were derived from all three germ layers, 
after 2 to 4 weeks the outgrowths were fixed in 4% PFA for 20min and stained for 
five differentiation markers: βIII-tubulin (ectoderm), vimentin (mesoderm), Troponin 
T (mesoderm), α-fetoprotein (endoderm) and cytokeratin-18 (endoderm). 
The differentiated G2 (G2 D) cells gave rise to cells belonging to all three germ 
layers. This cell line was positive to βIII-tubulin (Fig. 32), α-fetoprotein (Fig. 33),  





Figure 31. Differentiation course of different quality clones of ovine iPSCs: a spontaneous 
differentiation assay was carried out on G2 (d-f), D1 (g-i) and C3 (l, m) clones. (a-c) Positive control: 
mouse ESCs. (a, d, g, l) Undifferentiated cells. (b, e, h, m) Embryoid bodies. (c, f, i) Outgrows. C3 
clone did not form EBs, consequently it was not possible to obtain any outgrows. Scale bars: 100µm. 






Figure 32 (legend in the next page).  






Figure 32. Immunostaining of differentiated ovine iPSC clones against βIII tubulin. Differentiated 
mouse ESCs were employed as positive control; the parental fibroblasts were utilised as negative 
control. As additional negative control for each single clone, the undifferentiated cell lines were 
stained too. The undifferentiated G2 clone is negative to βIII tubulin, confirming its pluripotency 
profile, while the D1 iPSC clone stained positive, indicating it tends to differentiate even in ESC 
culture conditions. Scale bars: 100µm.  








Figure 33 (legend in the next page). 





Figure 33. Anti α-fetoprotein immunocytochemistry: the eight differentiated ovine clones were 
analysed alongside mouse ESCs as a positive control and OFFs and the undifferentiated iPSCs as a 
negative control. As in the anti βIII tubulin staining, the undifferentiated G2 iPSC clone is negative, 
while the undifferentiated D1 is positive. Scale bars: 100µm. 
  





Figure 34. Immunocytochemistry against cytokeratin-18: the differentiated G2 cells were strongly 
positive for this endodermal marker. The negative control, undifferentiated G2 iPSCs, was negative, 
while the positive control, LS174T colon carcinoma cells, was positive. A control reaction performed 
without the supplementation of the primary antibody was included. Scale bars: 100µm. 
  





Figure 35 (legend in the next page). 
  






Figure 35. Anti-vimentin staining on ovine G2 and D1 cell lines: both differentiated clones were 
positive. The undifferentiated G2 cells were negative, while the undifferentiated D1 cells were 
positive. This confirmed the previous results acquired with anti βIII tubulin and anti α-fetoprotein, 
which indicated that G2 iPSCs are pluripotent, while D1 iPSCs cannot be maintained in a completely 
undifferentiated state. Scale bars: 100µm. 
  





Figure 36 (legend in the next page). 
  






Figure 36. Staining against troponin T mesodermal marker: the ovine clones are negative in both 
differentiated and undifferentiated state. The positive control, differentiated mouse ESCs, is positive 
to the immunocytochemistry, with the staining co-localising where beating cells had appeared. Scale 
bars: 100µm.  
_____Derivation and in vitro characterization of ovine induced pluripotent stem cells 
164 
 
cytokeratin-18 (Fig. 34) and vimentin (Fig. 35), while troponin T 
immunocytochemistry was negative (Fig. 36). Undifferentiated G2 cells were stained 
against the same five markers and found negative, thus leading to an additional 
evidence of the pluripotency status of this clone (Fig. 32-36). 
The differentiated D1 (D1 D) cells also stained positive to βIII-tubulin (Fig. 32), 
α-fetoprotein (Fig. 33) and vimentin (Fig. 35), but also the undifferentiated D1 cells 
were positive to these markers (Fig. 32, 33, 35). This means that D1 clone is not able 
to maintain its pluripotency even in ESC conditions, thus it is likely that this cell line 
had undergone to only partial reprogramming. 
Results of immunocytofluorescence analyses for markers of differentiation are 
summarised in table 8. 
The absence of troponin T in the ovine iPSCs was consistent with the lack of beating 
cells observed during the differentiation process. In contrast, differentiated mouse 
ESCs displayed a strong troponin T signal, which was often colocalized with the 
beating cells we observed during the differentiation process. 
OFFs were employed as a negative control in the staining against βIII-tubulin, 
α-fetoprotein, cytokeratin-18 and troponin T. They were included also in the 
vimentin immunocytochemistry, but as a positive control. Vimentin is a marker of 
mesodermal cells and embryonic fibroblasts derive from mesoderm. The negative 
control for the vimentin reaction was represented by the undifferentiated iPSCs. 
In all the stainings a control reaction without the primary antibody was carried out to 
ensure that the secondary antibody did not produce any unspecific signal. 








 STAININGS FOR MARKERS OF DIFFERENTIATION 
βIII TUBULIN α FETOPROTEIN CYTOKERATIN 18 VIMENTIN TROPONIN T 
C3 - / 
Undiff: / Undiff: / Undiff: / Undiff: / Undiff: / 












Undiff: - Undiff: - Undiff: - Undiff: - Undiff: - 
Diff: + Diff: + Diff: + Diff: + Diff: - 
 
Table 8. Table summarizing the characteristics of three ovine iPSC clones upon differentiation. C3 
was not able to generate EBs, while D1 and G2 formed EBs that proliferated when plated again in cell 
culture dishes. The outgrowths (Diff) were then stained for markers of pluripotency, alongside the 
undifferentiated clones (Undiff). Both G2 D and D1 D gave rise to cells belonging to the three germ 
layers, but for D1 the undifferentiated counterpart also stained positive for these markers, suggesting 
the clone is not truly pluripotent; on the other hand, undifferentiated G2 cells were not positive for any 
of the markers. 
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5.2.6 Growth curve 
After analysing all clones for the main features linked to pluripotency and 
differentiation, we chose the cell line with characteristics more similar to those of 
ESCs to carry on further characterizations. 
An important trait of pluripotent cells is their very fast cell cycle. Although the high 
growth rate is not solely restricted to ESCs, it represents a significant mark in the 
identification of true iPSCs: the reprogramming process starts from differentiated 
cells whose growth is often slow. As a consequence of the dedifferentiation, these 
cells experience changes that accelerate their proliferation rate and make it similar to 
that of ESCs. The calculation of the doubling time of the ovine iPSC population and 
the comparison with that of the parental fibroblasts and ESCs could give further 
indication of the reprogramming of the generated cells. 
Based on these considerations, a growth curve was obtained for G2 cells, OFFs and 
mouse ESCs. For each cell line 3.55x104 cells were plated at day 0 in 24 wells of a 
48 well plate in the appropriate conditions. Three wells for each cell line were 
counted every 12h for 96h. The graph in figure 37 shows that ovine iPSCs have a 
proliferation rate much higher than that of the parental fibroblasts and similar to that 
of mouse ESCs. In order to have a more precise indication of the proliferation, the 
population doubling time (pdt) was calculated. The pdt is the period of time required 
for the cells to double their number. When the cells undergo exponential growth they 
have a constant pdt, which can be calculated directly from the growth curve: a linear 
regression was performed on the exponential phase of each cell type and the pdt was 
calculated as the slope of the equations obtained with the regression. The statistical 
results confirmed what we earlier predicted from the graph: during the 
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reprogramming process the doubling time had decreased from 63.01h (confidence 
interval: 41.07h – 135.28h) of the OFFs to the 17.46h (confidence interval: 
16.35h – 18.72h) of the ovine iPSCs; additionally, the pdt of the ovine iPSCs was 
similar to that of mouse ESCs (13.78h, confidence interval: 12.31h – 15.64h). 
 
5.2.7 Self-renewal 
Somatic cells give rise to primary cell cultures, which go towards senescence and 
death after a certain amount of passages (the Hayflick limit). Only after 
immortalization, a process often involving the mutation of genes responsible for the 
proliferation, somatic cells are able to be maintained in culture for an indefinite time 
(Sherr and DePinho, 2000; Wright and Shay, 2002). Conversely, pluripotent cells are 
characterised by their ability to indefinitely proliferate in culture without loss of 
phenotype (Suda, 1987; Smith, 2001a; Zeng, 2007). Partially reprogrammed iPSCs 
with time undergo to changes of morphology which are the early signal of loss of 
pluripotency (Okada, 2010). 
With the purpose of evaluating their self-renewal potential, our ovine iPSCs G2 were 
grown for more than 25 passages and then evaluated. As shown in figure 38, G2 
clone achieved to maintain an ESC-like morphology even after 25 passages. 
 
5.2.8 Metaphase spread 
One of the potential risks associated with fast growing cells, such as pluripotent cells, 
in long term cultures is the acquisition of karyotypic abnormalities (Robertson, 1987; 
Brown, 1992). The isolation of stem cells with chromosome aberrations would 
hamper future applications, restricting the possible uses of these cells. 
  




Figure 37. Growth curve of G2 iPSCs, mouse ESCs and OFFs. The growth rates of the three cell lines 
were compared. Mouse ESCs also represented a positive control for the reaction; in other reports it is 
stated that their pdt ranges between 10h and 16h (Berrill, 2004), which is comparable with the results 
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In order to examine whether our G2 cells were karyotypically stable, a metaphase 
spread of the cells at passage 24 was analysed and the chromosomes were counted. 
Out of 100, we counted 83 cells with a normal number of chromosomes (a 
representative sample in shown in figure 39a), which in sheep is 54. The other 17 
metaphase spreads had fewer chromosomes (ranging between 44 and 53), while no 
cells exhibited polyploidy (Fig. 39b). 
In mouse ESCs a karyotype is considered normal when more than 70%-80% of the 
cells show the correct number of chromosomes (Nagy, 2003); however in rat ESCs 
this threshold has not been reached and nonetheless cells were able to give rise to 
chimeric animals (Buehr, 2008). 
In our ovine iPSCs, we found 83% of normal cells; hence we can consider our cells 
to have a normal karyotype. 
 
5.3 Discussion 
In this chapter I have illustrated the derivation of ovine iPSCs that express markers 
of pluripotency and can give rise to cells characteristic of all three germ layers. 
After the first report in mouse (Takahashi and Yamanaka, 2006), iPSCs have been 
derived from many different species, including pig (Esteban, 2009; Ezashi, 2009; 
Wu, 2009) and recently reports of ovine iPSCs have been published (Bao, 2011; Li, 
2011). In ungulates the isolation of iPSCs has been achieved through a variety of 
different reprogramming genes and culture conditions, but always involving retro or 
lentiviral transduction. In mouse, iPSCs are considered fully reprogrammed when 
they are able to maintain the pluripotency without the continuative expression of the 
reprogramming factors (Hotta and Ellis, 2008). This has not been accomplished  in 
ovine, nor in porcine species. 




Figure 38. Comparison between (a) early (p10) and (b) late (p24) passage G2 ovine iPSCs: the 
morphology has not changed, suggesting this clone is able to maintain its undifferentiated state over 
time. Scale bars: 250µm.  







Figure 39. (a) A representative sample of the metaphase spread of G2 iPSCs (63x magnification). (b) 
Table displaying the percentage of cells with a normal karyotype consisting of 54 chromosomes. Scale 
bar: 10µm. 
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In our hands we were able to derive ovine iPSCs whose pluripotency was maintained 
after the silencing of the reprogramming genes; these cells exhibited many 
characteristics of iPSCs, a normal karyotype and displayed markers of the three 
lineages after differentiation from embryoid bodies in vitro. 
The derivation of pluripotent cells in sheep has always been a challenge: the isolation 
of ESC-like cells from ovine blastocysts has been described (Dattena, 2006), but 
these cells could not be preserved in an undifferentiated state. Ovine iPSCs have now 
been obtained (Bao, 2011; Li, 2011) but many differences exist among our results 
and those published by Li et al (Li, 2011) and Bao et al (Bao, 2011), in particular 
related to both the protocols employed and the distinct expression profiles of the 
ovine iPSCs generated. 
 
First iPSCs were initially isolated in mouse using only 4 genes: cMyc, Klf4, Oct4 
and Sox2 (Takahashi and Yamanaka, 2006). Subsequently these four reprogramming 
factors have been employed for the successful derivation of iPSCs from other species 
(Esteban, 2009; Li, 2009; Honda, 2010). Although reported by Bao and colleagues 
that this strategy was not sufficient for the derivation of ovine iPSCs (Bao, 2011), 
our data support those of Li and colleagues in showing that ovine cells displaying 
iPSC characteristics can be derived using the original 4 genes (Li, 2011). 
 
Second, our first colonies appeared 8 days after the transduction, only two days later 
than in the mouse control experiment but substantially quicker than the timing 
described by Li et al (14 days) and Bao et al (20 days). This may be the result of the 
choice of the vectors (MoML retrovirus versus dox-inducible lentivirus) or 
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differences in culture conditions. In mouse and human the growth conditions for 
pluripotent cells have been optimized. This has not been possible in other species due 
to the lack of ESCs. Consequently the challenge of deriving iPSCs in sheep is 
hampered by the need to identify the right conditions for the maintenance of the cells 
in an undifferentiated state after reprogramming. In accord with a previous report 
(Bai, 2008), we observed a better morphology when the ovine pluripotent cells were 
generated in SR rather than in FCS. When Li et al compared the two medium 
conditions they described a higher proportion of AP-positive cells in FCS, 
concluding the presence of serum had improved the quality of the iPSCs. In contrast 
to this was the observation that the morphology of their iPSC colonies was not 
characterised by the defined edge typical of ESCs, suggesting that FCS might not 
represent the optimal supplement to support the growth of ovine pluripotent cells. 
AP, which is the indicator utilised by Li et al to identify ovine iPSC colonies, 
although being a marker for ESCs, is not strictly specific to pluripotent cells. As 
such, the higher proportion of AP-positive cells in FCS might be due to this 
component being a more permissive culture condition than SR for the development 
of partially reprogrammed cells. This could be consistent with the observation that, 
in pig, transducing cells with only cMyc and growing them in presence of either FCS 
or SR, a higher proportion of AP-positive colonies appeared in the FCS conditions 
(personal communication, Dr Alison Thomson, University of Edinburgh). 
 
Another consideration is the expression status of the induced genes. When working 
with retroviral vectors, if the cells become pluripotent the reprogramming genes are 
silenced through a mechanism reflected in DNA methylation (Hotta and Ellis, 2008). 
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In mouse the silencing of the retroviral vectors is considered a critical indicator of 
full reprogramming (Hotta and Ellis, 2008) and after the exogenous factors cease to 
be expressed, a true iPSC clone will continue to self-renew given the appropriate 
culture environment (Okada, 2010). In contrast, the inability to silence the 
reprogramming factors results in cells that have considerably impaired differentiation 
capacity (Brambrink, 2008). In order to control the expression time frame of the 
transduced genes, lentiviral vectors with transgenes driven by inducible promoters 
such as that based on the TET system (Wernig, 2008a) have been engineered. 
Lentiviral vectors are not able to be silenced in pluripotent cells (Pfeifer, 2002), but 
with the inducible promoters it is possible to control the expression of exogenous 
factors in the cells. Again when the block of the reprogramming protein expression is 
followed by loss of self-renewal, there is an evidence that only partial 
reprogramming have occurred (Hotta and Ellis, 2008). 
In our iPSCs, we observe nearly complete silencing of the induced genes with 
maintenance of markers of pluripotency in contrast to the previous reports on ovine 
iPSCs (Bao, 2011; Li, 2011) where, employing a dox-inducible system, the 
withdrawn of doxycycline was shortly followed by differentiation of the cells. 
 
Pluripotency markers retain a great significance in the characterization of stem cells 
and represent the first step in the identification of real iPSCs. 
Although largely similar, differences between species (mouse and human) exist, for 
example SSEA1 is expressed in mouse and SSEA4 in human (Koestenbauer, 2006). 
The ovine iPSCs generated in this experiment expressed Nanog, but not SSEA1 or 
SSEA4, while Oct4 was not analysed due to the impossibility to discern between 
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viral and exogenous protein or transcript. This is in contrast with the other reports 
about ovine pluripotent stem cells, where the cells expressed either SSEA1 (Bao, 
2011) or SSEA4 (Li, 2011) or both (Dattena, 2006). Given the differences in 
expression profile obtained, it is premature to draw conclusions with respect to the 
ovine pluripotent cells marker profile and to how this compares to that established 
for mouse and human. 
 
In summary, I have explained a method for the reprogramming of OFFs into iPSCs. 
While the cells show many ESC-like characteristics, such as the expression of 
markers of pluripotency and fast growth, their differentiation potential is not 
complete, as suggested by the observation that the cells cannot give rise to beating 
cardiomyocyte. Whether this is a consequence of a sub-optimal culture condition or 
of an inappropriate differentiation protocol needs to be investigated. Further studies 
are required to obtain high quality ovine iPSCs; in particular the culture conditions 
need to be optimised. Although the generation of ovine iPSCs provides an important 
platform for the study of the mechanism underlying pluripotency and differentiation 
in ungulates, its medical and agricultural applications are impeded by the presence of 
the viral integration in the genome. Although retroviral vectors are silenced at the 
moment of dedifferentiation, it has been reported that the transgenes may be 
reactivated in chimeric animals (Okita, 2007). This problem may be overcome with a 
modification of the delivery strategy: integrating vectors might be replaced with 
adenoviruses, plasmids or even proteins, all non-integrating systems whose 






In vivo characterization of ovine induced pluripotent stem cells 




In chapter 5 I have illustrated that our ovine iPSCs display many markers of 
pluripotency and have demonstrated their ability to differentiate in vitro. The next 
step in the analyses is now the characterisation in vivo, which includes a test for the 
differentiation of the pluripotent cells towards the three germ lineages in an 
immunocompromised mouse and involves a chimera formation experiment in order 
to evaluate whether the cells can contribute to the offspring and go germline when 
injected in early stage embryos (Bradley, 1984; Huang, 2008). 
The contribution to chimeras and germline is considered the gold standard for 
pluripotent cells. Mouse and rat ESCs have passed this test (Evans, 1983; Bradley, 
1984; Buehr, 2008; Li, 2008), while human ESCs will never be tested for ethical 
reasons. Among iPSCs, mouse and rat have demonstrated contribution to the 
germline (Okita, 2007; Hamanaka, 2011), whereas pig iPSCs have so far shown their 
ability to give rise to chimeras  (West, 2010). 
The ability of pluripotent cells to contribute to an adult animal and to colonize the 
germ cell population allows for the birth of animals derived from only the pluripotent 
cells. This can be exploited for research and commercial applications: since ESCs 
can give rise to a whole animal, the production of genetically modified ESCs can 
lead to the generation of genetically modified offspring, which can be employed for 
the creation of disease models, for the production of specific proteins, for the 
generation of desired traits in farm animals or for the generation of more compatible 
organs for human xenotransplantation (Piedrahita and Olby, 2011) without the need 
to go through nuclear transfer or virus-mediated gene transfer. 
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In this chapter I will describe how I marked our ovine iPSCs with EGFP in order to 
make them traceable for in vivo studies; I will further describe the inoculation of the 
ovine iPSCs into the leg of SCID mice to assess for teratoma formation and the 





6.2.1 Ovine induced pluripotent stem cells expressing GFP for in vivo 
experiments 
EGFP-iPSCs were created for the in vivo experiments in order to be able to track the 
ovine iPSCs post-transplant. Indeed we wanted to prove the sheep origin of the 
tumours generated by injection of ovine iPSCs into SCID mice and we aimed at 
recognising green cells in sheep foetuses and lambs after injection of the iPSCs into 
early stage embryos. 
Since transfection efficiency in ESCs is usually quite low, I employed a 
transduction-mediated protocol to insert EGFP in the genome of the ovine iPSCs. 
Three viral vectors carrying a constitutive promoter followed by EGFP were already 
available in the laboratory: PGK-EGFP, CAG-EGFP and Ubi-EGFP (Fig. 40). 
Since iPSCs grow in colonies we wondered whether it were more efficient to 
transduce the cells when sub-confluent or just after passaging, when they are still at 
single cells. I sought to obtain the higher percentage of green cells, so that I would 
not need to perform cell sorting, with possible cell damage associated to the process. 
 





Figure 40. Lentiviral vectors employed to mark the ovine iPSCs; all carry EGFP, which is driven by 
different promoters: the phosphoglycerate kinase (PGK) promoter (a), the cytomegalovirus early 
enhancer element and chicken beta-actin (CAG) promoter (b) and the ubiquitin (Ubi) promoter (c). 
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I chose the PGK-EGFP viral vector to test the two different transduction protocols. 
Ovine iPSCs were split in two wells of 12 well plate; the first well was transduced 
when at 60%-70% confluence with 25µl of virus diluted in 500µl of medium; after 
3h 2.5ml of medium were added and the cells were incubated with the diluted virus 
until the next day, when they were passaged. When the second well was confluent, 
cells were trypsinized, separated from the feeders and plated in a 12 well plate with 
25µl of virus diluted in 500µl of medium; after 3h 2.5ml of medium were added and 
the cells were incubated with the diluted virus until the next day, when medium was 
replaced. Three days after transfection, the ovine iPSCs were quickly looked at under 
the fluorescence microscope and I evaluated that the transduction after passaging was 
the most efficient. No pictures of the experiment were taken in order to avoid 
exposure of expose the cells for too long to the UV light, which could cause DNA 
damage. 
 
After assessing the best transduction protocol, I compared the efficiency of the EGFP 
vectors; the three viruses were employed in the ovine iPSCs and when passaging, 
few cells for each viral transduction were placed on a slide and looked at under the 
fluorescent microscope (Fig. 41). PGK-EGFP vector gave the brighter signal and the 
higher percentage of transduced cell (88%, versus 2% of CAG-EGFP and 39% of 
Ubi-EGFP); therefore I decided to use the PGK-EGFP transduced cells for our in 
vivo experiments. 
 
6.2.2 Teratoma formation 
In the previous chapter, I have demonstrated that the G2 clone can generate cells 
 





Figure 41. Ovine iPSCs were transduced with the three different EGFP vectors and the efficiency, 
displayed on the top right corner of each FITC image,  was calculated as the ratio between the number 
of green cells divided by the number of total cells counted. PGK-EGFP was the viral vector which 
achieved to transduce the higher amount of cells (88% versus 2% of CAG-EGFP and 39% of Ubi-
EGFP. Scale bars: 100µm. 
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belonging to all three germ layers in vitro. To further verify the differentiation 
potential of our ovine iPSCs, it was necessary to investigate whether these cells 
could form teratomas in vivo, after injection in immunodeficient mice. 
An in vivo differentiation assay was performed injecting 2x106 cells in the right leg 
of severe combined immunodeficient (SCID) mice. The ovine cells were tested 
alongside a mouse ESC control. Between 3 and 5 weeks after injection, all mice had 
developed big tumours, with diameter of about 2cm (Fig. 42), and were sacrificed. 
The timing of the growth of the lumps is summarized in table 9. Tumours were 
surgically dissected from the mice, fixed in formal saline and decalcificated in order 
to remove bones which could compromise the section cutting protocol. Tumours 
were then paraffin-embedded and sections were cut and stained with H&E staining. 
While mouse ESCs displayed an evident differentiation into distinct types of cells 
and tissues (Fig. 43a-d), the mass formed by the ovine iPSCs was more homogenous, 
with a very primitive organization composed of different tissues (Fig. 43e-g), but 
with only some cartilaginous structures that could be recognised (Fig. 43h). A lot of 
necrosis was observed in the ovine tumours, but not in the murine counterparts. 
Analysing the lumps, we soon realised that, although very likely, we did not have 
any proof that the tumours were originated by the iPSC-derived cells. No antibodies 
against the three germ layers were available that could discriminate between mouse 
and sheep tissues, therefore we decided to repeat the experiment employing the 
EGFP-iPSCs. 
I injected the EGFP-G2 cell line into 6 SCID mice. Twenty two days later all mice 
had developed a big tumour and were sacrificed. The lumps were collected and cut in 
half, where one part was fixed in formal saline and paraffin embedded, while the 





Figure 42. The tumours developed in SCID mice after injection of ovine iPSCs (a) or mouse ESCs (b) 
are indicated with a black arrow. The teratomas appeared and developed with similar timing for both 
cell types. (c) Figure of a teratoma derived by the ovine iPSCs how it appeared after excision from the 
mouse leg. 
  





Table 9. Table summarising the inoculation of mouse ESCs and ovine iPSCs in SCID mice with the 
correspondent timing of tumour growth. 
  





 Figure 43. H&E staining of the paraffin embedded tumours derived from the mouse ESCs (a-d) or 
from the ovine iPSCs (e-h). Mouse ESC teratomas show that many different organised structures have 
developed within the tumour (a), among them we could recognise neural tissues (b), cartilage (c) and 
squamous epithelium (d); on the other side, ovine iPSCs gave rise to a very immature tissue (e) where 
it was possible to distinguish different tissue (f-h), but only few of them could be identified (h, 
cartilage). Scale bars: 100µm for (a), (e), (h); 50µm for (b), (c), (d), (f), (g).  
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other was OCT embedded and snap frozen in order to cut cryosections. The 
EGFP-positive sections confirmed that the tumours had been generated by the ovine 
iPSCs (Fig. 44a), then a H&E staining was performed, showing again mostly 
immature tissues with some evidence of early differentiation (Fig. 44b-e). After the 
examination of these and the previous tumours, I realised that the differentiation 
obtained with our ovine cells was not as clear as the differentiation obtained with 
mouse ESCs, so we proceeded with antibody stainings to be able to detect cells 
which, although had not given rise to defined structures yet, had started expressing 
proteins typical of differentiated cells. Cells were stained against markers 
characteristic of each of the three germ lineages: cytokeratin-18 (Fig. 44f) and α-
fetoprotein (Fig. 44g) representing endoderm, vimentin (Fig. 44h) and troponin T 
(Fig. 44i) for mesoderm and neurofilament (Fig. 44l) and βIII tubulin (Fig. 44m) 
corresponding to ectoderm. Immunocytochemistry gave positive results for all 
markers. The stainings against cytokeratin-18, α-fetoprotein, vimentin, troponin T 
and βIII tubulin appeared authentic because of the morphology of the tissues: 
although forming some sort of structures, the positive cells were not as organised as 
in a healthy tissue. For the same reason we are unsure about the neurofilament 
results: the anti-neurofilament antibody stains in very organised areas, which do not 
resemble tumour tissues and might simply be nerves of the mouse around which the 
tumour had developed. Troponin T staining on the other hand is likely to be 
unspecific, since it is localised in structures that are similar to nerves more than 
muscle. 
  





Figure 44. Teratomas generated by the inoculation of EGFP-iPSCs: (a) a section of the tumour looked 
at with the fluorescent microscope shows the teratoma is indeed of ovine origin; (b-e) different tissues 
can be observed in the H&E stained sections of the tumours; (f) anti cytokeratin-18 
immunohistochemistry of a slide show a positive signal in a primitive epithelium; (g) α-fetoprotein 
staining, the positive cells are not correlated to any visible organization of the tissues; (h) 
anti-vimentin antibody marks cells which form a defined structure; (i) troponin T 
immunohistochemistry showing a false positive: the tissue stained appears to be nerve, not cardiac 
muscle; (l) neurofilament staining is localised in a nerve, however the structure is very organised and 
we cannot be sure it does not belong to the mouse host; (m) βIII tubulin immunohistochemistry 
reveals a positive tissue with a morphology resembling that of a nerve; (n) the section sequential to 
that of the βIII tubulin staining confirms that the neural tissue is derived from the ovine iPSCs; (o-q) 
EGFP-positive muscle in the teratoma sections at different magnifications (o and q, fluorescence field, 
p bright field). Scale bars: 50µm for (a), (c) - (g), (i) – (n), (q); 100µm for (b), (h), (o), (p). 
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Looking at sequential sections I identified bright green cells covering the same area 
of the βIII tubulin staining (Fig. 44n), which gave us a further confirmation that the 
differentiated cells derived from the injected ovine iPSCs. 
Investigating the areas at the edge of the tumours I noticed that in 2 of the 6 tumours, 
among the muscle fibres of the mouse, EGFP was clearly detectable with a 
morphology similar to that of muscle tissues (Fig. 44o-q), indicating that our ovine 
iPSCs generated muscle fibres infiltrating among the tissues of the mouse. The green 
cells with muscle morphology may however be the result of cell fusion, instead of 
differentiation of the iPSCs: this event is described by Reinecke et al (Reinecke, 
2004) and Nussbaum et al (Nussbaum, 2007); in both reports, however, the fusion 
event is very low (quantified by Reinecke et al as 0.01% likelihood), while in the 
teratomas derived from the iPSCs, same areas inside the muscle accounted for more 
than 30% EGFP positive cells, suggesting that the green cells might be authentically 
differentiated iPSCs. This hypothesis could match with the timing of in vitro 
differentiation of ESCs into muscle: in mouse ESCs usually a differentiation of 12 
days is indeed needed to get more than 80% of cells show myogenic differentiation 
(Rohwedel, 1995).  
 
6.2.3 Injection of ovine induced pluripotent stem cells in ovine embryos 
Once assessed that the ovine iPSCs were able to give rise to teratomas, I moved on to 
the following step of characterization and tested the ability of the cells to contribute 
to animals. 
A preliminary analysis was performed to verify what embryonic stage was more 
suitable for injection of the cells; classically ESCs are injected in the cavity of the 
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expanded blastocysts, but recently a study reported the successful generation of 
chimeras by injecting ESCs in the zygote or the 8 cell stage (Huang, 2008). 
EGFP-iPSCs (Fig. 45) were inoculated in ovine embryos at zygote, 8 cell and 
blastocyst stage (Table 10). The fate of the cells was followed in order to assess 
whether the cells survived and were incorporated into the early embryos. When 
injected at zygote stage, the cells were bright green after 2h (Fig. 46a), but already 
after 1 day the fluorescence was weakening (Fig. 46b) and at blastocyst stage no 
green cells were detectable (Fig. 46c). When cells were inoculated at the morula 
stage, again no fluorescence was visible in the blastocysts (Fig. 46d, e). When 
inoculated into blastocysts and looked at 2-3 hours later, only few fluorescent cells 
were noticeable (Fig. 46f, g). 
From 5 to 16 cells were injected in each embryo, but already few hours afterwards 
most of them were not visible anymore (Fig. 46a, f). The inability to detect the 
majority of the injected cells that were inoculated might be due to a number of 
possible reasons: cells may have died and burst or most of the injected cells were not 
EGFP transduced or simply EGFP penetrating power was not enough to pass through 
the layers of cells composing the embryos. 
The hypothesis of the death of the ovine iPSCs is in contrast with the fact that in the 
zygote-injected embryos some fluorescence, albeit very weak, was detectable even 
the day after injection. 
Although possible, the supposition that most of the injected cells were not 
EGFP-positive is not very likely, indeed, I calculated that after the transduction 
roughly 88% of the cells were green and just before the inoculation the cells were 
looked at again under the fluorescent microscope in order to confirm that EGFP was 





Figure 45. Fluorescence and bright field of EGFP transduced ovine iPSCs employed for the chimera 
experiment. Scale bars: 100µm. 
  





Table 10. Table summarising the preliminary injection of EGFP-iPSCs into embryos at different 
stages. 
  





Figure 46. Outcome of the preliminary injection of EGFP-iPSCs into embryos at the zygote (a-c), 8 
cell (d, e) and blastocyst (f, g) stages. (a) Zygotes 2h after inoculation, (b) 24h after inoculation and 
(c) at blastocyst stage. Bright (d) and fluorescent (e) fields of a blastocyst injected at 8 cell stage; 
bright (f) and fluorescent (g) fields of a blastocyst injected at blastocyst stage and uninjected 
blastocysts (h, i). Scale bars: 25µm for (a) – (e); 100µm for (f) – (i).  
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still expressed. It is worth to note that for the injection procedure the cells with the 
best morphology were chosen, so it might have happened that the non-transduced 
cells looked healthier and were therefore preferentially inoculated. 
Regarding the third assumption, I realised that when the green cells were underneath 
the zygote, the fluorescence could not be seen anymore, but was visible when 
rotating the embryos; while the rotation could be performed on the zygote to locate 
all the green cells, this could not be applied to the blastocysts, since they are formed 
by different layers of cells; so if some green cells were not on the surface, it was 
possible that I could not detect their fluorescence; additionally ovine blastocysts 
possess auto-fluorescence in the culture conditions we employed (Fig. 46h), which 
could have further masked the low EGFP signal coming from hidden cells. 
 
Since the preliminary analyses on the different stage injections did not give any clear 
result, we transferred the embryos inoculated at the three different stages into 
synchronised recipients. The ewes were culled just after 3 weeks post fertilization. 
Out of 19 blastocysts transferred, 9 embryos had developed (Table 11) and were 
recovered alongside their extra-embryonic membranes: 6 foetuses and the 
membranes were first looked at under the fluorescence stereoscopic microscope and 
then their gDNA was extracted, while the other 3 embryos were snap frozen for 
cryosectioning. Neither the analysis at the stereoscopic microscope nor the 
cryosection assay displayed any fluorescence (Fig. 47a-c). The PCR on the gDNA 
extracted from the foetuses and the placentas was problematic: the primers initially 
utilised were those already employed for the silencing and a very weak band was 
  





Table 11. Table summarising the preliminary transfers of EGFP-iPSCs into recipients. 
  






Figure 47. Analyses on the foetuses recovered from recipients carrying EGFP-iPSCs: (a-b) Image of a 
foetus observed at the fluorescent microscope: no EGFP signal could be detected; (b-c) cryosections 
of an embryo in fluorescent field (b) and bright field (c): again no fluorescence was visible; (d) PCR 
for viral Oct4 reveals a little contribution of the ovine iPSCs to one of the foetuses; the negative 
control is OFF gDNA, the positive controls consist of ovine iPSC gDNA spiked into the negative 
control in a ratio of 1:102, 1:103 and 1:104. The contribution of the ovine iPSCs to the embryos 
appears to be lower than 1 cell in 10000.  
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visible in one of the samples; I then attempted to perform a nested PCR, to verify 
whether one of the samples was truly positive, but, although very careful, I had to 
deal with contamination problems. I therefore designed new primers that recognise 
the viral Oct4 sequence. These primers were able to detect lower concentrations of 
Oct4 than the previous and allowed for a weak band to be visible in one foetus (Fig. 
47), corresponding to a contribution lower than 1 in 104 cells. In the different 
replicates others sample would sometimes be weakly positive and we wondered 
whether the results I obtained were due to a very low contribution which was at the 
detection limit of the PCR or whether the bands I saw were contaminations of some 
sort; however the latter option is unlikely because the no gDNA control was always 
negative. 
 
6.2.4 Analyses on the lambs 
Since no clear results were obtained from the previous analyses, we injected around 
20 cells from two cell lines (G2 and D1) in day 6 blastocysts. The embryos were 
transferred in recipients and the ewes were left to carry the pregnancy to term. 
Initially we inoculated the EGFP cells, but after noticing that the fluorescence was 
soon switched off and was not visible in any of the foetuses, we decided to start 
injecting unmodified cells, assuming that fewer modifications in the genome and in 
the protein content of the iPSCs would increase the chances of achieving a 
contribution to the animals. Eighteen lambs (17 alive and 1 mummified) were born 
out of 99 blastocysts transferred (Table 12); at the moment of the birth the placenta 
samples were collected for analyses.  
 




Table 12. Table summarising the transfers of EGFP-iPSCs into recipients and the outcome. 
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Some of the ewes had a gestation term a few days longer than expected and three 
lambs were very big, with a weight ranging between 7.5 and 10.2kg, whereas one 
was very small, weighting only 2kg. The bigger lambs were likely the result of the 
large offspring syndrome typical of bovine and ovine embryos exposed to a variety 
of unusual environments prior to the blastocyst stage (Young, 1998), not a 
consequence of the inoculation of the ovine iPSCs. 
Only one round of D1 cell injections gave rise to lambs, producing 4 lambs (OT046, 
OT047, OT048, OT051), suggesting that this cell line is less suitable for the growth 
in early embryos. Among them was one of the heavy lambs, weighting 7.5kg. 
One lamb (OT029) was found dead 1 day after birth, apparently because of twisted 
gut; another lamb (OT027) suffered of pneumonia and was sacrificed 4 days after 
birth. 
Ear clips and blood were collected for the live lambs, while different tissues were 
collected from the animals which had died and from the mummified lamb; placental 
samples from the mothers were gathered too. The tissues were looked at under the 
fluorescence microscope revealing no EGFP signal; multiple PCRs targeting the viral 
Oct4 were performed on the samples in order to assess whether the lambs were 
chimeric. Few samples were positive, even though the contribution to the animals 
was calculated to be lower than 1:103 (Fig. 48). 
 
Due to the previous results, we decided to sacrifice the lambs to investigate whether 
other organs and tissues may carry a higher number of iPSC-derived cells. Two 
animals were maintained alive: OT058 lamb, whose ear clip was positive to the Oct4 
PCR and OT059 as a negative control in case other analyses needed to be done. 




Figure 48. A representative Oct4 PCR assay on ovine tissues collected from the lambs. Negative 
control is OFFs gDNA, while positive control is represented by ovine iPSC gDNA spiked into the 
negative control at different concentrations.  
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The lambs were sacrificed at 5 to 16 weeks of age and multiple samples were 
collected from a wide range of tissues (Table 13), looked at under the stereoscopic 
fluorescent microscope and subjected to PCR specific to the Oct4 transgene. 
No green tissues were observed at the microscope and the Oct4 PCR results showed 
a very low iPSC contribution in different tissues (Fig. 49a), which is summarised in 
table 13. The samples reproducibly positive to Oct4 belong to the three germ layers 
and also to the extraembryonic membranes. Again the contribution of the cells to the 
tissues was lower than 1 in 103 cells. Interestingly, while most of the G2-derived 
lambs had a wide range of tissues positive to Oct4 PCR, D1 cells achieved to weakly 
contribute to only one tissue of one lamb, suggesting that this second cell lines is less 
suitable for chimera formation, results which is consistent with the in vitro 
differentiation data. 
 
In order to confirm the Oct4 results a viral cMyc PCR and a viral Klf4 PCR were 
performed on the samples positive for viral Oct4: only three tissues (skin from lamb 
OT028, muscle from lamb OT030 and placenta from ewe OB043) were positive for 
cMyc or Klf4 (Fig. 49b). Remarkably lamb OT028 and lamb OT030 are the 
offspring of ewe OB043. Lamb OT030, which displayed the higher contribution of 
iPSCs, was born mummified and, although different tissues (muscle, liver, heart and 
kidney) were collected from it, gDNA could be extracted only from muscle. 
 
These results confirm that the ovine iPSCs are able to contribute to the generation of 
live chimeras, even though at low level. 
  









































































In this chapter I have demonstrated that the ovine iPSCs I have generated are able to 
differentiate in vivo and to contribute to chimera formation. 
At first sight the teratomas produced by the ovine iPSCs appeared to be extremely 
immature when compared to the mouse counterparts; nonetheless I was able to 
recognise many different cell types belonging to all three germ layers through 
immunohistochemistry. Among the immature tissues I could detect some organised 
structures, but initially I was not able to address whether these structures were 
derived from the ovine cells or were part of the mouse body, due to the lack of 
antibodies specific for ovine tissues. In order to trace ovine contribution we repeated 
the experiment marking the cells with EGFP and were able to demonstrate that the 
tumours, including some of the primitively organised tissues, were specifically 
formed by iPSCs. 
The early differentiation state of our tumours might suggest a non-complete 
reprogramming of our ovine iPSCs; however other causes may be at the basis of the 
immature teratomas. Ovine pluripotent cells have been recently isolated and the 
literature about teratoma formation is very scarce. Only two reports are available 
which describe the injection of ovine iPSCs into SCID mice (Bao, 2011; Li, 2011), 
but in both cases there is a statement that the cells can give rise to different tissues 
belonging to the three germ layers, without commenting whether the teratomas were 
extremely differentiated or still naïve. 
Culture conditions can be another explanation, even though EpiSCs and human 
ESCs, which are cultured in the same condition as our ovine iPSCs, do not exhibit 
this limitation. 






Figure 49. (a) PCR analysis targeting the viral Oct4 on a selected group of samples suggests that 
tissues coming from the different germ layers and from the germ cells have a low contribution of 
ovine iPSCs; (b) in order to confirm the assumption PCRs for the viral cMyc and viral Klf4 were 
performed: only few samples resulted positive to one or both genes.  
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Another possibility for the reduced differentiation that I observed can be linked to the 
site of injection: many reports (Cooke, 2006; Prokhorova, 2008) underline that 
teratoma formation from human ESCs is dependent on the graft site and the 
intramuscular injection is the least efficient method among those employed 
(Prokhorova, 2008); although the mouse ESCs employed as a control were 
inoculated in the same site producing widely differentiated tumours, the site-
dependency might be a characteristic regarding only inter-species teratoma 
formation.  
It is also possible that the ovine cells required more time to differentiate and the mice 
were sacrificed too early. 
It also true that spontaneous in vitro differentiation of ICMs from ungulates does not 
give rise to the variety of different tissues seen in the mouse, but mostly 
neuroectoderm; this may suggest that we have not found yet the optimal culture 
conditions for the differentiation of pluripotent cells from ungulates. 
 
EGFP however was not uniformly expressed among the teratomas, suggesting that 
either the PGK promoter have undergone silencing during the differentiation process 
towards some specific cell lines or simply that the EGFP-negative portions of the 
tumours had been generated by the few non transduced ovine iPSCs injected. 
Both hypotheses are plausible: reports state that the PGK EGFP cassette introduced 
in ESCs is sometimes silenced upon differentiation (Hamaguchi, 2000); likewise it is 
important to bear in mind that the ovine iPSCs that we injected were 88% 
fluorescent, but there was still a small percentage of non-transduced cells among the 
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EGFP positive cells. The lack of fluorescence found in some areas of the teratomas 
may be the result of the combination of the two events. 
 
A similar issue was encountered when performing the preliminary experiments for 
the ovine iPSCs injections in early stage embryos: while 2h after inoculation bright 
green cells were still detectable, at the blastocyst stage no fluorescence was visible. 
Again, this may be explained by inhibition of the PGK promoter that drives EGFP 
expression or by the presence of non-transduced cells among the green cells. 
Although at first sight it is very unlikely we inoculated mostly non fluorescent cells 
since they accounted only for the 22% of the total cells, it is possible that the EGFP 
cells had a slightly different morphology compared to the non-transduced cells and 
were unintentionally overlooked at the moment of the injection. This hypothesis 
might also explain why, although from 5 to 25 cells were inoculated into each 
embryos, only 1 or 2 green cells were noticeable only few hours post injection. 
Analysing the embryos inoculated at zygote stage I noticed that already after 24h the 
fluorescence tended to fade greatly. This may be a consequence of cell death, which 
brought to loss of the cytoplasm content, including the EGFP protein; however the 
cell membrane looked apparently undamaged. Again the loss of fluorescence may be 
the result of inhibition of EGFP expression: EGFP half-life is roughly 26h (Corish 
and Tyler-Smith, 1999), so the fading could be explained as an intermediate state 
where the gene does not transcribed anymore, but the proteins are still in the 
cytoplasm and are slowly degraded or diluted by cellular division events. 
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Chimeric animals have been produced from mouse (Okita, 2007; Wernig, 2007) and 
rat iPSCs (Hamanaka, 2011). Among the ungulates a group has reported the 
generation of chimeric animals employing pig iPSCs (West, 2010), but the result has 
not been described yet in sheep. 
Here I show that, albeit at low level, ovine iPSCs can contribute to live offspring. 
The sample showing the higher amount of iPSC-derived cells was collected from the 
mummified animal, raising the question whether the higher contribution was the 
responsible for the lack of viability of the lamb. 
The low contribution to the chimeric animals may be the effect and the combination 
of different factors. The culture medium conditions in which our ovine iPSCs are 
grown could have had a major impact on the efficiency of the process: human ESC 
conditions are known to promote the EpiSC state both in mouse and in human. 
EpiSCs express the key pluripotency factors and can differentiate into numerous cell 
types in vitro, but they can hardly contribute to live animals after injection into 
blastocysts (Brons, 2007; Tesar, 2007). In the light of this consideration, the low 
contribution to the chimaeras is to be expected. 
Another possibility may reside in differences in growth characteristics: even though 
the growth rate of our ovine iPSCs was comparable to established mouse ESCs, I 
observed that after trypsinization our ovine iPSCs took longer to recover than the 
mouse ESCs. This delay may reduce the proliferation capability of cells injected into 
the blastocyst. 
Alternatively and reflecting the limited morphology observed in teratoma studies, our 
iPSCs may not be reprogrammed enough to allow for chimera formation. In a 2007 
report Piliszek et al (Piliszek, 2007) demonstrated that embryonic fibroblasts can 
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contribute to full term mice; this might raise the question whether our ovine iPSCs 
are simply OFFs which succeeded to partially being incorporated  into the offspring. 
However this would strongly be in contrast with the results presented in this and in 
the previous chapters, where the ovine iPSCs showed to express markers of 
pluripotency, to be able to partially silence the transgenes and to differentiate 
towards cells belonging to the three germ layers both in vitro and in vivo. 
It is also important to underline that very little is known about the development of the 
early embryo in sheep; indeed there is no prior knowledge about how a pluripotent 
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7.1 Final discussion 
The data described in this thesis illustrate the generation of iPSCs in sheep and their 
characterisation both in vitro and in vivo. The generated cells express some 
pluripotent markers, are able to differentiate into cells deriving from all three germ 
layers both in culture and after injection in an animal and can give rise to chimeras. 
 
7.1.1 Viral vector preparation 
The first step of the project was to repeat the original report of Takahashi and 
Yamanaka (Takahashi and Yamanaka, 2006) in order to establish the novel iPSC 
generation protocol at The Roslin Institute. The expression plasmids we employed 
were those generated and used in the original iPSC work, while the packaging 
plasmids were purchased. In order to assess whether viable viruses could be 
produced and in order to verify that the reprogramming factors were indeed 
expressed in the target cells, the viruses were generated by transfecting HEK cells 
and were employed for the transduction of immortalised MFF lines. Those cells were 
fixed and the staining against Klf4, Oct4 and Sox2 confirmed that the viruses were 
functioning. We could not perform cMyc staining because of issues faced with the 
antibody we were employing: even after performing numerous optimizations varying 
the concentration of primary and secondary antibody, the negative control was 
always positive, indicating a poor specificity of the anti cMyc antibody. Being that 
the other three viruses were viable we assumed that also the cMyc virus might be 
able to express its reprogramming gene; since cMyc is not an essential factor for 
reprogramming (Nakagawa, 2008), we presumably could have isolated iPSCs albeit 
with a lower efficiency. 
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The immunocytochemistry assay was initially performed on cells transduced with a 
frozen virus. Since the protocol for the generation of iPSCs requires the use of fresh 
virus (Takahashi, 2007a), I repeated the transduction for the Sox2 virus and the 
staining confirmed that the use of a freshly prepared virus permits optimal cell 
transduction. 
 
7.1.2 Generation of putative mouse induced pluripotent stem cells 
Once confirmed the viruses were viable, they were employed for the reprogramming 
protocol in MFFs: the fresh cMyc, Klf4, Oct4 and Sox2 viral vector were transduced 
into MFFs which were grown on feeder layer. A week later small colonies appeared 
with a morphology similar to that of mouse ESCs; colonies were picked, expanded 
and tested for the basic features of pluripotency. The four clones evaluated were 
positive for Nanog, but, in contrast to mouse ESCs where the staining was strictly 
localised in the nucleus, Nanog appeared to be expressed in both nucleus and 
cytoplasm. This kind of Nanog expression pattern has been observed in ASCs (Zuk, 
2009; Carlson, 2011), primitive germ cells (Goel, 2008) and tumours (Ezeh, 2005; 
Ye, 2008), suggesting that the mouse cells I have generated were in a partially 
reprogrammed state or were still in the middle of the reprogramming process and 
needed more time to fully reprogram. 
The putative murine iPSCs were then allowed to differentiate in vitro through 
spontaneous differentiation via EB formation; the outgrowths derived from the plated 
EBs were stained against ectodermal, endodermal and mesodermal markers. The 
cells were positive for βIII-tubulin and Troponin T but no clear results could be 
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obtained for α-fetoprotein; the antibody optimisation required a long time and when I 
achieved it, I was already working on the ovine iPSCs. 
Further characterisation of these cells might have been performed to have a more 
complete indication of whether the cells are authentic iPSCs (e.g. staining against a 
higher number of pluripotency markers, RT-PCR to verify whether the exogenous 
genes had been silenced, in vitro differentiation assay where alongside 
immunocytochemistry a RT-PCR was performed on a higher number of markers, 
blastocyst injection, germline transmission). 
 
The efficiency of reprogramming was variable between different wells, ranging from 
2.8% to 13.2%. This figure is much higher than those already published, but cannot 
be compared with them, because of the different techniques employed for the 
calculation of the efficiencies in the other studies. Indeed I counted all the colonies 
that had developed, while other studies calculated only those which had Oct4 or 
Nanog promoters activated or those positive to AP staining, which are substantially 
fewer than the total number of colonies generated.  
 
The generation of mouse reprogrammed cells was performed in order to assess 
whether the protocol was functional and to find what may be improved. Indeed we 
found many points that could be changed in order to ensure a better outcome: the 
transduction protocol would have been more efficient without the presence of the 
feeder layer. Additionally, the presence of a retroviral vector carrying a marker in 
order to evaluate whether the transduction protocol had worked and the use of 
optimised number of feeder cells to expand the reprogrammed cells would have 
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probably improved the process. Again, the use of different culture conditions may 
have been interesting: the 3i or the 2i (Ying, 2008) media could have been employed, 
since they select only pluripotent cells, leaving the differentiating cells to die. 
 
Although the characterisation of the mouse cells was not complete, we achieved the 
purpose of verifying that the Takahashi and Yamanaka’s published protocol was able 
to reprogram embryonic fibroblast to a more naïve state; furthermore the feasibility 
of the method was proved by many other studies that were later published by other 
groups. We therefore decided to proceed to the main aim of my study: the derivation 
of iPSCs in sheep. 
 
7.1.3 Generation and in vitro characterisation of ovine induced pluripotent stem 
cells 
When I began the ovine iPSC generation experiment many reports had been recently 
published where new techniques were employed for the isolation of iPSCs. In 
particular, more efficient methods such as lentiviral transduction  (Yu, 2007) or safer 
approaches, employing non integrating viruses (Stadtfeld, 2008c), plasmids or even 
cell permeable proteins (Zhou, 2009; Cho, 2010) have been developed. We evaluated 
the opportunity to employ these novel techniques, but decided to continue working 
with the MoML viral vectors for four main reasons. First, although not as efficient as 
the lentiviruses, retroviral vectors are more efficient than all other published 
protocols. Second retroviruses have a main advantage over lentiviruses for the 
production of iPSCs: they are silenced in pluripotent cells (Cherry, 2000), property 
which discerns between fully and partially reprogrammed iPSCs. Third, we knew the 
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retroviral protocol worked because of the mouse experiment, which moreover 
allowed us to be aware of the potential issues encountered during the process and of 
some hints to improve the protocol. Last, we had already all the reagents and 
plasmids we needed since the alignment of the murine and ovine reprogramming 
genes showed the mouse factors were highly homologous to those of the sheep. 
 
The reprogramming protocol in sheep was based on that carried out on mouse cells, 
with minor modifications: OFFs were transduced on gelatin and only later passaged 
on feeder cells, a new packaging vector able to target all mammalian cells was 
employed and a GFP retroviral vector was employed in the negative control in order 
to verify whether the four genes, and not just the viral transduction, were the 
elements that brought to the colony formation; furthermore the GFP virus was useful 
to assess whether  the viral vectors packaged with the new envelop were viable. After 
transduction the cells were passaged once at low density in order not to need to be 
passaged again, so that colonies derived from single cells were obtained. Since ovine 
ESCs had not been derived yet, I grew the cells in mouse ESC medium or in human 
ESC medium to test which was more suitable for the maintenance of pluripotent cells 
in sheep. Colonies were derived in both media, but the morphology was different: in 
mouse ESC medium the ovine colonies were granulated, while in the human ESC 
conditions the colonies looked more mouse ESC-like. In another study iPSCs were 
preferentially grown in FCS, because a higher number of AP-positive colonies were 
observed when ovine iPSCs were grown in these conditions (Li, 2011); however it is 
important to bear in mind that, although AP is a marker of pluripotent cells, it can 
also be found in other differentiated cell types (Weiss, 1986), so it cannot be 
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employed as the only marker to discriminate between fully and partially 
reprogrammed cells. Indeed this assumption is supported by the fact that the ovine 
iPSCs isolated by Li et al were not able to maintain their pluripotency without the 
sustained expression of the inducible transgene and could differentiate only upon 
withdrawal of drug employed to induce the reprogramming factors. 
 
The cells growing in the human ESC medium were picked, expanded and tested for 
the main feature distinctive of ESCs and iPSCs. The characterisation was initially 
performed in vitro: ovine iPSCs displayed a morphology and a population doubling 
time similar to those of mouse ESCs; even after many passages they were able to 
retain a normal number of chromosomes, did not change their morphology and did 
not senesce, characteristics all typical of ESCs. The staining against markers of 
pluripotency revealed that some of the colonies were positive to both Nanog and AP, 
some others only to one of the two markers, but none of them was consistently 
positive to the surface markers SSEA1 or SSEA4. These last markers were chosen to 
understand whether the ovine iPSCs were closer to human or mouse ESCs, since 
SSEA1 is specific for the former, while SSEA4 for the latter. Although mostly 
negative for the two markers, some of the clones displayed a few cells positive for 
them, with a higher amount of cells positive to SSEA4, suggesting that, albeit ovine 
iPSCs have a morphology resembling that of mouse ESCs, their expression profile 
may be more similar to that of human ESCs. 
After verifying that the transgenes were integrated into the different ovine iPSC 
lines, a RT-PCR was performed on ovine iPSCs to evaluate whether the 
reprogramming factors were still expressed: 4 out of 8 clones still expressed all 4 
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genes, while in 2 clones only one transgene was silenced, with the remaining 2 
clones only expressing Oct4 (whose level was extremely low in the G2 cell line). 
Since the other clones had a strong expression, we supposed that the weak Oct4 
expression found in G2 cells may be derived from only few cells that were not 
reprogrammed and strongly expressed the protein, even though we cannot exclude 
that all cells still expressed Oct4 at low level. Silencing of the transgenes is 
considered the final proof that full reprogramming had happened, at least in mouse 
ESCs. Silencing of the transgenes had not been accomplished in ovine or in porcine 
species so far. 
 
The ovine cells were allowed to spontaneously differentiate in vitro in suspensions 
for about 5 days, until large EBs developed. The EBs were then plated and the 
outgrowths were allowed to spontaneously differentiate. Immunocytochemistry 
showed that the ovine iPSCs were able to give rise to cells belonging to the three 
germ layers, even though the differentiation potential was reduced when compared to 
mouse ESCs: for example beating cardiomyocyte which I had observed during 
mouse ESC and iPSC differentiation, were not seen for ovine iPSCs and I could not 
detect any troponin T staining. 
 
7.1.4 In vivo characterisation of ovine induced pluripotent stem cells 
The in vivo differentiation confirmed the in vitro data; teratomas generated by the 
injection of the ovine iPSCs formed primitive structures in some areas, yet the 
neoplastic tissue was mainly very naïve; on the other hand the control experiment 
performed employing mouse ESCs showed the formation of a wide variety of cells 
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belonging to different tissues, confirming the assay was effective. Although looking 
mostly embryonic, immunohistochemistry confirmed that our ovine iPSCs are able to 
differentiate along the three germ lineages and are therefore pluripotent. 
Since no literature is available on ESCs from sheep and only two studies have been 
published on ovine iPSCs, we cannot determine if the limited potential of our iPSCs 
compared to that of mouse cells depends upon a not complete reprogramming of the 
cells, wrong culture conditions applied to the differentiating cells or it is intrinsic of 
pluripotent cells in sheep. 
 
Finally, ovine iPSCs were injected in early stage embryos where they demonstrated 
the ability to contribute to animals, although the contribution of the ovine iPSCs in 
live born animals was very low. While our ovine iPSCs have a normal karyotype and 
show features similar to that of ESCs (such as morphology, population doubling time 
and ability to differentiate in vitro and in vivo) very little is known about the 
development of the early embryo in sheep. Growth conditions are likely to play a 
role in this; for example mouse EpiSCs, grown in a medium similar to that employed 
for human ESCs, have been shown to seldom contribute to chimeras (Brons, 2007; 
Tesar, 2007). Optimization of culture conditions for the maintenance of ovine iPSCs 
may be pivotal for the achievement of a higher contribution of the cells to chimeric 
animals. 
 
7.1.5 Comparison with induced pluripotent stem cells from other species 
The establishment of pluripotent cells from species different from mouse has 
remained an elusive goal for many years. Human ESCs were derived in 1998, about 
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20 years after the generation of the mouse counterparts, while the isolation of rat 
ESCs was reported only 3 years ago. The establishment of authentic ESCs from 
ungulates has never been achieved; the derivation of pluripotent cells from those 
animals has been hampered by the costs and the technical challenges of the embryo 
production in these species: while many mouse embryos can be obtained in a short 
amount of time and with relative low expenses, the in vitro fertilization necessary to 
obtain blastocysts from these commercially-important livestock species is a costly 
process, the number of embryos is limited and the timing is longer. 
 
The generation of iPSCs has circumvented the need for a large number of animals 
and is seen as a useful alternative to the blastocyst-derived pluripotent cells. The first 
report describing the derivation of iPSCs from ungulates was published in 2009 
(Esteban, 2009), 3 years after Takahashi and Yamanaka’s original study. Esteban and 
his group transduced porcine foetal fibroblasts (PFFs) isolated from Tibetan 
miniature pig with MoML viral vectors carrying the four original reprogramming 
factors; they employed three different media (mouse ESC medium, human ESC 
medium and a mixture of the two conditions) and at day 8-10 observed that colonies 
were generated in all conditions, but at day 16 these colonies were maintained only 
in human ESC conditions. These pig iPSCs showed human ESC-like morphology 
(colonies with clear-cut borders and with flat cells). They were positive to AP, 
SSEA4, Nanog, Rex1, endogenous Sox2 and Lin28 and had an increased TERT 
expression compared with the parental cells. Esteban’s iPSCs were also able to give 
rise to teratomas, but did not achieve the silencing of the transgenes. 
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Esteban’s study was shortly followed by other three reports employing a similar 
approach (Ezashi, 2009; Wu, 2009; West, 2010): cells were transduced with 
lentivirus carrying different combinations of the reprogramming factors: the four 
original factors in Ezashi’s study, the four factors plus Nanog and Lin28 in West’s 
report and both combinations in Wu’s work. The iPSCs derived were maintained in 
human ESC cell culture medium. 
The cells generated by the different groups did not have identical phenotypes, at least 
in terms of morphology and markers. The porcine iPSCs generated by Wu et al were 
positive to SSEA3, SSEA4 and Tra-1-81, but negative to SSEA1, while the cells 
generated by West et al were mainly negative to both SSEA4 and 
Tra-1-81. Esteban’s cells also were negative to SSEA4, while Ezashi et al only 
stained for Oct4, Nanog and Sox2. 
Notwithstanding these differences, all cell lines were able to differentiate along the 
three germ layers and one group also reported the production of chimeric offspring 
(West, 2010); however, no groups were able to maintain the cells in an 
undifferentiated state without continued expression of the reprogramming factors. 
 
Early this year the first description of ovine iPSCs was reported (Bao, 2011; Li, 
2011) by two groups employing different combinations of the pluripotent factors: 
Bao et al utilised Oct4, Sox2, cMyc, Klf4, Nanog, Lin28, SV40 large T and hTERT 
and stated in their hands it was not possible to generate the ovine iPSCs using only 
the four original genes; however shortly afterward, Li et al reported the establishment 
of ovine iPSCs employing only cMyc, Klf4, Oct4 and Sox2. 
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Bao’s cells were positive to many markers of pluripotency (AP, Oct4, Nanog, Sox2, 
Rex1, SSEA1, TRA-1-60, TRA-1-81 and E-cadherin); Li’s iPSCs were positive to 
AP, Oct4, Sox2, Nanog and SSEA4. The morphology of the cells reflected the 
expression pattern of the surface markers: Bao’s cells, which were positive to SSEA1 
and mouse-like, while Li’s cells, positive to SSEA4, had a morphology more similar 
to that of human ESCs. Both groups demonstrated that the iPSCs were capable of 
cellular differentiation in vitro and in vivo. However like porcine iPSCs, maintenance 
of the cells in an undifferentiated state required continual transgene expression. 
 
The iPSCs I have generated have a morphology similar to that of mouse ESCs, stain 
for AP and Nanog, but only few cells are positive to SSEA1 and SSEA4. These cells 
are also able to give rise to cells belonging to the three germ layers both in vitro and 
in vivo and can contribute to live animals when injected into early stage embryos. 
Moreover, in contrast to the previous reports, my ovine iPSCs were able to 
substantially silence the transgenes. 
 
Likewise porcine iPSCs, ovine iPSCs generated by the different groups express 
dissimilar markers of pluripotency; yet they are able to differentiate towards all 
lineages in vitro and in vivo. The reason may stem from the different breed of the 
animals employed, from the stage of the parental cell lines (adult versus foetal) or 
from the differences of the medium utilised for the derivation and the maintenance. 
Also horse iPSCs have been reported (Nagy, 2011). Equine iPSCs are positive to AP, 
Oct4, Nanog, SSEA1, SSEA4, TRA-1-60 and TRA-1-81, but only one report is 
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available, it is not therefore possible to estimate whether cells derived by different 
groups in this species have distinct expression profiles as happens in pig and sheep. 
 
As said above, iPSCs from ungulates able to give rise to chimeras have already been 
established (West, 2010); however, they were derived from porcine mesenchymal 
stem cells and employing six reprogramming factors (the original cMyc, Klf4, Oct4 
and Sox2 with the addition of Nanog and Lin28). We now report the first 
demonstration that iPSCs derived from a differentiated non rodent cell type 
(fibroblast) by employing the four Takahashi and Yamanaka’s genes can contribute 
to live born following blastocyst injection. 
 
Since ESCs from sheep have not been established yet, these ovine iPSCs hold great 
promise for the understanding of how pluripotency functions in species other than 
mouse, rat and human. They may also allow the production of transgenic modified 
animals which could be employed to study disease which are not reproducible in 
mouse or simply for agricultural purposes. 
 
7.2 Conclusions 
In conclusion we demonstrated that the Takahashi and Yamanaka’s protocol for the 
establishment of iPSCs in mouse (Takahashi and Yamanaka, 2006) can be 
successfully applied also to the sheep. Indeed we have generated ovine iPSCs which 
have a morphology and a population doubling time similar to that of mouse ESCs, 
stain for markers of pluripotency and can differentiate along the three lineages both 
in vitro and in vivo. Those cells have maintained their pluripotency and a normal 
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karyotype over more than 24 passages and were able to contribute to live animals 
after injection in ovine blastocysts, albeit at low level. 
 
Although many assays were performed to characterise the ovine iPSCs generated, 
numerous other tests should have been carried out in order to achieve a better 
depiction of the features of the cells. An important trait in iPSC establishment is the 
ability of the differentiated cells to reactivate the expression of the endogenous 
counterparts of the exogenous factors upon reprogramming. While the 
immunocytochemistry would not be able to discern between viral and cellular genes, 
a RT-PCR specific for the ovine sequences could be easily performed. 
Microarrays comparing the whole gene expression profile of the ovine iPSCs to the 
parental OFFs, to the ovine ICM and to mouse ESCs would give an interesting data, 
useful to evaluate whether the generated ovine iPSCs are similar to the ovine 
pluripotent cells in the embryo and have characteristics comparable to ESCs in 
mouse. 
 
The generation of iPSCs from sheep hold great promise for the understanding of the 
mechanisms at the bases of pluripotency in species other than mouse, rat and human; 
beside, ovine iPSCs can be exploited for the generation of animal models for human 
disease which do not have a correspondence in the species normally employed for 
this purpose. 
 
Although the establishment of ovine iPSCs able to contribute to chimeras is a 
significant step forward, the generation of iPSCs with higher ability to contribute to 
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the offspring would be desirable in order to have a more efficient platform for the 
derivation of transgenic animals for research and medical purposes. 
Increasing the efficiency of iPSC generation through the optimization of the current 
protocol or the use of a lentiviral-mediated protocol could be useful; however the 
generation of ovine iPSCs by employing integrating viral vectors to drive the 
expression of the reprogramming factors does not allow full exploitation of the 
potential of the cells either in research or in the clinical field. Ovine iPSCs derived 
without the use of integrating vectors or even with proteins may provide a valuable 
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Ovine iPSCs were established and maintained on SNL feeder layer. SNL cells are 
STO cells (immortalised MFFs) that were genetically modified in order to express 
mouse LIF and neomycin phosphotransferase (McMahon and Bradley, 1990). As 
reported in the general introduction, LIF is the key cytokine for the maintenance of 
mouse ESCs in their pluripotent state, I therefore aimed to understand whether LIF 




Through RT-PCR I first confirmed that the SNL cells expressed LIF (Fig. 50a). I 
then grew the ovine iPSCs on SNL feeder layer or gelatin, in order to address 
whether the iPSCs undergo differentiation without supplementation of LIF (Fig. 
50b). Ovine iPSCs maintained on SNLs retained their pluripotency, while the same 
cells growing on gelatin showed a strong weakening of AP staining, which is the first 
signal of cell differentiation. 
The addition of exogenous LIF, which rescued mouse ESCs growing on gelatin, did 
not produced the same outcome on the sheep cells. This suggests that the mouse LIF 
does not have an effect on the ovine iPSCs. 
 
In order to confirm that LIF is not able to trigger a response in sheep I performed an 
induction assay: as already mentioned in the general introduction, LIF fulfils its role 
by binding to the heterodimer composed by LIFR and gp130, which in turn induces 
STAT3 phosphorylation; therefore measuring the proportion of phospho-STAT3 






Figure 50. (a) RT-PCR showed that SNL feeder cells express LIF; no band was detected in the no 
template control (NTC). (b) LIF withdrawal assay: ovine iPSCs were grown in human ESC medium 
on SNL feeders or gelatin; the cells were cultured both in presence or absence of exogenous LIF and 
mouse ESCs were employed as control. (c) LIF induction assay: ovine iPSCs and OFFs were starved 
for 4h and induced with LIF for 10min, the cells were then lysed in the wells and collected; the lysate 
was employed in a western blotting where phospho-STAT3 levels were evaluated, while STAT3 and 
βactin were utilised as loading controls. LIF-induced mouse ESCs and MFFs represented the positive 




A STAT3 induction assay was performed on ovine iPSCs and OFFs: the cells were 
initially starved for 4h with medium depleted of bFGF and SR; then the medium was 
replaced with induction medium, which was composed of starving medium with the 
addition of 1000U/ml of mouse LIF. For each cell line a non-induced negative 
control was performed. The Western blotting (Fig. 50c) against STAT3 and 
phospho-STAT3 (pSTAT3) revealed that the assay had worked: indeed both positive 
controls (mouse ESCs and MFFs) strongly increased the proportion of pSTAT3 upon 
treatment with LIF. The OFFs showed a very low amount of STAT3, which was 
consistent with the result obtained in MFFs; in contrast to the mouse, however, the 
LIF-induced OFFs did not display any rise in the phospho-STAT3 proportion 
compared to the untreated controls. This might suggest that ovine cells do not 
respond to mouse LIF. Yet the result obtained with the ovine iPSCs was unexpected: 
while no difference was detectable in the phospho-STAT3/ STAT3 ratio between 
induced and non-induced cells, the induction increased the amount of both 
phosphorylated and unphosphorylated proteins. 
 
Conclusions 
While SNL cells truly expressed LIF and were able to maintain mouse ESCs 
proliferating without loss of phenotype, the LIF withdrawal assay demonstrated that 
that ovine iPSCs do not respond to it. A STAT3 induction assay was performed in 
order to confirm this data, but, instead, generated an unpredicted result: while mouse 
cells (ESCs and MFFs) and OFFs reacted as expected, the ovine iPSCs did not: while 
the proportion of phospho-STAT3 over STAT3 was not different in induced or non-
induced ovine iPSCs, the use of an additional loading control (βactin) indicated that 




of the assay was performed, this may be the result of errors happened during the 
induction assay, even though the other cell lines responded as expected; furthermore, 
also the βactin control of the induced iPSCs did not show any anomaly, nor did the 
non-induced ovine iPSCs. 
The antibodies did not present any issues either, since they successfully worked for 
the other cell lines, nor could it be a species matter, since the antibodies stained the 
OFFs and the non-induced iPSCs as expected. 
 
In some cell lines STAT3 autoregulates its own expression, acting through a 
composite response element in its promoter that contains a STAT3-binding element 
(Narimatsu, 2001). It is therefore possible that in ovine iPSCs LIF does not induce 
the phosphorylation of STAT3, but its synthesis. 
Since it is demonstrated that also the unphosphorylated form of STAT3 can drive a 
wave of gene expression (Yang, 2005), our data do not allow us to conclude whether 
the mouse LIF produced by the SNL feeder layer influences the pluripotency of the 
ovine iPSCs. The assay should be repeated in order to exclude a possible error during 
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